
<html lang="en"     class="pb-page"  data-request-id="6c4d2681-a206-4b0c-b0f7-40f7bc16d801"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm201322r;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2012.55.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors" /></meta><meta name="dc.Creator" content="Kevin X.  Chen" /></meta><meta name="dc.Creator" content="Charles A.  Lesburg" /></meta><meta name="dc.Creator" content="Bancha  Vibulbhan" /></meta><meta name="dc.Creator" content="Weiying  Yang" /></meta><meta name="dc.Creator" content="Tin-Yau  Chan" /></meta><meta name="dc.Creator" content="Srikanth  Venkatraman" /></meta><meta name="dc.Creator" content="Francisco  Velazquez" /></meta><meta name="dc.Creator" content="Qingbei  Zeng" /></meta><meta name="dc.Creator" content="Frank  Bennett" /></meta><meta name="dc.Creator" content="Gopinadhan N.  Anilkumar" /></meta><meta name="dc.Creator" content="Jose  Duca" /></meta><meta name="dc.Creator" content="Yueheng  Jiang" /></meta><meta name="dc.Creator" content="Patrick  Pinto" /></meta><meta name="dc.Creator" content="Li  Wang" /></meta><meta name="dc.Creator" content="Yuhua  Huang" /></meta><meta name="dc.Creator" content="Oleg  Selyutin" /></meta><meta name="dc.Creator" content="Stephen  Gavalas" /></meta><meta name="dc.Creator" content="Haiyan  Pu" /></meta><meta name="dc.Creator" content="Sony  Agrawal" /></meta><meta name="dc.Creator" content="Boris  Feld" /></meta><meta name="dc.Creator" content="Hsueh-Cheng  Huang" /></meta><meta name="dc.Creator" content="Cheng  Li" /></meta><meta name="dc.Creator" content="Kuo-Chi  Cheng" /></meta><meta name="dc.Creator" content="Neng-Yang  Shih" /></meta><meta name="dc.Creator" content="Joseph A.  Kozlowski" /></meta><meta name="dc.Creator" content="Stuart B.  Rosenblum" /></meta><meta name="dc.Creator" content="F. George  Njoroge" /></meta><meta name="dc.Description" content="Starting from indole-based C-3 pyridone HCV NS5B polymerase inhibitor 2, structure–activity relationship (SAR) investigations of the indole N-1 benzyl moiety were performed. This study led to the d..." /></meta><meta name="Description" content="Starting from indole-based C-3 pyridone HCV NS5B polymerase inhibitor 2, structure–activity relationship (SAR) investigations of the indole N-1 benzyl moiety were performed. This study led to the d..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 22, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201322r" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201322r" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201322r" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201322r" /></link>
        
    
    

<title>A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201322r" /></meta><meta property="og:title" content="A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0014.jpeg" /></meta><meta property="og:description" content="Starting from indole-based C-3 pyridone HCV NS5B polymerase inhibitor 2, structure–activity relationship (SAR) investigations of the indole N-1 benzyl moiety were performed. This study led to the discovery of irreversible inhibitors with p-fluoro-sulfone- or p-fluoro-nitro-substituted N-1 benzyl groups which achieved breakthrough replicon assay potency (EC50 = 1 nM). The formation of a covalent bond with adjacent cysteine-366 thiol was was proved by mass spectroscopy and X-ray crystal structure studies. The C-5 ethyl C-2 carboxylic acid derivative 47 had an excellent oral area-under-the-curve (AUC) of 18 μM·h (10 mg/kg). Its oral exposure in monkeys and dogs was also very good. The NMR ALARM assay, mass spectroscopy experiments, in vitro counter screening, and toxicology assays demonstrated that the covalent bond formation between compound 47 and the protein was highly selective and specific. The overall excellent profile of 47 made it an interesting candidate for further investigation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201322r"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201322r">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201322r&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201322r&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201322r&amp;href=/doi/10.1021/jm201322r" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2089-2101</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm2012694" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm2013375" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+X.++Chen">Kevin X. Chen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+A.++Lesburg">Charles A. Lesburg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bancha++Vibulbhan">Bancha Vibulbhan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weiying++Yang">Weiying Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tin-Yau++Chan">Tin-Yau Chan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Srikanth++Venkatraman">Srikanth Venkatraman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francisco++Velazquez">Francisco Velazquez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qingbei++Zeng">Qingbei Zeng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Bennett">Frank Bennett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gopinadhan+N.++Anilkumar">Gopinadhan N. Anilkumar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jose++Duca">Jose Duca</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yueheng++Jiang">Yueheng Jiang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Pinto">Patrick Pinto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Wang">Li Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuhua++Huang">Yuhua Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oleg++Selyutin">Oleg Selyutin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Gavalas">Stephen Gavalas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haiyan++Pu">Haiyan Pu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sony++Agrawal">Sony Agrawal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Boris++Feld">Boris Feld</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hsueh-Cheng++Huang">Hsueh-Cheng Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Li">Cheng Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kuo-Chi++Cheng">Kuo-Chi Cheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Neng-Yang++Shih">Neng-Yang Shih</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+A.++Kozlowski">Joseph A. Kozlowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuart+B.++Rosenblum">Stuart B. Rosenblum</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F.+George++Njoroge">F. George Njoroge</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Drug Design, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div><div class="corresp-info"><strong>*</strong>Telephone: 732-662-1333. Fax: 908-740-7556. E-mail: <a href="/cdn-cgi/l/email-protection#4823302b26083129202727662b2725"><span class="__cf_email__" data-cfemail="254e5d464b655c444d4a4a0b464a48">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201322r&amp;href=/doi/10.1021%2Fjm201322r" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2089–2101</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 16, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 October 2011</li><li><span class="item_label"><b>Published</b> online</span>22 February 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 March 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201322r" title="DOI URL">https://doi.org/10.1021/jm201322r</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2089%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKevin%2BX.%2BChen%252C%2BCharles%2BA.%2BLesburg%252C%2BBancha%2BVibulbhan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D5%26contentID%3Djm201322r%26title%3DA%2BNovel%2BClass%2Bof%2BHighly%2BPotent%2BIrreversible%2BHepatitis%2BC%2BVirus%2BNS5B%2BPolymerase%2BInhibitors%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2101%26publicationDate%3DMarch%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201322r"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2163</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201322r" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;A Novel Class of Highly Potent Irreversible Hepatitis C Virus NS5B Polymerase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;X. Chen&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;A. Lesburg&quot;},{&quot;first_name&quot;:&quot;Bancha&quot;,&quot;last_name&quot;:&quot;Vibulbhan&quot;},{&quot;first_name&quot;:&quot;Weiying&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Tin-Yau&quot;,&quot;last_name&quot;:&quot;Chan&quot;},{&quot;first_name&quot;:&quot;Srikanth&quot;,&quot;last_name&quot;:&quot;Venkatraman&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Velazquez&quot;},{&quot;first_name&quot;:&quot;Qingbei&quot;,&quot;last_name&quot;:&quot;Zeng&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Bennett&quot;},{&quot;first_name&quot;:&quot;Gopinadhan&quot;,&quot;last_name&quot;:&quot;N. Anilkumar&quot;},{&quot;first_name&quot;:&quot;Jose&quot;,&quot;last_name&quot;:&quot;Duca&quot;},{&quot;first_name&quot;:&quot;Yueheng&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Pinto&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Yuhua&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Oleg&quot;,&quot;last_name&quot;:&quot;Selyutin&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Gavalas&quot;},{&quot;first_name&quot;:&quot;Haiyan&quot;,&quot;last_name&quot;:&quot;Pu&quot;},{&quot;first_name&quot;:&quot;Sony&quot;,&quot;last_name&quot;:&quot;Agrawal&quot;},{&quot;first_name&quot;:&quot;Boris&quot;,&quot;last_name&quot;:&quot;Feld&quot;},{&quot;first_name&quot;:&quot;Hsueh-Cheng&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Kuo-Chi&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Neng-Yang&quot;,&quot;last_name&quot;:&quot;Shih&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;A. Kozlowski&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;B. Rosenblum&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;George Njoroge&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;2089-2101&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201322r&quot;},&quot;abstract&quot;:&quot;Starting from indole-based C-3 pyridone HCV NS5B polymerase inhibitor 2, structure–activity relationship (SAR) investigations of the indole N-1 benzyl moiety were performed. This study led to the discovery of irreversible inhibitors with p-fluoro-sulfone- or p-fluoro-nitro-substituted N-1 benzyl groups which achieved breakthrough replicon assay potency (EC50 = 1 nM). The formation of a covalent bond with adjacent cysteine-366 thiol was was proved by mass spectroscopy and X-ray crystal structure studies. The C-5 ethyl C-2 carboxylic acid derivative 47 had an excellent oral area-under-the-curve (AUC) of 18 μM·h (10 mg/kg). Its oral exposure in monkeys and dogs was also very good. The NMR ALARM assay, mass spectroscopy experiments, in vitro counter screening, and toxicology assays demonstrated that the covalent bond formation between compound 47 and the protein was highly selective and specific. The overall excellent profile of 47 made it an interesting candidate for further investigation.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201322r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201322r" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201322r&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201322r" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201322r&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201322r" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201322r&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201322r&amp;href=/doi/10.1021/jm201322r" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201322r" /></input><a href="/doi/pdf/10.1021/jm201322r" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201322r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201322r%26sid%3Dliteratum%253Aachs%26pmid%3D22247956%26genre%3Darticle%26aulast%3DChen%26date%3D2012%26atitle%3DA%2BNovel%2BClass%2Bof%2BHighly%2BPotent%2BIrreversible%2BHepatitis%2BC%2BVirus%2BNS5B%2BPolymerase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D5%26spage%3D2089%26epage%3D2101%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291862" title="Indoles">Indoles</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jmcmar.2012.55.issue-5/production/jmcmar.2012.55.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201322r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Starting from indole-based C-3 pyridone HCV NS5B polymerase inhibitor <b>2</b>, structure–activity relationship (SAR) investigations of the indole N-1 benzyl moiety were performed. This study led to the discovery of irreversible inhibitors with <i>p</i>-fluoro-sulfone- or <i>p</i>-fluoro-nitro-substituted N-1 benzyl groups which achieved breakthrough replicon assay potency (EC<sub>50</sub> = 1 nM). The formation of a covalent bond with adjacent cysteine-366 thiol was was proved by mass spectroscopy and X-ray crystal structure studies. The C-5 ethyl C-2 carboxylic acid derivative <b>47</b> had an excellent oral area-under-the-curve (AUC) of 18 μM·h (10 mg/kg). Its oral exposure in monkeys and dogs was also very good. The NMR ALARM assay, mass spectroscopy experiments, in vitro counter screening, and toxicology assays demonstrated that the covalent bond formation between compound <b>47</b> and the protein was highly selective and specific. The overall excellent profile of <b>47</b> made it an interesting candidate for further investigation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hepatitis C virus (HCV) has infected an estimated 3% of the world’s population (over 170 million people).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The slow progression and mild symptoms of the HCV infection make it a stealth epidemic. Most infections progress to a chronic state that persists for decades and eventually lead to cirrhosis, liver failure, or liver cancer.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The new standard of care (SOC) after recent protease inhibitor approval involves the combination of a protease inhibitor with pegylated-interferon and the oral nucleoside antiviral agent ribavirin.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The outcome of the treatment is defined by the sustained virologic response (SVR) or undetectable HCV RNA in serum at the end of treatment and six-months post treatment. The SVR rate for patients with the most-difficult-to-treat genotype-1 HCV is about 70% with the new current therapy.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Large pill-burden (750–800 mg, three times a day), relapse (mutations), and discontinuation due to the presence of side effects with these therapies necessitates the need for safe and more effective HCV treatments.</div><div class="NLM_p">Hepatitis C virus was identified more than two decades ago.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> It belongs to the Flaviviridae family of enveloped viruses. It is a positive-sense single-stranded RNA virus with a single open frame of ∼9600 nucleosides. The viral genome encodes a polyprotein of more than 3000 amino acids. The polyprotein is divided into structural and nonstructural precursor regions. The structural protein contains the nucleocapsid core protein (C) and two glycoproteins E1 and E2 (NS1). The nonstructural (NS) proteins located downstream are NS2, NS3, NS4A, NS4B, NS5A, and NS5B. Because of their essential role in the replication of HCV virus, intensive research has been focused on finding drugs which directly target these nonstructural proteins.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Exciting progress has been made in these endeavors.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Recent clinical trials have demonstrated dramatic improvements in SVR rate in patients treated with a direct-acting agent in combination with standard of care.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Recent approval of the two HCV NS3 protease inhibitors boceprevir<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (Victrelis, Merck & Co.) and telaprevir<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (Incivek, Vertex Pharmaceuticals) by the FDA have generated great excitement for the new treatments of HCV infection. Several other NS3 protease inhibitors and a number of candidates targeting other nonstructural enzymes are also under development.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">The HCV NS5B gene encodes an RNA-dependent RNA polymerase (RdRp) whose enzymatic activity is critical to the replication of the viral RNA genome.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Replication of the plus-strand RNA viral genome consists of two steps: synthesis of the complementary negative-strand RNA using the positive-strand RNA as a template, and the subsequent synthesis of multiple positive-strand RNA genome using the minus-strand RNA as a template. Besides its direct role in the replication of viral RNA genome, the HCV NS5B polymerase is potentially associated with a number of other important functions. It forms a replicase complex (RC) with other HCV nonstructural proteins (NS3, NS4A, NS4B, and NS5A) and a number of cellular cofactors during replication.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> It was also suggested that NS5B might regulate the function of other HCV enzymes. The crystal structure of the catalytic domain of N5SB has revealed several significant features.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The polymerase shares many common features of other polymerases with characteristic thumb, finger, and palm domains analogous with a right-hand. In addition to a well-conserved active site (located in the palm domain) for nucleoside binding, mechanistic and structural studies have revealed the existence of multiple allosteric inhibitor binding sites.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Binding to these sites interferes with conformational changes required during RNA synthesis. Thumb pockets I and II are two allosteric sites thatz are located in thumb domain while palm site I and II are two pockets located adjacent to the active site. These thumb and palm region sites have been the targets for drug development, which makes the NS5B a particularly drugable target.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a></div><div class="NLM_p">Extensive efforts directed at inhibiting HCV NS5B polymerase have resulted in numerous drug candidates. They belong to two distinctive classes of inhibitors: nucleoside active site inhibitors (NIs) and non-nucleoside allosteric inhibitors (NNIs).<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> They target different stages of RNA synthesis.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> NNIs were shown to interfere with steps prior to or during the initiation of RNA synthesis. In contrast, the triphosphate form of NIs binds to the active site during elongation. NIs are analogues of natural substrates of the polymerase that are incorporated into the growing RNA chain leading to chain termination. These agents require phosphorylation before being active. Because NS5B is a highly conserved region of the HCV genome, NIs have similar activity against all genotypes and a high genetic barrier to resistance.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Several NIs have advanced into clinical trials, including prodrugs valopicitabine (Idenix), R1626 (Roche), RG-7128 (Pharmasset/Roche), PSI-7977 (Pharmasset), PSI-352938 (Pharmasset), IDX-184 (Idenix), and INX-189 (Inhibitex).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> NNIs, on the other hand, achieve NS5B inhibition by binding to one of at least four allosteric enzyme sites, resulting in conformational changes which alter the protein-inhibiting catalytic activity of polymerase. A number of clinical candidates have been identified.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Among them, HCV-796 (Wyeth/Viropharma),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> filibuvir (Pfizer),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> VX-222 (Vertex/Virochem),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> ANA598 (Anadys),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> BI207127 (Boehringer Ingelheim),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and BMS-791325 (Bristol-Myers Squibb)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> have progressed to phase II clinical trials. The rapid development of resistant mutants has been observed with NNIs because they bind distantly to the active center of NS5B, and mutations at the NNI binding site may not necessary lead to impairment of the enzyme function.</div><div class="NLM_p">Our early research effort on the optimization of an indole-based screening hit led to compound <b>1</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> It had good potency (IC<sub>50</sub> = 53 nM) in an NS5B RdRp enzyme assay.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> It was active in a cell-based replicon assay<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> with an EC<sub>50</sub> of 4800 nM). The X-ray structure of <b>1</b> in complex with NS5B indicated that it bound to a NS5B apoprotein cavity adjacent to the active site at the 'palm’ site of the protein.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Further SAR studies were carried out to improve potency, especially replicon assay potency. Since compound <b>1</b> had poor pharmacokinetic (PK) properties with very low AUC value when dosed orally in rats, it was also desirable to improve PK properties through structural modifications. Because the X-ray structure of <b>1</b> also revealed that the C-3 pyridone carbonyl and N-H formed hydrogen bonds with the backbone isoleucine-447 residue, it was decided to leave this moiety intact while changes were made at other substitutions at the indole core. After considerable effort, new structures such as compound <b>2</b> with much improved potency and PK profiles emerged as the new lead series.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The indole core of inhibitor <b>2</b> was substituted by a methyl at C-5 and a cyclopropyl acylsulfonamide at C-2. The indole nitrogen was substituted by a 2′,5′-difluorobenzyl group. A 7-fold improvement in enzyme potency to an IC<sub>50</sub> of 6 nM was observed, probably as a result of increased hydrophobic interactions with the enzyme surface from the C-5 and N-1 substituents. More importantly, this compound demonstrated greatly improved (50-fold) activity in replicon assay with an EC<sub>50</sub> of 90 nM. Compound <b>2</b> also had an improved AUC of 9.1 μM·h in rats following 10 mg/kg oral dosing. Despite its good overall profile, further improvement in compound <b>2</b> is required to have a drug candidate, particularly in the potency in the cellular assay. Thus, the optimization of the indole series of inhibitors continued. Herein, we report our SAR development and the discovery of a novel class of irreversible highly potent HCV NS5B polymerase inhibitors.(see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>.)</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead compounds from early SAR studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201322r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Synthesis of HCV NS5B Polymerase Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The general synthesis of inhibitors is outlined in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The ethyl indole-2-carboxylate starting material <b>3</b>, with desired substituents at the 4-, 5-, and 6-position, was either commercially available or could be prepared via known procedures. The intermediate <b>3</b> was iodinated at C-3 with <i>N</i>-iodosuccinimide (NIS) to give compound <b>4</b>. The Suzuki–Miyaura cross-coupling reaction<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> between <b>4</b> and 2-methoxy-3-pyridineboronic acid in the presence of a palladium catalyst afforded product <b>5</b>. The indole nitrogen was then alkylated to provide compound <b>6</b> through alkylation with a benzylic halide. The ethyl ester was hydrolyzed to its corresponding carboxylic acid <b>7</b>, which, after activation by carbonyl diimidazole (CDI), was converted to an acylsulfonamide <b>8</b> through reaction with a primary alkylsulfonamide.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The methoxypyridine <b>8</b> was then demethylated to afford pyridone <b>9</b> upon treatment with hydrochloric acid. The final compounds were tested in RdRp enzyme assay and replicon cell-based assay.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201322r&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) NIS, CHCl<sub>3</sub>; (b) 2-methoxy-3-pyridineboronic acid, PdCl<sub>2</sub>(dppf)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,2-dimethoxyethane, 50–85% (two steps); (c) ArCH<sub>2</sub>Br (or ArCH<sub>2</sub>Cl), Cs<sub>2</sub>CO<sub>3</sub>, DMF, 40–90%; (d) LiOH, THF/H<sub>2</sub>O, 60–90%; (e) CDI, then RSO<sub>2</sub>NH<sub>2</sub>, DBU, THF, 50–80%; (f) 4 M HCl, dioxane, 30–60%.</p></p></figure><div class="NLM_p">Alternatively, the indole-2-acylsulfonamide series of polymerase inhibitors were prepared according to the procedures shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Compound <b>5</b> was treated with hydrochloric acid to provide C-3 pyridone product <b>10</b>, which was hydrolyzed to its corresponding C-2 carboxylic acid <b>11</b>. The acid was activated with EDC and cyclized intramolecularly to the pyridone to form the tetracyclic lactone <b>12</b>. The indole nitrogen was then alkylated with either a benzylic halide similar to the conversion of <b>5</b> to <b>6</b>, or via a Mitsunobu reaction<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> with a benzylic alcohol. The resulting lactone product <b>13</b> was either reacted with a sulfonamide in the presence of 1,8-diazabicyclocundec-7-ene (DBU) to give the desired acylsulfonamide analogue <b>9</b>, or hydrolyzed with lithium hydroxide to carboxylic acid inhibitor <b>14</b>. The products <b>9</b> and <b>14</b> were then evaluated in enzyme and replicon assays to determine their biological activities.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201322r&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) 4 M HCl, dioxane; (b) LiOH, THF/H<sub>2</sub>O; (c) EDC, NEt<sub>3</sub>, DMF, 60–90%; (d) ArCH<sub>2</sub>Br (or ArCH<sub>2</sub>Cl), Cs<sub>2</sub>CO<sub>3</sub>, DMF; or ArCH<sub>2</sub>OH, DIAD, PPh<sub>3</sub>, THF, 60–90%; (e) RSO<sub>2</sub>NH<sub>2</sub>, DBU, DMF, 30–60%; (f) LiOH, THF/H<sub>2</sub>O, 20–60%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although lead compound <b>2</b> had an overall good profile, better potency was desired for a potential drug development candidate. Several modifications attempted at the indole core failed to improve the potency of the resulting inhibitors. We decided to keep the indole core intact but to make changes at substituents that attached to various positions of the indole ring system. Thus, to optimize the indole N-1 substituent, a number of benzyl type structures with various substitution patterns were examined. Results from selected examples are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. Compound <b>15</b> had only one fluoro group at the 2′-position and had slightly better potency in both RdRp enzyme (EC<sub>50</sub> = 50 nM) and replicon cell-based assays (EC<sub>50</sub> = 50 nM) than that of the benchmark compound <b>2</b> which had two fluoro substitutions at the 2′,5′-positions. When an additional methyl was introduced to C-3′ of <b>15</b>, the activity of compound <b>16</b> against enzyme improved even further to an IC<sub>50</sub> of 4 nM. However, its replicon assay potency decreased to an EC<sub>50</sub> of 380 nM probably due to some unfavorable interactions from 3′-methyl group. Analogue <b>17</b> had the same N-1 4-(2′-aminopyridine)methyl moiety as that of compound <b>1</b>. It maintained enzyme activity (IC<sub>50</sub> = 6 nM) but lost even more cellular potency (EC<sub>50</sub> = 500 nM). Further exploration at the 5′-substitution was also conducted to search for a group that was capable of establishing additional interactions with nearby protein backbone residues. Toward that end, moieties with different functionalities were examined. A 5′-nitrile group in compound <b>18</b> caused a drop in both enzyme and replicon potency (IC<sub>50</sub> = 9 nM, EC<sub>50</sub> = 220 nM) when compared to 5′-nonsubstituted <b>15</b>. The 5′-primary amide analogue <b>19</b> faired better in the enzyme assay (IC<sub>50</sub> = 4 nM) but lost activity in the replicon assay by 3-fold.</div><div class="NLM_p">Several analogues with a sulfonyl moiety para to the fluoro group were also prepared (<b>20</b> to <b>22</b>). The compound bearing a C-5′-methyl sulfone (<b>20</b>) maintained a good IC<sub>50</sub> of 6 nM while losing significant cellular assay activity (EC<sub>50</sub> = 580 nM). The primary sulfonamide derivative <b>21</b> did not provide any improvement, having almost the same IC<sub>50</sub> and EC<sub>50</sub>. When an additional nitrile group was introduced at C-3′ however, dramatic changes in potency were observed. The 3′-nitrile-5′-methyl sulfone analogue <b>22</b> not only gave a better IC<sub>50</sub> of 3 nM but also provided a much better EC<sub>50</sub> (5 nM) in the replicon assay. The 100-fold improvement in cellular potency compared to <b>20</b> cannot be easily explained by any extra simple contact(s) established by the nitrile group, and there was a possibility that some unusual interaction(s) had occurred when this additional nitrile group was present. Looking at the structure, one could make an educated guess from chemistry knowledge and literature that two strong electron-withdrawing-groups at para-and ortho-positions could have made the fluoro substituent very susceptible to attack by an adjacent nucleophile. By checking out the amino acid residues of the enzyme backbone in the region to where the benzyl group was bound, cysteine-366 appeared to be within attacking distance. The thiol of cysteine-366 could replace the fluoro atom to form a covalent irreversible sulfide bond with the benzene ring. Although reversible covalent bond formation with cysteine-366 has been reported previously,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> no irreversible inhibitors were ever identified. If the irreversible sulfide bond formation could be confirmed, a new class of covalently bonded HCV NS5B polymerase inhibitors was then discovered. We decided to conduct further investigation into this class of compounds.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Exploration of Potential Irreversible Inhibitors</h3><div class="NLM_p">To explore other phenyl rings that had the potential to form a covalent bond with cysteine-366, a number of N-1 benzyl groups with multiple electron-withdrawing groups were studied (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Leaving groups other than fluoride, such as chloride, were also examined. In compound <b>23</b>, the benzene ring was substituted by 2′-chloro and strongly electron-withdrawing 5′-trifluoromethyl sulfone. However, with an IC<sub>50</sub> of 46 nM and an EC<sub>50</sub> of 900 nM, <b>23</b> was even less potent than that for most noncovalent inhibitors in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and definitely much less potent than that for potential covalent inhibitor <b>22</b>. The less electron-withdrawing trifluoromethyl sulfoxide <b>24</b> was, not surprisingly, even less potent in the replicon assay (EC<sub>50</sub> = 3400 nM) than that of <b>23</b>. The 2′,3′,6′-trifluoro-5′-methylsulfonylbenzene analogue <b>25</b> was also not very potent, although it had a better EC<sub>50</sub> (270 nM) than those of <b>23</b> and <b>24</b>. Apparently, the two extra fluorines were not strong enough electron-withdrawing groups. Similarly, an additional 4′-chloro substituent in <b>26</b> was not sufficient to make the compound susceptible to covalent bonding. But both its enzymatic and cellular potency (IC<sub>50</sub> = 2 nM, EC<sub>50</sub> = 60 nM) improved significantly over other sulfones <b>23</b>–<b>25</b>, probably because of favorable interaction(s) with the 4′-substituent. When the 4′-position was substituted with a cyano group (<b>27</b>), however, the potency was dramatically improved to an EC<sub>50</sub> of 3 nM, even better than that of compound <b>22</b>. Again, it was speculated that the strong electron-withdrawing sulfone and cyano groups made the nucleophilic replacement of 2′-F much easier. The two multisubstituted 5′-sulfonamide or primary amide analogues <b>28</b> and <b>29</b> were, as expected, much less potent inhibitors (EC<sub>50</sub> = 1400 and 3300 nM, respectively) due to the weaker electron-withdrawing ability of sulfonamides, amides and halogens. The fact that C-5 was substituted by an ethyl group in compounds <b>26</b>, <b>27</b>, and <b>28</b> instead of a methyl group in other compounds might have small impact on the IC<sub>50</sub>s and EC<sub>50</sub>s of these inhibitors, but the difference in potency should be quite small based on SAR from other series.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Substitution at the Benzyl Group at the Indole Core N-1 Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0005.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0006.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">Because the nitro group is known to be one of the strongest electron-withdrawing groups, we hoped that it would provide facile covalent bond formation. Indeed, in the presence of the C-5′ nitro group, significant improvement in potency for the 2′-chloro analogue <b>30</b> (EC<sub>50</sub> = 16 nM) was observed compared to <b>23</b> and <b>24</b>. The 5′-nitro-2′-fluoro analogue <b>31</b> had an EC<sub>50</sub> of 1 nM. Simple hydrophobic interactions are unlikely to explain the significant difference in potency among the inhibitors in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Evidence for covalent bond formation from mass spectroscopy and X-ray crystal structure studies will be discussed in the later section.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. NS5B Polymerase Inhibitors<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0007.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0008.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">An asterisk denotes that the C5 substituent was an ethyl group for these inhibitors.</p></div></div><div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Optimization of Substitutions at C-2 and the Pyridone Ring</h3><div class="NLM_p">Because of the increased potency of <i>p</i>-nitro-fluoro-benzyl-substituted compound <b>31</b>, further investigation of more compounds with this N-1 substituent was conducted. Thus, analogues with a series of C-2 moieties were prepared and tested (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The C-2 carboxylic acid derivative <b>32</b> maintained the excellent replicon potency (EC<sub>50</sub> = 1 nM) of compound <b>31</b>. The methyl acylsulfonamide <b>33</b> also proved to be an equally potent inhibitor. Isopropyl acylsulfonamide <b>35</b> and acylsulfinamide <b>36</b>, however, were slightly less potent than that of <b>31</b>–<b>33</b>. Dimethyl acylsulfonylurea inhibitor <b>36</b>, surprisingly, had subnanomolar replicon potency (EC<sub>50</sub> = 0.5 nM), although it was found to be unstable in PK studies and possessed no appreciable AUC in rats.</div><div class="NLM_p">Our early SAR studies indicated that introduction of a methyl substitution at the indole C-3 pyridone ring could improve rodent PK, probably due to less metabolism at the pyridone. A methyl group was introduced to pyridone C-6 of compounds <b>31</b>–<b>33</b> to give compounds <b>37</b>, <b>38</b>, and <b>39</b>, respectively. Unfortunately, acid analogue <b>37</b> lost substantial activity in both enzyme and cellular assays. Although methyl acylsulfonamide <b>38</b> was as active as <b>33</b> in the enzyme assay, it was 8-fold less potent in replicon assay. The cyclopropyl acylsulfonamide analogue <b>39</b> also lost potency in both the enzyme assay (by 2-fold) and replicon assay (by 9-fold). The decrease in potency of in these methyl-substituted pyridone analogues could be attributed to the unfavorable interactions between methyl and the protein backbone (see X-ray structure in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> for protein surface). On the basis of these results, we decided to continue to use the C-2 cyclopropyl acylsulfonamide moiety in further SAR development.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. C-2 and Pyridone Ring Substituent Modifications</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0009.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0010.gif" alt="" id="fx6" /></img><div></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> SAR Development of C-5 and C-6 Substituents</h3><div class="NLM_p">Keeping the N-1, C-2, and C-3 moieties constant, the effects of varying C-5 and C-6 substituents were studied and the results are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Because our previous SAR indicated that the C-5-position cannot tolerate large groups, a number of small and compact substituents were tested in compounds <b>40</b>–<b>45</b>. Compared to benchmark methyl-substituted analogue <b>31</b>, the smaller C-5 substituent such as fluoro decreased activity in the replicon assay (<b>40</b>, EC<sub>50</sub> = 6 nM).A similar loss of potency was observed in nonsubstituted compound <b>41</b>. Although the size of a chloro atom is close to that of a methyl group, C-5 chloro derivative <b>42</b> was still five times less active than that of <b>31</b>. The slightly larger trifluoromethyl group in compound <b>43</b> faired better (EC<sub>50</sub> = 2 nM) with only a 2-fold loss of potency compared to <b>31</b>. The large <i>tert</i>-butyl group in inhibitor <b>44</b> was tolerated as evidenced by the same IC<sub>50</sub> of 6 nM as that of compound <b>31</b>. However, the fact that a 10-fold loss in cellular assay activity (EC<sub>50</sub> of 10 vs 1 nM) was observed could not be easily explained. The slightly larger ethyl group gave excellent potency in both the enzyme and replicon assays (IC<sub>50</sub> = 4 nM and EC<sub>50</sub> = 1 nM, respectively). In summary, the C-5-position preferred small alkyl substituents such as methyl, ethyl, and trifluoromethyl groups. To explore the effect of C-6 substitution, a small fluoro atom was introduced to <b>31</b>, which resulted in compound <b>46</b>. Unfortunately, this substitution caused a 4-fold drop in replicon potency to an EC<sub>50</sub> of 4 nM.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Optimization of C-5 Substitution and the Effect of the C6 Substituent</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0011.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sup>5</sup></th><th class="colsep0 rowsep0" align="center">R<sup>6</sup></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM) (<i>n</i> ≥ 2)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM) (<i>n</i> = 2)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left"><i>t</i>-Bu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">4</td></tr></tbody></table></div></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Investigation of PK Properties of Best Compounds</h3><div class="NLM_p">With the discovery of a number of potent inhibitors with superb potency, the next step was to evaluate their pharmacokinetic properties. Thus, a series of potent and representative compounds were selected for rat PK studies, and some results are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. It was very disappointing to find out that all four C-5 methyl derivatives (<b>31</b>, <b>33</b>, <b>36</b>, and <b>32</b>) with various C-2 acylsulfonamide or carboxylic acid moieties had very low or no AUC when dosed orally in rats at 10 mg/kg. The C-6 fluoro-substituted analogue <b>46</b> was slightly better with an AUC of 0.35 μM·h. The C-5 chloro and ethyl compounds (<b>42</b> and <b>45</b>, respectively) did not provide good exposure with AUCs of 0.30 and 0.17 μM·h, respectively, although they were somewhat better than that of the C-5 methyl compound <b>31</b>. However, it was very gratifying to see good oral exposure (18 μM·h) with compound <b>47</b>, a C-2 carboxylic acid inhibitor. The combination of both potency and good oral exposure in rats led us to further evaluate this compound.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Evaluation of Pharmacokinetic Property of Selective Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0012.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0013.gif" alt="" id="fx9" /></img><div></div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Profile of Lead Compound <b>47</b></h3><div class="NLM_p">In addition to good oral exposure in rats at 10 mg/kg, the C-5 ethyl C-2 carboxylic acid derivative <b>47</b> demonstrated a bioavailability of 37% with an IV half-life of 8.2 h in rats (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). In monkey PK studies with a 3 mg/kg oral dosing, it also exhibited a good AUC of 3.4 μM·h along with 30% bioavailability. The PK profile was even more impressive in dogs: an oral AUC of 11 μM·h coupled with 95% bioavailability when dosed at 3 mg/kg. The half-lives of compound <b>47</b> in monkeys and dogs are on the short side (1.3 and 1.2 h, respectively). The clearance rates (CL) were moderate for <b>47</b> in all three species. It had a good liver concentration of 200 ng/g (0.46 μM) in rats 6 h after dosing. It was stable for up to 3 h in rat, monkey, dog, and human plasma. No inhibition of CYP P450 enzymes 2D6, 3A4, and 2C9 was observed when tested up to 30 μM. It was also clean in a P450 enzyme induction assay at 10 μM. Overall, compound <b>47</b> exhibited very favorable potency, PK, and selectivity. It was considered as a potential candidate for further evaluation.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. PK Parameters of Compound <b>47</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound <b>47</b></th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">monkey</th><th class="colsep0 rowsep0" align="center">dog</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC(PO) (μM·h)</td><td class="colsep0 rowsep0" align="center">18<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">3.4<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">11<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bioavailability (<i>F</i>)</td><td class="colsep0 rowsep0" align="center">37%</td><td class="colsep0 rowsep0" align="center">30%</td><td class="colsep0 rowsep0" align="center">95%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (IV) (h)</td><td class="colsep0 rowsep0" align="center">8.2</td><td class="colsep0 rowsep0" align="center">1.3</td><td class="colsep0 rowsep0" align="center">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="center">8.0</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat liver concn (μM @ 6 h)</td><td class="colsep0 rowsep0" align="center">0.46</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">10 mg/kg.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">3 mg/kg. All administered with 0.4% MC.</p></div></div></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> X-ray Structure of Compound <b>47</b><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></h3><div class="NLM_p">The X-ray crystal structure of compound <b>47</b> bound to HCV NS5B polymerase was solved (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>). Similar to the X-ray structure of compound <b>1</b> bound to the protein, <b>47</b> is bound to the ‘palm’ site of NS5B apoprotein within the active site cavity. The refined structure showed a bond between the side chain of Cys-366 and the phenyl ring of the compound with a 1.8 to 1.9 Å S–C distance. This covalent bond is a result of the side chain thiol attacking the electron-deficient benzene ring at the position para to the nitro group with departure of the fluoro group via a presumed SNAr reaction. The indole core and the C3 pyridone ring contact the side chain of Met-414 while the C3 pyridone forms two hydrogen bond interactions with the backbone of Ile-447 and Tyr-448. The C-2 carboxylic acid does not make direct interactions with the protein, but it rather interacts indirectly with amino acid residues Gly-449 and Ser-556 via hydrogen bonds with bridging water molecules. The indole C5 ethyl group projects into a constricted tunnel which extends to the protein surface on the other side of the 'thumb’ subdomain.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structure of compound <b>47</b> bound to the palm site of HCV NS5B polymerase. The compound (yellow) is covalently attached to the protein (cyan) via a bond between the side chain sulfur of Cys-366 (depicted as a small sphere) and the 5′-position of the compound. The electron density for the compound and residue Cys-366 is best modeled as two alternate conformations and are included as such in the deposited PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYQ">3TYQ</a>. A single conformation is shown here for clarity. The compound makes identical interactions as observed in the complex between inhibitor <b>1</b> and NS5B,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> with a pair of hydrogen bonds from the C3-pyridone group to the backbone of residues Ile-447 and Tyr-448. Furthermore, the interaction of the C2-carboxylate group with the protein is mediated by a pair of water molecules, shown as red spheres. Besides the backbone atoms of Ile-447 and Tyr-448, all side-chain atoms within 5 Å of the ligand are depicted as sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201322r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Selectivity and Toxicity Concerns about Irreversible Inhibitors</h3><div class="NLM_p">Although we were very excited by the potency brought by the covalent bonding with the <i>p</i>-fluoro-nitro-benzyl moiety, and covalently bonded irreversible inhibitors have been seen in numerous drugs and drug candidates,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> the reactive nature of these compounds is always raising an alarm of potentially nonselective bond formations. The potential side reactions from this nitro-fluoro series of irreversible inhibitors was also a concern we felt we needed to address. A NMR spectroscopy-based assay (ALARM NMR)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> which was designed to identify thiol reactive compounds was used to evaluate these inhibitors. In this assay, the highly reactive thiols in the cysteines of the human La antigen were exploited to detect nonspecific covalent bonding activity. When compounds <b>45</b> and <b>47</b> were tested in the ALARM assay, no reactions between these two compounds and the reactive thiols in the human La antigen were detected by NMR studies. This indicated that the reactivity of the <i>p</i>-fluoro-nitro-substituted benzene moiety was not indiscriminately reactive toward any cysteines present in the protein. Rather, the reaction was selective and specific toward cysteine-366 which existed in close proximity. The specificity was also confirmed by mass spectroscopy studies. When compound <b>33</b> was incubated with NS5B enzyme, only tryptic peptide sequence 346–379 was modified by changing from 3533 Da to 4012 Da, which was consistent with covalent bonding with cysteine-366. No other tryptic peptide was found to be modified by 480.0 Da. All these studies suggested that this class of irreversible inhibitors was highly selective and specific in the formation of a covalent adduct, reacting only with cysteine-366. The SAR trends of these irreversible inhibitors also indicated that the covalent bonding was induced by proximity after the inhibitor bound to the enzyme surface through traditional binding interactions.</div><div class="NLM_p last">Even though there are several marketed drugs that contain nitro-aromatic moieties, some concerns still exist about the potential safety issues arising from the metabolites of the nitrobenzene. The partial reduction of the nitro group could lead to the formation of nitro-anion radical or a nitroso group, which could cause cytotoxic effects.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> To address this concern, compound <b>45</b> and <b>47</b> were tested in the <i>Salmonella</i>/mammalian microsome Mini-AMES reverse mutation assay. No bacterial mutagenicity was observed with or without metabolic activation. Both compounds were also evaluated in the in vitro micronucleus induction assay. No chromosome damage was found with either <b>45</b> or <b>47</b>. Inhibitor <b>47</b> was also found to be clean in counterscreens of kinases and protease panels. In summary, the fact that compound <b>47</b> was clean in all in vitro assays discussed above and no toxicity was observed in single dose animal PK studies demonstrated that no evidence for potential safety issues related to the aromatic nitro moiety has been found.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Starting from lead compound <b>2</b>, extensive SAR development on the indole N-1 benzyl moiety was performed. The effort led to the discovery of irreversible inhibitors of NS5B polymerase with significant improvements in cellular replicon assay potency. Some indole-based inhibitors with <i>p</i>-fluoro-sulfone-substituted N-1 benzyl groups were speculated to be capable of forming a covalent bond with the cysteine-366 thiol of the NS5B polymerase. The compounds with a <i>p</i>-nitro-fluoro-benzyl substituent at the indole nitrogen were the most potent inhibitors found which achieved impressive replicon potencies with EC<sub>50</sub>s down to 1 nM. The effect of C-3 pyridone substitution and variation of C-2 moieties were also investigated. While all C-2 carboxylic acid, acylsulfonamide, and acylsulfonylurea analogues had superior potency, the methyl substitution at the C-3 pyridone decreased activity of the corresponding inhibitors. The C-5 SAR investigation demonstrated that small alkyl groups such as methyl and ethyl groups were preferred. The addition of a C-6 fluoro substituent did not improve either potency or PK profile. A selected group of the most promising compounds were evaluated in rat PK studies. Most of them exhibited disappointing oral exposure (AUC < 0.4 μM·h when dosed at 10 mg/kg). However, the C-5 ethyl C-2 carboxylic acid analogue <b>47</b> stood out, having an excellent oral AUC of 18 μM·h at 10 mg/kg. Further studies proved that <b>47</b> also had good oral exposure and bioavailability in monkeys and dogs. The NMR ALARM assay and mass spectroscopy experiments demonstrated that compound <b>47</b> was highly selective and specific in the formation of a covalent bond with cystaine-366 thiol. The concerns about the potential nonselective reactivity and reactive intermediates from the partially reduced nitro group were largely alleviated by the negative results in several in vitro counter screens and toxicology assays. The overall profile of <b>47</b> in terms of potency, PK, and safety made it a good candidate for further evaluation.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Methods</h3><div class="NLM_p">Reagents and solvents, including anhydrous solvents, such as THF, dichloromethane, and DMF, were purchased from Aldrich or other commercial sources and were used without further purification. Reactions that were moisture sensitive or using anhydrous solvents were performed under either a nitrogen or an argon atmosphere. Analytical thin layer chromatography (TLC) was performed on precoated silica gel plates obtained from Analtech. Visualization was accomplished with UV light or by staining with basic KMnO<sub>4</sub> solution, ethanolic H<sub>2</sub>SO<sub>4</sub>, or Vaughn’s reagent. Some compounds were purified by flash chromatography either on a glass column using Merck silica gel 60 (230–400 mesh) or on an ISCO RediSep disposable silica gel column. More polar compounds were purified by reverse phase HPLC on a Sunfire C18 preparative column (50 × 250 mm, 10 μm) running at 30 mL/minute using 20–100% acetonitrile/water (both as a 0.1% trifluoroacetic acid solution) as eluent. NMR spectra were recorded at 400 or 500 MHz for <sup>1</sup>H and at 100 or 125 MHz for <sup>13</sup>C on a Bruker or Varian spectrometer with CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> as solvent. The chemical shifts are given in ppm, referenced to the internal TMS or deuterated solvent signal. HPLC, LC-MS, and/or <sup>1</sup>H NMR methods were employed to determine the purity of all synthesized compounds. All new compounds tested had purity at or above 95%.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> General Procedures for Iodination of <b>3</b></h4><div class="NLM_p last">The solution of compound <b>3</b> (1 mmol) and <i>N</i>-iodosuccinimide (NIS) (1.05 mmol) in acetone (15 mL) was stirred at room temperature (rt) for 3 h (h). Saturated aqueous sodium thiosulfate (5 mL) was added. After the mixture was stirred for 5 min (min), ethyl acetate (30 mL) and water (20 mL) were added. Layers were separated. The aqueous solution was extracted with ethyl acetate (2 × 25 mL). The combined organic layer was washed with brine, dried over magnesium sulfate, and concentrated in vacuo to give the crude product, which was usually pure enough to be used in the next reaction directly.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Procedures for Suzuki Coupling between <b>4</b> and 2-Methoxy-3-pyridineboronic Acids</h4><div class="NLM_p last">To the suspension of 3-iodoindole (<b>4</b>, 10.0 mmol) and [1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium (PdCl<sub>2</sub>(dppf)<sub>2</sub>) (1.0 mmol) in dimethoxyethane (DME) (120 mL) at rt was added a solution of boronic acid (12.0 mmol) and potassium carbonate (50 mmol) in water (30 mL). The mixture was bubbled with argon gas through a frit glass bubbler for 5 min before it was heated to 90 °C in an oil bath and stirred for 4 h. After being cooled to rt, the mixture was diluted with water and ethyl acetate (300 mL each), and the two layers were separated. The aqueous solution was extracted with ethyl acetate (2 × 200 mL). The combined organic solution was washed with brine, dried over magnesium sulfate, and concentrated in vacuo to give the crude product, which was purified by silica gel flash chromatography using 0–50% ethyl acetate in hexanes as eluent to give the desired product <b>5</b> in 50–85% yield (two steps).</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedures for the Preparation of <b>6</b></h4><div class="NLM_p last">The mixture of <b>5</b> (5.0 mmol), arylmethyl bromide (or arylmethyl chloride) (7.5 mmol), and cesium carbonate (7.5 mmol) in anhydrous dimethylformamide (DMF) (80 mL) was vigorously stirred at rt for 16 h. It was then diluted with water and ethyl acetate (200 mL each), and the two layers were separated. The aqueous solution was extracted with ethyl acetate (100 mL). The combined organic solution was washed with water (2 × 300 mL) and brine, dried over magnesium sulfate, and concentrated in vacuo to give the crude product, which was purified by silica gel flash chromatography using 0–60% ethyl acetate in hexanes as eluent to give the desired product <b>6</b> in 40–90% yield.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> General Procedures for the Preparation of <b>7</b></h4><div class="NLM_p last">Compound <b>6</b>(1.0 mmol) and lithium hydroxide (4.0 mmol) were dissolved in THF and water (10 mL each). The solution was then heated to 70 °C in an oil bath and stirred for 16 h before it was cooled to rt. The solution was then made acidic (pH ∼ 2) by addition of 1 N hydrochloric acid. Ethyl acetate was added (30 mL), and the layers were separated. The aqueous solution was extracted with ethyl acetate (2 × 20 mL). The combined organic solution was washed with brine, dried over magnesium sulfate, and concentrated in vacuo to give the crude product <b>7</b> in 60–90% yield, which was used without further purification.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedures for the Preparation of <b>8</b></h4><div class="NLM_p last">The mixture of <b>7</b> (0.50 mmol) and carbonyl diimidazole (CDI) (0.60 mmol) in anhydrous THF (5 mL) was heated to 75 °C in an oil bath and stirred 1.5 h. It was then cooled to rt, alkyl sulfonamide and 1,8-diazabicyclocundec-7-ene (DBU) (1.5 mmol each) were added, and the resulting mixture was stirred at rt for 18 h. The mixture was then diluted with water and ethyl acetate (30 mL each), and the two layers were separated. The aqueous solution was extracted with ethyl acetate (2 × 15 mL). The combined organic solution was washed with brine, dried over magnesium sulfate, and concentrated in vacuo to give the crude product, which was purified by silica gel flash chromatography using 0–80% acetone in dichloromethane as eluent to give the desired product <b>8</b> in 50–80% yield.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Procedures for the Preparation of <b>9</b></h4><div class="NLM_p">Compound <b>8</b>(1.0 mmol) was dissolved in a solution of 4 M hydrogen chloride in <i>p</i>-dioxane (50 mL) in a pressure glass tube. The solution was then sealed and heated to 90 °C in an oil bath and stirred for 3 h before it was cooled to rt. The solution was then concentrated in vacuo to give the crude product, which was purified by reverse phase HPLC to give the desired product <b>9</b> in 30–60% yield.</div><div class="NLM_p">Compound <b>10</b> was prepared from compound <b>5</b> according to the same procedures described above for the preparation of <b>9</b> from compound <b>8</b>.</div><div class="NLM_p last">Compound <b>11</b> was prepared from compound <b>10</b> according to the same procedures described above for the preparation of <b>7</b>. The crude product was used in the next reaction without further purification.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> General Procedures for the Preparation of <b>12</b></h4><div class="NLM_p">To the solution of compound <b>11</b> (1.0 mmol) in anhydrous DMF (5 mL) at rt was added 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) (442 mg, 2.3 mmol) and triethylamine (0.69 mL, 5.0 mmol). The mixture was stirred overnight (17 h). EtOAc (15 mL), 5% aqueous phosphoric acid solution (7 mL), and water (7 mL) were added. After the layers were separated, the aqueous solution was extracted with EtOAc (3 × 22 mL). The combined organic solution was dried over magnesium sulfate and concentrated in vacuo to give the crude product in 60–90% yield, which was used without further purification.</div><div class="NLM_p last">Compound <b>13</b> was prepared from compound <b>12</b> according to the same general procedures described above for the preparation of <b>6</b> from <b>5</b>. The crude product was used in the next reaction without further purification.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Alternative General Method for Preparation of <b>13</b> from <b>12</b> through a Mitsunobu Reaction</h4><div class="NLM_p last">To the mixture of <b>12</b> (2.0 mmol), arylmethyl alcohol (2.8 mmol), and triphenylphosphine (3.8 mmol) in anhydrous THF (50 mL) was added diisopropyl azodicarboxylate (DIAD) (3.8 mmol). The resulting mixture was stirred at rt for 16 h. It was concentrated in vacuo to give the crude product, which was purified by silica gel flash chromatography using 0–60% ethyl acetate in hexanes as eluent to give the desired product <b>13</b> in 60–90% yield.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> General Procedures for the Preparation of <b>9</b> from <b>13</b></h4><div class="NLM_p last">To the solution of compound <b>13</b> (0.2 mmol) and appropriate alkyl primary sulfonamide (0.4 mmol) in anhydrous THF (5 mL) at rt was added sodium hydride (30 mg, 1.5 mmol, 60% in mineral oil). The mixture was heated to 70 °C in an oil bath for 1.5 h. After the mixture was cooled to rt, EtOAc (30 mL) and water (40 mL) were added. After the layers were separated, the aqueous solution was extracted with EtOAc (2 × 40 mL). The combined organic solution was dried over magnesium sulfate and concentrated in vacuo to give the crude product in 30–60% yield.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> General Procedures for the Preparation of <b>14</b></h4><div class="NLM_p last">Compound <b>14</b>(0.3 mmol) and lithium hydroxide (2.0 mmol) were dissolved in THF and water (10 mL each). The solution was stirred at rt for 4 h. EtOAc (40 mL) and 5% aqueous phosphoric acid solution (20 mL) were added. After the layers were separated, the aqueous solution was extracted with ethyl acetate (2 × 30 mL). The combined organic solution was dried over magnesium sulfate and concentrated in vacuo to give the crude product, which was purified by reverse phase HPLC to give the desired product (<b>14</b>) in 20–60% yield.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(Cyclopropylsulfonyl)-1-[(2,5-difluorophenyl)methyl]-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>2</b>)</h3><div class="NLM_p last">Compound <b>2</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.79 (s, 1 H), 12.71 (s, 1 H), 7.81 (q, <i>J</i> = 1.9 Hz, 1 H), 7.69 (s, 1 H), 7.54–7.52(m, 1 H), 7.32–7.27 (m, 1 H), 7.21–7.20 (m, 2 H), 7.18–7.13 (m, 1 H), 6.64–6.16 (m, 1 H), 6.60–6.56 (m, 1 H), 5.73 (s, 2 H), 2.97–2.91 (m, 1 H), 2.36 (s, 3 H), 0.97 (d, <i>J</i> = 6.3 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.5, 161.9, 160.0, 158.0, 157.6, 155.7, 145.0, 136.9, 136.5, 131.2, 128.1, 127.9, 127.2, 123.9, 120.7, 118.0, 117.9, 117.8, 117.7, 116.6, 115.9, 115.8, 111.6, 108.3, 42.4, 31.5, 21.9, 6.3. LRMS calcd for C<sub>25</sub>H<sub>22</sub>N<sub>3</sub>O<sub>4</sub>F<sub>2</sub>S (M + H)<sup>+</sup>, 498.1; found, 498.3.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(Cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-1-[(2-fluorophenyl)methyl]-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>15</b>)</h3><div class="NLM_p last">Compound <b>15</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.80 (s, 1 H), 12.74 (s, 1 H), 7.7 9(d, <i>J</i> = 2.2 Hz, 1 H), 7.69 (t, <i>J</i> = 4.4 Hz, 1 H), 7.52 (d, <i>J</i> = 9.0 Hz, 1 H), 7.33–7.28 (m, 1 H), 7.23–7.18 (m, 3 H), 7.10–7.06 (m, 1 H), 6.87–6.82 (m, 1 H), 6.30 (t, <i>J</i> = 6.6 Hz, 1 H), 5.75 (s, 2 H), 2.93–2.89 (m, 1 H), 2.35 (s, 3 H), 0.96 (d, <i>J</i> = 6.3 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 174.0, 172.4, 172.0, 170.1, 166.0, 162.8, 157.4, 155.6, 150.5, 147.5, 141.6, 140.8, 140.0, 138.5, 137.7, 135.9, 131.1, 126.8, 126.6, 122.2, 118.9, 116.5, 78.4, 52.8, 45.7, 42.0, 41.8, 32.4, 16.8. LRMS calcd for C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>4</sub>FS (M + H)<sup>+</sup>, 480.1; found, 480.3.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(Cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-1-[(2-fluoro-3-methylphenyl)methyl]-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>16</b>)</h3><div class="NLM_p last">Compound <b>16</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.79 (s, 1 H), 12.73 (s, 1 H), 7.78 (q, <i>J</i> = 1.8 Hz, 1 H), 7.69 (t, <i>J</i> = 5.8 Hz, 1 H), 7.51 (d, <i>J</i> = 9.0 Hz, 1 H), 7.19–7.15 (m, 3 H), 6.95 (t, <i>J</i> = 7.6 Hz, 1 H), 6.64 (q, <i>J</i> = 5.0 Hz, 2 H), 5.73 (s, 2 H), 2.95–2.90 (m, 1 H), 2.35 (s, 3 H), 2.22 (s, 3 H), 0.97 (d, <i>J</i> = 6.6 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 174.0, 172.4, 155.6, 147.5, 147.0, 145.4, 142.0, 141.5, 140.0, 138.4, 137.6, 137.4, 136.2, 135.3, 134.4, 131.0, 125.9, 122.2, 118.8, 52.9, 45.9, 42.0, 41.8, 32.4, 25.4, 16.8. LRMS calcd for C<sub>26</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub>FS (M + H)<sup>+</sup>, 494.2; found, 494.3.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 1-[(2-Amino-4-pyridinyl)methyl]-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>17</b>)</h3><div class="NLM_p last">Compound <b>17</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.45 (s, 1 H), 12.84 (s, 2 H), 7.94 (s, 1 H), 7.90 (d, <i>J</i> = 6.6 Hz, 1 H), 7.81 (q, <i>J</i> = 1.9 Hz, 1 H), 7.74 (s, 1 H), 7.45 (d, <i>J</i> = 8.2 Hz, 1 H), 7.24 (s, 2 H), 6.68 (t, <i>J</i> = 6.9 Hz, 1 H), 6.60 (d, <i>J</i> = 7.0 Hz, 1 H), 6.41 (s, 1 H), 5.67 (s, 2 H), 2.98–2.93 (m, 1 H), 2.37 (s, 3 H), 1.01 (d, <i>J</i> = 7.9 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 174.0, 172.1, 167.3, 165.4, 155.8, 147.5, 142.1, 139.9, 139.0, 137.8, 134.1, 131.3, 130.0, 126.2, 122.0, 121.9, 120.4, 119.1, 109.3, 58.6, 42.6, 42.1, 41.8, 33.4, 32.4, 25.3, 16.8. LRMS calcd for C<sub>24</sub>H<sub>24</sub>N<sub>5</sub>O<sub>4</sub>S (M + H)<sup>+</sup>, 478.2; found, 478.3.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-[(5-Cyano-2-fluorophenyl)methyl]-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>8</b>)</h3><div class="NLM_p last">Compound <b>18</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.73 (s, 1 H), 12.65 (s, 1 H), 7.90–7.86 (m, 1 H), 7.82 (d, <i>J</i> = 6.4 Hz, 1 H), 7.67 (s, 1 H), 7.56–7.49 (s, 2 H), 7.23–7.20 (m, 3 H), 6.61 (t, <i>J</i> = 6.2 Hz, 1 H), 5.76 (s, 2 H), 2.93–2.87 (m, 1 H), 2.37 (s, 3 H), 0.95 (d, <i>J</i> = 7.6 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 164.1, 163.9, 163.4, 162.1, 161.9, 161.5, 146.4, 144.9, 143.8, 140.1, 139.7, 139.4, 136.9, 136.4, 135.3, 134.8, 133.5, 133.2, 131.4, 129.6, 129.4, 128.2, 127.2, 125.8, 123.8, 123.0, 120.8, 118.8, 118.2, 118.1, 115.9, 111.5, 108.7, 108.3, 107.2, 98.3, 42.2, 35.2, 34.8, 32.9, 31.5, 31.3, 30.1, 29.9, 21.9, 6.3, 5.9, 5.1. LRMS calcd for C<sub>26</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub>FS (M + H)<sup>+</sup>, 505.1; found, 505.3.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-[[5-(Aminocarbonyl)-2-fluorophenyl]methyl]-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>19</b>)</h3><div class="NLM_p last">Compound <b>19</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.82 (s, 1 H), 12.78 (s, 1 H), 7.89 (s, 1 H), 7.84–7.80 (m, 2 H), 7.70 (s, 1 H), 7.55 (d, <i>J</i> = 7.8 Hz, 2 H), 7.38 (s, 1 H), 7.30 (t, <i>J</i> = 9.3 Hz, 1 H), 7.21–7.18 (m, 2 H), 6.65–6.62 (m, 1 H), 5.76 (s, 2 H), 2.96–2.89 (m, 1 H), 2.36 (s, 3 H), 0.96 (d, <i>J</i> = 6.0 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 167.6, 163.5, 161.9, 161.5, 152.5, 145.3, 137.2, 136.6, 131.6, 131.1, 130.0, 129.7, 128.1, 127.2, 125.9, 125.8, 125.2, 123.9, 120.7, 116.2, 116.0, 115.6, 111.7, 108.4, 67.9, 42.7, 35.3, 31.6, 31.3, 30.1, 28.9, 16.0, 24.9, 21.9, 6.3. LRMS calcd for C<sub>26</sub>H<sub>24</sub>N<sub>4</sub>O<sub>5</sub>FS (M + H)<sup>+</sup>, 523.1; found, 523.3.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-[[5-(Aminosulfonyl)-2-fluorophenyl]methyl]-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>21</b>)</h3><div class="NLM_p last">Compound <b>21</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.84 (s, 2 H), 7.82–7.78 (m, 2 H), 7.73–7.71 (m, 1 H), 7.54 (d, <i>J</i> = 8.1 Hz, 1 H), 7.49–7.43 (m, 2 H), 7.38 (s, 2 H), 7.21 (d, <i>J</i> = 8.8 Hz, 1 H), 7.19 (s, 1 H), 6.66 (t, <i>J</i> = 8.0 Hz, 1 H), 5.78 (s, 2 H), 2.96–2.91 (m, 1 H), 2.36 (s, 3 H), 0.97 (d, <i>J</i> = 6.1 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.6, 163.2, 161.8, 161.2, 152.3, 145.4, 141.4, 137.3, 136.7, 131.3, 128.5, 127.5, 127.3, 126.9, 125.8, 120.8, 117.3, 115.7, 111.6, 108.6, 67.9, 42.8, 31.6, 31.3, 30.1, 26.0, 21.9. LRMS calcd for C<sub>25</sub>H<sub>24</sub>N<sub>4</sub>O<sub>6</sub>FS<sub>2</sub> (M + H)<sup>+</sup>, 559.1; found, 559.3.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-[[3-Cyano-2-fluoro-5-(methylsulfonyl)phenyl]methyl]-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>22</b>)</h3><div class="NLM_p last">Compound <b>22</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.89 (s, 1 H), 12.83 (s, 1 H), 8.32 (d, <i>J</i> = 9.5 HZ, 1 H), 7.82 (q, <i>J</i> = 1.6 Hz, 1 H), 7.72 (s, 1 H), 7.62 (q, <i>J</i> = 6.8 Hz, 2 H), 7.24 (d, <i>J</i> = 8.9 Hz, 1 H), 7.22 (s, 1 H), 6.67–6.62 (m, 1 H), 5.87 (s, 2 H), 3.31 (s, 3 H), 2.93–2.89 (m, 1 H), 2.37 (s, 3 H), 0.97 (s, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.6, 161.8, 161.4, 158.8, 157.0, 152.8, 145.4, 139.5, 137.3, 136.8, 133.1, 131.6, 131.2, 131.1, 128.5, 127.3, 120.8, 116.1, 115.3, 111.9, 111.5, 108.6, 44.0, 43.1, 31.6, 31.3, 21.9, 6.3. LRMS calcd for C<sub>27</sub>H<sub>24</sub>N<sub>4</sub>O<sub>6</sub>FS<sub>2</sub> (M + H)<sup>+</sup>, 583.1; found, 583.0.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-[[2-Chloro-5-[(trifluoromethyl)sulfonyl]phenyl]methyl]-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>23</b>)</h3><div class="NLM_p last">Compound <b>23</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.03 (s, 1 H), 12.88 (s, 1 H), 8.08–8.02 (m, 2 H), 7.84 (dd, <i>J</i> = 1.6, 1.5 Hz, 1 H), 7.76–7.74 (m, 1 H), 7.50 (d, <i>J</i> = 8.8 Hz, 1 H), 7.24 (s, 1 H), 7.21 (d, <i>J</i> = 8.8 Hz,1 H), 7.06 (d, <i>J</i> = 1.8 Hz, 1 H), 6.68 (t, <i>J</i> = 6.6 Hz, 1 H), 5.87 (s, 2 H), 2.86–2.81 (m, 1 H), 2.37 (s, 3 H), 0.92 (d, <i>J</i> = 6.0 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.6, 161.7, 156.9, 145.6, 142.4, 140.1, 137.1, 136.8, 133.0, 131.8, 131.6, 131.1, 129.6, 129.4, 128.6, 127.3, 123.5, 120.9, 116.0, 111.4, 109.8, 108.8, 16.6, 31.5, 21.9, 6.2, 5.1. LRMS calcd for C<sub>26</sub>H<sub>22</sub>N<sub>3</sub>O<sub>6</sub>ClF<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup>, 628.0; found, 628.3.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-[[2-Chloro-5-[(trifluoromethyl)sulfinyl]phenyl]methyl]-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>24</b>)</h3><div class="NLM_p last">Compound <b>24</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.93 (s, 1 H), 12.83 (s,1 H), 7.89 (d, <i>J</i> = 1.6 Hz, 1 H), 7.84–7.81 (m, 1 H), 7.73 (s,1 H), 7.43 (d, <i>J</i> = 8.8 Hz, 1 H), 7.23 (s,1 H), 7.18 (d, <i>J</i> = 8.4 Hz, 1 H), 6.91 (s, 1 H), 6.87 (s, 1 H), 6.71–6.63 (m, 1 H), 5.83 (s, 2 H), 2.88–2.80 (m, 1 H), 2.36 (s, 3 H), 1.35 (d, <i>J</i> = 1.6 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.6, 152.3, 145.4, 140.0, 138.8, 137.8, 136.7, 135.5, 131.8, 131.5, 129.6, 128.9, 128.3, 127.3, 127.2, 126.7, 125.8, 125.2, 120.9, 111.5, 108.6, 108.5, 46.6, 35.2, 31.5, 31.3, 30.1, 21.9, 61.2. LRMS calcd for C<sub>26</sub>H<sub>22</sub>N<sub>3</sub>O<sub>5</sub>ClF<sub>3</sub>S<sub>2</sub> (M + H)<sup>+</sup>, 612.1; found, 612.3.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-[[4-Chloro-2-fluoro-5-(methylsulfonyl)phenyl]methyl]-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>26</b>)</h3><div class="NLM_p last">Compound <b>26</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.89 (s, 1 H), 12.83 (s, 1 H), 7.87 (d, <i>J</i> = 9.8 Hz, 1 H), 7.81 (d, <i>J</i> = 6.4 Hz, 1 H), 7.76 (d, <i>J</i> = 7.6 Hz, 1 H), 7.72 (s, 1 H), 7.61 (d, <i>J</i> = 8.4 Hz, 1 H), 7.28 (d, <i>J</i> = 8.5 Hz, 1 H), 7.20 (s, 1 H), 6.66 (t, <i>J</i> = 6.7 Hz, 1 H), 5.79 (s, 2 H), 3.31 (s, 3 H), 2.95–2.90 (m, 1 H), 2.67 (q, <i>J</i> = 7.5 Hz, 2 H), 1.18 (t, <i>J</i> = 7.6 Hz, 3 H), 0.99 (d, <i>J</i> = 8.5 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 164.2, 163.5, 162.1, 161.8, 161.4, 157.0, 145.5, 138.1, 137.4, 136.7, 136.3, 135.2, 133.1, 132.1, 129.2, 127.4, 127.1, 126.4, 126.3, 123.6, 120.7, 120.4, 119.5, 116.1, 111.6, 108.7, 43.3, 42.4, 31.6, 29.9, 29.4, 29.0, 17.0, 6.3, 5.9, 5.1. LRMS calcd for C<sub>27</sub>H<sub>26</sub>N<sub>3</sub>O<sub>6</sub>ClFS<sub>2</sub> (M + H)<sup>+</sup>, 606.1; found, 606.3.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-[[4-Cyano-2-fluoro-5-(methylsulfonyl)phenyl]methyl]-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.90 (s, 1 H), 12.85 (s, 1 H), 8.33 (d, <i>J</i> = 9.4 Hz, 1 H), 7.83 (d, <i>J</i> = 5.7 Hz, 1 H), 7.72 (s, 1 H), 7.67 (d, <i>J</i> = 6.7 Hz, 1 H), 7.62 (d, <i>J</i> = 8.8 Hz, 1 H), 7.29 (d, <i>J</i> = 9.0 Hz, 1 H), 7.22 (s, 1 H), 6.66 (s, 1 H), 5.87 (s, 2 H), 3.32 (s, 3 H), 2.90 (s, 1 H), 2.67 (q, <i>J</i> = 7.5 Hz, 2 H), 1.18 (t, <i>J</i> = 7.3 Hz, 3 H), 0.97 (s, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.4, 163.0, 162.4, 161.4, 161.0, 156.4, 155.6, 147.0, 141.3, 140.4, 139.7, 134.4, 132.5, 132.4, 130.9, 130.0, 128.2, 124.5, 124.3, 122.6, 122.0, 121.0, 114.4, 112.6, 85.4, 69.1, 67.0, 63.0, 44.0, 32.9, 29.8, 29.2, 28.3, 24.7, 22.6, 17.2, 6.1, 5.8, 4.7. LRMS calcd for C<sub>28</sub>H<sub>26</sub>N<sub>4</sub>O<sub>6</sub>FS<sub>2</sub> (M + H)<sup>+</sup>, 597.1; found, 597.3</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-[[5-(Aminosulfonyl)-2,4-dichlorophenyl]methyl]-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-ethyl-1<i>H</i>-indole-2-carboxamide (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.87 (s, 2 H), 7.94 (s, 1 H), 7.83 (q, <i>J</i> = 1.8 Hz, 1 H), 7.75–7.73 (m, 1 H), 7.62 (s, 2 H), 7.44 (d, <i>J</i> = 8.6 Hz, 1 H), 7.29 (s, 1 H), 7.25 (q, <i>J</i> = 1.7 Hz, 1 H), 7.23 (s, 1 H), 6.69 (t, <i>J</i> = 6.6 Hz, 1 H), 5.72 (s, 2 H), 2.93–2.88 (m, 1 H), 2.67 (q, <i>J</i> = 7.5 Hz, 2 H), 1.18 (t, <i>J</i> = 7.6 Hz, 3 H), 0.98–0.96 (m, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 163.6, 161.6, 147.0, 145.5, 141.0, 139.6, 138.1, 137.5, 136.8, 136.4, 136.1, 132.5, 130.7, 128.6, 127.5, 127.3, 123.7, 119.7, 115.9, 111.6, 108.7, 46.6, 31.6, 30.2, 29.1, 16.9, 6.3. LRMS calcd for C<sub>26</sub>H<sub>25</sub>N<sub>4</sub>O<sub>6</sub>Cl<sub>2</sub>S<sub>2</sub> (M + H)<sup>+</sup>, 623.1; found, 624.8.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-[[3-(Aminocarbonyl)-2,5,6-trifluorophenyl]methyl]-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>29</b>)</h3><div class="NLM_p last">Compound <b>29</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.67 (s, 1 H), 12.64 (d, <i>J</i> = 5.0 Hz, 1 H), 7.81 (s, 1 H), 7.75 (s, 1 H), 7.73 (q, <i>J</i> = 1.8 Hz, 1 H), 7.70–7.64 (m, 2 H), 7.54 (d, <i>J</i> = 8.5 Hz, 1 H), 7.23 (d, <i>J</i> = 8.6 Hz, 1 H), 7.17 (s, 1 H), 6.59 (t, <i>J</i> = 6.6 Hz, 1 H), 5.86 (s, 2 H), 2.98–2.93 (m, 1 H), 2.35 (s, 3 H), 1.06–0.99 (m, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 164.1, 163.3, 162.0, 152.3, 144.8, 137.0, 136.5, 131.1, 129.8, 128.0, 127.2, 125.8, 123.8, 120.8, 118.0, 117.9, 115.9, 111.2, 108.1, 67.9, 37.5, 31.3, 26.0, 21.8, 6.3. LRMS calcd for C<sub>26</sub>H<sub>22</sub>N<sub>4</sub>O<sub>5</sub>F<sub>3</sub>S (M + H)<sup>+</sup>, 559.1; found, 559.3.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1-[(2-Chloro-5-nitrophenyl)methyl]-<i>N</i>-(-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>30</b>)</h3><div class="NLM_p last">Compound <b>30</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.88 (s, 1 H), 12.77 (s, 1 H), 8.15 (q, <i>J</i> = 2.8 Hz, 1 H), 7.86–7.84 (m, 2 H), 7.72 (s, 1 H), 7.48 (d, <i>J</i> = 8.5 Hz, 1 H), 7.27 (s, 2 H), 7.21 (d, <i>J</i> = 8.6 Hz, 1 H), 6.65 (t, <i>J</i> = 6.6 Hz, 1 H), 5.80 (s, 2 H), 2.88 – 2.82 (m, 1 H), 2.38 (s, 3 H), 0.92 (d, <i>J</i> = 6.2 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 164.4, 163.8, 163.5, 161.8, 148.7, 147.5, 145.2, 139.1, 138.8, 137.1, 136.6, 131.8, 131.5, 130.7, 128.5, 127.3, 124.6, 122.8, 120.9, 111.5, 108.4, 46.6, 31.5, 21.9, 6.2. LRMS calcd for C<sub>25</sub>H<sub>22</sub>N<sub>4</sub>O<sub>6</sub>ClS (M + H)<sup>+</sup>, 541.1; found, 541.3.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-(Cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-1-[(2-fluoro-5-nitrophenyl)methyl]-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>31</b>)</h3><div class="NLM_p last">Compound <b>31</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.86 (s, 1 H), 12.76 (s, 1 H), 8.25 −8.22 (m, 1 H), 7.82 (d, <i>J</i> = 7.2 Hz, 1 H), 7.75–7.73 (m, 1 H), 7.70 (s, 1 H), 7.58 (q, <i>J</i> = 7.8 Hz, 2 H), 7.23 (d, <i>J</i> = 6.5 Hz, 2 H), 6.66–6.61 (m, 1 H), 5.82 (s, 2 H), 2.93–2.87 (s, 1 H), 2.37 (s, 3 H), 0.96 (d, <i>J</i> = 5.7 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 165.1, 163.5, 163.1, 161.9, 145.2, 144.9, 137.1, 136.6, 131.4, 129.5, 128.3, 128.1, 128.0, 127.3, 126.3, 125.2, 123.8, 120.8, 118.1, 117.9, 115.9, 108.4, 42.6, 31.6, 21.9, 6.3. LRMS calcd for C<sub>25</sub>H<sub>22</sub>N<sub>4</sub>O<sub>6</sub>FS (M + H)<sup>+</sup>, 525.1; found, 525.3.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-[(2-Fluoro-5-nitrophenyl)methyl]-3-(2-hydroxy-3-pyridinyl)-5-methyl-1<i>H</i>-indole-2-carboxylic acid (<b>32</b>)</h3><div class="NLM_p last">Compound <b>32</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>14</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.04 (s, 1 H), 11.81 (s, 1 H), 8.23–8.20 (m, 1 H), 7.61 (q, <i>J</i> = 2.85 Hz, 1 H), 7.58–7.53 (m, 3 H), 7.42 (q, <i>J</i> = 1.9 Hz, 1 H), 7.26 (s, 1 H), 7.19–7.17 (m, 1 H), 6.35 (t, <i>J</i> = 6.6 Hz, 1 H), 5.91 (s, 2 H), 2.37 (s, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 174.5, 173.5, 172.7, 164.6, 155.4, 151.6, 149.1, 147.4, 145.6, 141.5, 141.3, 139.3, 138.3, 137.6, 136.6, 135.0, 131.3, 128.7, 128.5, 128.3, 121.9, 116.6, 108.9, 87.0, 52.9, 41.8, 36.8, 32.4. LRMS calcd for C<sub>22</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub>F (M + H)<sup>+</sup>, 422.1; found, 422.2.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3-(1,2-Dihydro-2-oxo-3-pyridinyl)-1-[(2-fluoro-5-nitrophenyl)methyl]-5-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-2-carboxamide (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.83 (s, 1 H), 12.71 (s, 1 H), 8.25–8.22 (m, 1 H), 7.83 (d, <i>J</i> = 6.9 Hz, 1 H), 7.76–7.74 (m, 1 H), 7.68 (s, 1 H), 7.59–7.53 (m, 2 H), 7.24 (s, 2 H), 6.65–6.62 (m, 1 H), 5.80 (s, 2 H), 3.25 (s, 3 H), 2.37 (s, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 65.1, 163.3, 163.1, 162.2, 155.6, 145.0, 140.1, 137.0, 136.4, 134.2, 131.5, 128.4, 128.0, 127.9, 115.8, 111.5, 108.4, 42.6, 42.0, 35.2, 31.3, 30.1, 22.5, 21.8. LRMS calcd for C<sub>23</sub>H<sub>20</sub>N<sub>4</sub>O<sub>6</sub>FS (M + H)<sup>+</sup>, 499.1; found, 499.3.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3-(1,2-Dihydro-2-oxo-3-pyridinyl)-1-[(2-fluoro-5-nitrophenyl)methyl]-5-methyl-<i>N</i>-[(1-methylethyl)sulfonyl]-1<i>H</i>-indole-2-carboxamide (<b>34</b>)</h3><div class="NLM_p last">Compound <b>34</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.81 (s, 1 H), 12.74 (s, 1 H), 8.25–8.22 (m, 1 H), 7.84–7.83 (m, 1 H), 7.71 (q, <i>J</i> = 8.8 Hz, 2 H), 7.61–7.54 (m, 2 H), 7.24 (s, 1 H), 7.22 (s, 1 H), 6.65 (t, <i>J</i> = 6.6 Hz, 1 H), 5.81 (s, 2 H), 3.61–3.55 (m, 1 H), 2.37 (s, 3 H), 1.13 (d, <i>J</i> = 6.9 Hz, 6 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 165.2, 163.6, 163.1, 162.0, 145.4, 144.9, 137.2, 136.7, 131.5, 129.3, 128.5, 128.2, 128.1, 127.2, 126.4, 126.3, 125.1, 123.7, 120.8, 118.1, 117.9, 116.1, 111.5, 108.5, 53.6, 42.7, 31.3, 21.9, 16.1. LRMS calcd for C<sub>25</sub>H<sub>24</sub>N<sub>4</sub>O<sub>6</sub>FS (M + H)<sup>+</sup>, 527.1; found, 527.3.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 3-(1,2-Dihydro-6-methyl-2-oxo-3-pyridinyl)-1-[(2-fluoro-5-nitrophenyl)methyl]-5-methyl-1<i>H</i>-indole-2-carboxylic acid (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>14</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.20 (s, 1 H), 11.91 (s, 1 H), 8.24–8.20 (m, 1 H), 7.62–7.61 (m, 1 H), 7.58–7.47 (m, 3 H), 7.24 (s, 1 H), 7.18 (d, <i>J</i> = 8.5 Hz, 2 H), 6.19 (d, <i>J</i> = 6.9 Hz, 1 H), 5.90 (s, 2 H), 2.36 (s, 3 H), 2.26 (s, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 175.2, 174.6, 173.4, 155.4, 152.2, 150.9, 147.5, 141.2, 139.2, 138.3, 137.7, 135.1, 133.0, 131.4, 128.7, 128.5, 128.3, 121.8, 116.1, 108.5, 78.4, 32.4, 29.8. LRMS calcd for C<sub>23</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>F (M + H)<sup>+</sup>, C<sub>23</sub>H<sub>18</sub>N<sub>3</sub>O<sub>5</sub>F: 436.1; found, 436.2.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 3-(1,2-Dihydro-6-methyl-2-oxo-3-pyridinyl)-1-[(2-fluoro-5-nitrophenyl)methyl)methyl]-5-methyl-<i>N</i>-(methylsulfonyl)-1<i>H</i>-indole-2-carboxamide (<b>38</b>)</h3><div class="NLM_p last">Compound <b>38</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.12(s, 1 H), 12.83 (s, 1 H), 8.25–8.22 (m, 1 H), 7.77–7.75 (m, 2 H), 7.58–7.54 (m, 2 H), 7.23–7.21 (m, 2 H), 6.50 (d, <i>J</i> = 7.2 Hz, 1 H), 5.80 (s, 2 H), 3.27 (s, 3 H), 2.37 (d, <i>J</i> = 1.8 Hz, 6 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 172.8, 163.6, 162.9, 158.2, 156.1, 155.2, 147.7, 141.8, 139.7, 138.9, 136.9, 135.7, 133.5, 133.4, 133.2, 131.5, 131.3, 130.3, 129.9, 129.8, 129.6, 128.4, 126.4, 123.4, 122.0, 118.7, 66.3, 52.6, 45.8, 32.4, 29.8, 27.2. LRMS calcd for C<sub>24</sub>H<sub>22</sub>N<sub>4</sub>O<sub>6</sub>FS (M + H)<sup>+</sup>, 513.1; found, 513.3.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-(Cyclopropylsulfonyl)-3-(1,2-dihydro-6-methyl-2-oxo-3-pyridinyl)-1-[(2-fluoro-5-nitrophenyl)methyl]-5-methyl-1<i>H</i>-indole-2-carboxamide (<b>39</b>)</h3><div class="NLM_p last">Compound <b>39</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 13.12 (s, 1 H), 12.87 (s, 1 H), 8.26–8.22 (m, 1 H), 7.76 (s, 2 H), 7.59–7.55 (m, 2 H), 7.23–7.20 (m, 2 H), 6.50 (s, 1 H), 5.82 (s, 2 H), 2.92 (s, 1 H), 2.36 (s, 6 H), 0.97 (s, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 164.0, 163.1, 162.0, 147.8, 145.7, 144.9, 137.2, 134.4, 131.4, 129.3, 128.4, 128.1, 128.0, 127.4, 126.4, 125.1, 123.0, 120.9, 119.8, 118.1, 117.9, 116.0, 111.5, 108.3, 45.6, 31.6, 26.1, 25.2, 24.6, 21.8, 19.3, 6.2, 5.8. LRMS calcd for C<sub>26</sub>H<sub>24</sub>N<sub>4</sub>O<sub>6</sub>FS (M + H)<sup>+</sup>, 539.1; found, 539.3.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 5-Chloro-<i>N</i>-(cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-1-[(2-fluoro-5-nitrophenyl)methyl]-1<i>H</i>-indole-2-carboxamide (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.81 (s, 1 H), 12.64 (s, 1 H), 8.26–8.23 (m, 1 H), 7.81 (q, <i>J</i> = 1.8 Hz, 1 H), 7.79–7.77 (m, 2 H), 7.67 (s, 1 H), 7.56 (t, <i>J</i> = 9.5 Hz, 1 H), 7.47 (d, <i>J</i> = 1.9 Hz, 1 H), 7.41 (q, J=2.2 Hz, 1 H), 6.59 (t, <i>J</i> = 6.8 Hz, 1 H), 5.85 (s, 2 H), 2.92–2.87 (m, 1 H), 0.97 (d, <i>J</i> = 5.9 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 165.2, 163.1, 161.6, 152.3, 145.0, 144.8, 136.9, 128.0, 127.6, 127.5, 127.0, 126.6, 126.5, 126.4, 125.8, 125.4, 125.3, 120.9, 118.1, 117.9, 115.7, 113.7, 108.2, 42.8, 35.2, 31.5, 31.3, 22.6, 6.3. LRMS calcd for C<sub>24</sub>H<sub>18</sub>N<sub>4</sub>O<sub>6</sub>ClFS, 544.1; found, 544.8.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-(Cyclopropylsulfonyl)-3-(1,2-dihydro-2-oxo-3-pyridinyl)-1-[(2-fluoro-5-nitrophenyl)methyl]-5-(trifluoromethyl-1<i>H</i>-indole-2-carboxamide (<b>43</b>)</h3><div class="NLM_p last">Compound <b>43</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>9</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.80 (s, 1 H), 12.60 (s, 1 H), 8.27–8.23 (m, 1 H), 7.97 (d, <i>J</i> = 8.8 Hz, 1 H), 7.84–7.81 (m, 2 H), 7.80 (s, 1 H), 7.69 (q, <i>J</i> = 1.4 Hz, 2 H), 7.56 (t, <i>J</i> = 9.2 Hz, 1 H), 6.59 (t, <i>J</i> = 6.6 Hz, 1 H), 5.9 (s, 2 H), 2.92–2.87 (m, 1 H), 0.97 (d, <i>J</i> = 5.2 Hz, 4 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 165.3, 163.2, 163.0, 161.6, 152.3, 145.0, 144.7, 139.7, 136.9, 128.9, 127.4, 127.2, 126.9, 126.6, 126.3, 125.8, 125.5, 124.7, 122.9, 122.3, 119.7, 118.2, 118.0, 117.0, 113.1, 108.0, 42.9, 31.5, 31.3, 30.1, 6.3. LRMS calcd for C<sub>25</sub>H<sub>18</sub>N<sub>4</sub>O<sub>6</sub>F<sub>4</sub>S, 578.1; found, 578.8.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 3-(1,2-Dihydro-2-oxo-3-pyridinyl)-5-ethyl-1-[(2-fluoro-5-nitrophenyl)methyl]-1<i>H</i>-indole-2-carboxylic Acid (<b>47</b>)</h3><div class="NLM_p last">Compound <b>47</b> was prepared according to the reaction sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and the general procedures described above for the preparation of generic compound <b>14</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>), 12.99 (s, 1 H), 11.80 (s, 1 H), 8.23–8.20 (m, 1 H), 7.65 (q, <i>J</i> = 2.9 Hz, 1 H), 7.58–7.54 (m, 3 H), 7.42 (q, <i>J</i> = 1.9 Hz, 1 H), 7.26 (s, 1 H), 7.23 (d, <i>J</i> = 8.4 Hz, 1 H), 6.36 (t, <i>J</i> = 6.9 Hz, 1 H), 5.91 (s, 2 H), 2.67 (q, <i>J</i> = 7.6 Hz, 2 H), 1.18 (t, <i>J</i> = 7.6 Hz, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>), 165.0, 164.0, 163.0, 162.3, 144.9, 141.1, 137.5, 137.1, 135.1, 128.8, 128.6, 127.9, 127.1, 126.8, 126.2, 126.1, 124.7, 124.6, 119.6, 118.4, 118.0, 117.8, 111.5, 106.2, 42.4, 29.1, 17.1. LRMS calcd for C<sub>23</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub>F (M + H)<sup>+</sup>, 436.1; found, 436.0.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36003" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36003" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin X. Chen</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c5aebda6ab85bca4adaaaaeba6aaa8"><span class="__cf_email__" data-cfemail="3d56455e537d445c555252135e5250">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles A. Lesburg</span> - <span class="hlFld-Affiliation affiliation">Drug Design, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bancha Vibulbhan</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiying Yang</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tin-Yau Chan</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Srikanth Venkatraman</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Velazquez</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingbei Zeng</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Bennett</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gopinadhan N. Anilkumar</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jose Duca</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yueheng Jiang</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Pinto</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Wang</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuhua Huang</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oleg Selyutin</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Gavalas</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiyan Pu</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sony Agrawal</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Boris Feld</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hsueh-Cheng Huang</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Li</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuo-Chi Cheng</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Neng-Yang Shih</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph A. Kozlowski</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart B. Rosenblum</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. George Njoroge</span> - <span class="hlFld-Affiliation affiliation">Merck Research Laboratories,
2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm201322r" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i57" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i57"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> Abbreviations Used</h2><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">NS</td><td class="NLM_def"><p class="first last">nonstructural</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area-under-the-curve</p></td></tr><tr><td class="NLM_term">SOC</td><td class="NLM_def"><p class="first last">standard of care</p></td></tr><tr><td class="NLM_term">SVR</td><td class="NLM_def"><p class="first last">sustained virologic response</p></td></tr><tr><td class="NLM_term">RdRp</td><td class="NLM_def"><p class="first last">RNA dependent RNA polymerase</p></td></tr><tr><td class="NLM_term">RC</td><td class="NLM_def"><p class="first last">replicase complex</p></td></tr><tr><td class="NLM_term">NIs</td><td class="NLM_def"><p class="first last">nucleoside inhibitors</p></td></tr><tr><td class="NLM_term">NNIs</td><td class="NLM_def"><p class="first last">non-nucleoside inhibitors</p></td></tr><tr><td class="NLM_term">NIS</td><td class="NLM_def"><p class="first last">N-iodosuccinimide</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last">carbonyl diimidazole</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicyclocundec-7-ene</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance rate</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">the human ether-a- go-go-related gene</p></td></tr><tr><td class="NLM_term">PXR</td><td class="NLM_def"><p class="first last">pregnane X receptor</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">rt or RT</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minutes</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">methyl sulfoxide</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cohen, J.</span><span> </span><span class="NLM_article-title">The scientific challenge of hepatitis C</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=26-30&author=J.+Cohen&title=The+scientific+challenge+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%26atitle%3DThe%2520scientific%2520challenge%2520of%2520hepatitis%2520C%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D26%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruszon-Moran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nainan, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuillan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, H. S.</span><span> </span><span class="NLM_article-title">The prevalence of hepatitis C virus infection in the United States, 1988 through 1994</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1056%2FNEJM199908193410802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=10451460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=556-562&author=M.+J.+Alterauthor=D.+Kruszon-Moranauthor=O.+V.+Nainanauthor=G.+M.+McQuillanauthor=F.+Gaoauthor=L.+A.+Moyerauthor=R.+A.+Kaslowauthor=H.+S.+Margolis&title=The+prevalence+of+hepatitis+C+virus+infection+in+the+United+States%2C+1988+through+1994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence of hepatitis C virus infection in the United States, 1988 through 1994</span></div><div class="casAuthors">Alter M J; Kruszon-Moran D; Nainan O V; McQuillan G M; Gao F; Moyer L A; Kaslow R A; Margolis H S</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">556-62</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Because many persons with chronic hepatitis C virus (HCV) infection are asymptomatic, population-based serologic studies are needed to estimate the prevalence of the infection and to develop and evaluate prevention efforts.  METHODS:  We performed tests for antibody to HCV (anti-HCV) on serum samples from 21,241 persons six years old or older who participated in the third National Health and Nutrition Examination Survey, conducted during 1988 through 1994.  We determined the prevalence of HCV RNA by means of nucleic acid amplification and the genotype by means of sequencing.  RESULTS:  The overall prevalence of anti-HCV was 1.8 percent, corresponding to an estimated 3.9 million persons nationwide (95 percent confidence interval, 3.1 million to 4.8 million) with HCV infection.  Sixty-five percent of the persons with HCV infection were 30 to 49 years old.  Seventy-four percent were positive for HCV RNA, indicating that an estimated 2.7 million persons in the United States (95 percent confidence interval, 2.4 million to 3.0 million) were chronically infected, of whom 73.7 percent were infected with genotype 1 (56.7 percent with genotype 1a, and 17.0 percent with genotype 1b).  Among subjects 17 to 59 years of age, the strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior.  Other factors independently associated with infection included poverty, having had 12 or fewer years of education, and having been divorced or separated.  Neither sex nor racial-ethnic group was independently associated with HCV infection.  CONCLUSIONS:  In the United States, about 2.7 million persons are chronically infected with HCV.  People who use illegal drugs or engage in high-risk sexual behavior account for most persons with HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTwajewlRkP_tos8R3JUhXfW6udTcc2eYdwOQ05E3POrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D&md5=d36f80ca56095fcd3cb19271f9e80dca</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1056%2FNEJM199908193410802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199908193410802%26sid%3Dliteratum%253Aachs%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26aulast%3DKruszon-Moran%26aufirst%3DD.%26aulast%3DNainan%26aufirst%3DO.%2BV.%26aulast%3DMcQuillan%26aufirst%3DG.%2BM.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DMoyer%26aufirst%3DL.%2BA.%26aulast%3DKaslow%26aufirst%3DR.%2BA.%26aulast%3DMargolis%26aufirst%3DH.%2BS.%26atitle%3DThe%2520prevalence%2520of%2520hepatitis%2520C%2520virus%2520infection%2520in%2520the%2520United%2520States%252C%25201988%2520through%25201994%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D556%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cuthbert, J. A.</span><span> </span><span class="NLM_article-title">Hepatitis C: Progress and problems</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=7834603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1994&pages=505-532&author=J.+A.+Cuthbert&title=Hepatitis+C%3A+Progress+and+problems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C: progress and problems</span></div><div class="casAuthors">Cuthbert J A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-32</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV), a single-stranded RNA virus, is the major cause of posttransfusion hepatitis.  HCV isolates differ in nucleotide and amino acid sequences.  Nucleotide changes are concentrated in hypervariable regions and may be related to immune selection.  In most immunocompetent persons, HCV infection is diagnosed serologically, using antigens from conserved regions.  Amplification of RNA may be necessary to detect infection in immunosuppressed patients.  Transmission by known parenteral routes is frequent; other means of spread are less common and may represent inapparent, percutaneous dissemination.  Infection can lead to classical acute hepatitis, but most infected persons have no history of acute disease.  Once infected, most individuals apparently remain carriers of the virus, with varying degrees of hepatocyte damage and fibrosis ensuing.  Chronic hepatitis may lead to cirrhosis and hepatocellular carcinoma.  However, disease progression varies widely, from less than 2 years to cirrhosis in some patients to more than 30 years with only chronic hepatitis in others.  Determinants important in deciding outcome are unknown.  Alpha interferon, which results in sustained remission in selected patients, is the only available therapy.  Long-term benefits from such therapy have not been demonstrated.  Prevention of HCV infection by vaccination is likely to be challenging if ongoing viral mutation results in escape from neutralization and clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXDQuuyW-2sDEC-75aqa5AfW6udTcc2eaxFia8zI_eSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D&md5=b4434f7061f607052197da39e1916b0a</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuthbert%26aufirst%3DJ.%2BA.%26atitle%3DHepatitis%2520C%253A%2520Progress%2520and%2520problems%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D1994%26volume%3D7%26spage%3D505%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shepard, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Global epidemiology of hepatitis C virus infection</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1016%2FS1473-3099%2805%2970216-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=16122679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=558-567&author=C.+W.+Shepardauthor=L.+Finelliauthor=M.+J.+Alter&title=Global+epidemiology+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Global epidemiology of hepatitis C virus infection</span></div><div class="casAuthors">Shepard Colin W; Finelli Lyn; Alter Miriam J</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">558-67</span>
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    </div><div class="casAbstract">Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future.  The complexity and uncertainty related to the geographic distribution of HCV infection and chronic hepatitis C, determination of its associated risk factors, and evaluation of cofactors that accelerate its progression, underscore the difficulties in global prevention and control of HCV.  Because there is no vaccine and no post-exposure prophylaxis for HCV, the focus of primary prevention efforts should be safer blood supply in the developing world, safe injection practices in health care and other settings, and decreasing the number of people who initiate injection drug use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyQ65qEM2alVm8bhe6roZYfW6udTcc2eaxFia8zI_eSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D&md5=4d5f81fa0c2191b8c32b328e39933fad</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2805%2970216-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252805%252970216-4%26sid%3Dliteratum%253Aachs%26aulast%3DShepard%26aufirst%3DC.%2BW.%26aulast%3DFinelli%26aufirst%3DL.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DGlobal%2520epidemiology%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2005%26volume%3D5%26spage%3D558%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, T. L.</span><span> </span><span class="NLM_article-title">The epidemiology and prevention of hepatocellular carcinoma</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1016%2FS0093-7754%2801%2990137-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=11685737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A280%3ADC%252BD3MngvVOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=441-449&author=A.+Montoauthor=T.+L.+Wright&title=The+epidemiology+and+prevention+of+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">The epidemiology and prevention of hepatocellular carcinoma</span></div><div class="casAuthors">Monto A; Wright T L</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">441-9</span>
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is a common cancer.  Its incidence is higher in countries where hepatitis B is endemic.  HCC is substantially a complication of liver cirrhosis.  Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the predominant causes of cirrhosis, and as such, HCC.  The link between HCC and alcoholic cirrhosis is less strong.  Other less common forms of chronic liver disease can also lead to HCC.  HBV is the HCC-determining disease worldwide.  In endemic regions, it tends to be acquired early in life.  The largest strides in prevention of HCC have been made with the HBV vaccine.  HCV has a lower global prevalence than HBV, but HCV causes the most HCC in economically developed regions.  In these areas, where the incidence of HCC is low, HCV now accounts for more than 50% of HCCs.  There is no vaccine for HCV, so prevention of HCV-associated HCC will focus on prevention of initial infection and elimination of infection through antiviral therapies.  HBV-HCV coinfection, and the combination of either with alcohol abuse or aflatoxin exposure seems to raise the risk of HCC development further.  Liver transplantation and other adjuvant therapies may offer better options for secondary prevention of HCC than resection alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuq0Don9pfEtTiMd2aNQVUfW6udTcc2eaxFia8zI_eSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MngvVOhtw%253D%253D&md5=1b421c8469c206780be4d03eafb412e2</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2FS0093-7754%2801%2990137-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0093-7754%252801%252990137-X%26sid%3Dliteratum%253Aachs%26aulast%3DMonto%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DT.%2BL.%26atitle%3DThe%2520epidemiology%2520and%2520prevention%2520of%2520hepatocellular%2520carcinoma%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D441%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sheridan, C.</span><span> </span><span class="NLM_article-title">New Merck and Vertex drugs raise standard of care in hepatitis C</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=553-554&author=C.+Sheridan&title=New+Merck+and+Vertex+drugs+raise+standard+of+care+in+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheridan%26aufirst%3DC.%26atitle%3DNew%2520Merck%2520and%2520Vertex%2520drugs%2520raise%2520standard%2520of%2520care%2520in%2520hepatitis%2520C%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D553%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fried, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, D. K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonçales, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häussinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhumeaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span> </span><span class="NLM_article-title">PEGinterferon-α-2a plus ribavirin for chronic hepatitis C virus infection</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1056%2FNEJMoa020047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=12324553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=975-982&author=M.+W.+Friedauthor=M.+L.+Shiffmanauthor=D.+K.+R.+Reddyauthor=C.+Smithauthor=G.+Marinosauthor=F.+L.+Gon%C3%A7alesauthor=D.+H%C3%A4ussingerauthor=M.+Diagoauthor=G.+Carosiauthor=D.+Dhumeauxauthor=A.+Craxiauthor=A.+Linauthor=J.+Hoffmanauthor=J.+Yu&title=PEGinterferon-%CE%B1-2a+plus+ribavirin+for+chronic+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span></div><div class="casAuthors">Fried, Michael W.; Shiffman, Mitchell L.; Reddy, K. Rajender; Smith, Coleman; Marinos, George; Goncales, Fernando L., Jr.; Haussinger, Dieter; Diago, Moises; Carosi, Giampiero; Dhumeaux, Daniel; Craxi, Antonio; Lin, Amy; Hoffman, Joseph; Yu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">975-982</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Treatment with peginterferon alfa-2a alone produces significantly higher sustained virol. responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection.  We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in the initial treatment of chronic hepatitis C.  Methods: A total of 1121 patients were randomly assigned to treatment and received at least one dose of study medication, consisting of 180 μg of peginterferon alfa-2a once weekly plus daily ribavirin (1000 or 1200 mg, depending on body wt.), weekly peginterferon alfa-2a plus daily placebo, or 3 million units of interferon alfa-2b thrice weekly plus daily ribavirin for 48 wk.  Results: A significantly higher proportion of patients who received peginterferon alfa-2a plus ribavirin had a sustained virol. response (defined as the absence of detectable HCV RNA 24 wk after cessation of therapy) than of patients who received interferon alfa-2b plus ribavirin (56 % vs. 44 %, P<0.001) or peginterferon alfa-2a alone (56 % vs. 29 %, P<0.001).  The proportions of patients with HCV genotype 1 who had sustained virol. responses were 46 %, 36 %, and 21 %, resp., for the three regimens.  Among patients with HCV genotype 1 and high base-line levels of HCV RNA, the proportions of those with sustained virol. responses were 41 %, 33 %, and 13 %, resp.  The overall safety profiles of the three treatment regimens were similar; the incidence of influenza-like symptoms and depression was lower in the groups receiving peginterferon alfa-2a than in the group receiving interferon alfa-2b plus ribavirin.  Conclusions: In patients with chronic hepatitis C, once-weekly peginterferon alfa-2a plus ribavirin was tolerated as well as interferon alfa-2b plus ribavirin and produced significant improvements in the rate of sustained virol. response, as compared with interferon alfa-2b plus ribavirin or peginterferon alfa-2a alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblwkeNXWJzbVg90H21EOLACvtfcHk0lh9dL7NS2Itfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D&md5=2fd959d790b9505384fbd26ef44b2963</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020047%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DReddy%26aufirst%3DD.%2BK.%2BR.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DMarinos%26aufirst%3DG.%26aulast%3DGon%25C3%25A7ales%26aufirst%3DF.%2BL.%26aulast%3DH%25C3%25A4ussinger%26aufirst%3DD.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DCarosi%26aufirst%3DG.%26aulast%3DDhumeaux%26aufirst%3DD.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DPEGinterferon-%25CE%25B1-2a%2520plus%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D975%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Di Bisceglie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">New therapeutic strategies for hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2002&pages=224-231&author=A.+M.+Di+Bisceglieauthor=J.+McHutchisonauthor=C.+M.+Rice&title=New+therapeutic+strategies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%2BM.%26aulast%3DMcHutchison%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DNew%2520therapeutic%2520strategies%2520for%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2002%26volume%3D35%26spage%3D224%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Choo, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=2523562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.+L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=A.+J.+Weinerauthor=L.+R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood-borne+non-A%2C+non-B+viral+hepatitis+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span></div><div class="casAuthors">Choo, Qui Lim; Kuo, George; Weiner, Amy J.; Overby, Lacy R.; Bradley, Daniel W.; Houghton, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4902</span>),
    <span class="NLM_cas:pages">359-62</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A random-primed cDNA library was constructed from plasma contg. the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH.  A cDNA clone was isolated that was shown to encode an antigen assocd. specifically with NANBH infections.  This clone is not derived from host DNA but from an RNA mol. present in NANBH infections that consists of ≥10,000 nucleotides, and that is pos.-stranded with respect to the encoded NANBH antigen.  These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae.  This mol. approach should be of great value in the isolation and characterization of other unidentified infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpVFx7nEkrVg90H21EOLACvtfcHk0lh9dL7NS2Itfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D&md5=25161cf212790856dd29d3aaf78f20b8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.%2BL.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL.%2BR.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood-borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">A review of HCV protease inhibitors</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=821-837&author=K.+X.+Chenauthor=F.+G.+Njoroge&title=A+review+of+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DA%2520review%2520of%2520HCV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D821%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Legrand-Abravanel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">New NS5B polymerase inhibitors for hepatitis C</span> <span class="citation_source-journal">Expert Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=963-975&author=F.+Legrand-Abravanelauthor=F.+Nicotauthor=J.+Izopet&title=New+NS5B+polymerase+inhibitors+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegrand-Abravanel%26aufirst%3DF.%26aulast%3DNicot%26aufirst%3DF.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DNew%2520NS5B%2520polymerase%2520inhibitors%2520for%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Investig.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D963%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V.+N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+genetics+strategy+identifies+an+HCV+NS5A+inhibitor+with+a+potent+clinical+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-α and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0lh9dL7NS2Itfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520genetics%2520strategy%2520identifies%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520a%2520potent%2520clinical%2520effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afdhal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzowej, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bisceglie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dienstag, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faruqui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fried, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugelmas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poordad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younossi, Z.</span><span> </span><span class="NLM_article-title">Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection</span> <span class="citation_source-journal">N. Eng. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">1827</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1056%2FNEJMoa0806104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=19403902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVGmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=1827-1838&author=J.+G.+McHutchisonauthor=G.+T.+Eversonauthor=S.+C.+Gordonauthor=I.+M.+Jacobsonauthor=M.+Sulkowskiauthor=R.+Kauffmanauthor=L.+McNairauthor=J.+Alamauthor=A.+J.+Muirauthor=N.+Afdhalauthor=S.+Aroraauthor=V.+Balanauthor=H.+Vargasauthor=D.+Bernsteinauthor=M.+Blackauthor=R.+Brownauthor=N.+Bzowejauthor=G.+Davisauthor=A.+Di+Bisceglieauthor=J.+Dienstagauthor=G.+Eversonauthor=S.+Faruquiauthor=J.+Francoauthor=M.+Friedauthor=R.+Ghalibauthor=S.+C.+Gordonauthor=J.+Grossauthor=I.+M.+Jacobsonauthor=D.+Jensenauthor=M.+Kugelmasauthor=P.+Kwoauthor=E.+Lawitzauthor=W.+Leeauthor=P.+Martinauthor=D.+Nelsonauthor=P.+Northupauthor=K.+Patelauthor=F.+Poordadauthor=R.+K.+Reddyauthor=M.+Rodriguez-Torresauthor=V.+Rustgiauthor=E.+Schiffauthor=K.+Shermanauthor=M.+Shiffmanauthor=M.+Sulkowskiauthor=G.+Szabolauthor=Z.+Younossi&title=Telaprevir+with+peginterferon+and+ribavirin+for+chronic+HCV+genotype+1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection</span></div><div class="casAuthors">McHutchison, John G.; Everson, Gregory T.; Gordon, Stuart C.; Jacobson, Ira M.; Sulkowski, Mark; Kauffman, Robert; McNair, Lindsay; Alam, John; Muir, Andrew J.; Afdhal, N.; Arora, S.; Balan, V.; Vargas, H.; Bernstein, D.; Black, M.; Brown, R.; Bzowej, N.; Davis, G.; Di Bisceglie, A.; Dienstag, J.; Everson, G.; Faruqui, S.; Franco, J.; Fried, M.; Ghalib, R.; Gordon, S. C.; Gross, J.; Jacobson, I. M.; Jensen, D.; Kugelmas, M.; Kwo, P.; Lawitz, E.; Lee, W.; Martin, P.; Nelson, D.; Northup, P.; Patel, K.; Poordad, F.; Reddy, R. K.; Rodriguez-Torres, M.; Rustgi, V.; Schiff, E.; Sherman, K.; Shiffman, M.; Sulkowski, M.; Szabol, G.; Younossi, Z.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1827-1838</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Current therapy for chronic hepatitis C virus (HCV) infection is effective in less than 50% of patients infected with HCV genotype 1.  Telaprevir, a protease inhibitor specific to the HCV nonstructural 3/4A serine protease, rapidly reduced HCV RNA levels in early studies.  METHODS We randomly assigned patients infected with HCV genotype 1 to one of three telaprevir groups or to the control group.  The control group (called the PR48 group) received peginterferon alfa-2a (180 μg per wk) and ribavirin (1000 or 1200 mg per day, according to body wt.) for 48 wk, plus telaprevir-matched placebo for the first 12 wk (75 patients).  The telaprevir groups received telaprevir (1250 mg on day 1 and 750 mg every 8 h thereafter) for 12 wk, as well as peginterferon alfa-2a and ribavirin (at the same doses as in the PR48 group) for the same 12 wk (the T12PR12 group, 17 patients) or for a total of 24 wk (the T12PR24 group, 79 patients) or 48 wk (the T12PR48 group, 79 patients).  The primary outcome was a sustained virol. response (an undetectable HCV RNA level 24 wk after the end of therapy).  RESULTS The rate of sustained virol. response was 41% (31 of 75 patients) in the PR48 group, as compared with 61% (48 of 79 patients) in the T12PR24 group (P = 0.02), 67% (53 of 79 patients) in the T12PR48 group (P = 0.002), and 35% (6 of 17 patients) in the T12PR12 group (this group was exploratory and not compared with the control group).  Viral breakthrough occurred in 7% of patients receiving telaprevir.  The rate of discontinuation because of adverse events was higher in the three telaprevir-based groups (21%, vs. 11% in the PR48 group), with rash the most common reason for discontinuation.  CONCLUSIONS Treatment with a telaprevir-based regimen significantly improved sustained virol. response rates in patients with genotype 1 HCV, albeit with higher rates of discontinuation because of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnK2pWAKIzM7Vg90H21EOLACvtfcHk0liqZx61EU747A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVGmtrc%253D&md5=574eed8a6bd101631bb1e3d904a072b5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0806104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0806104%26sid%3Dliteratum%253Aachs%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DR.%26aulast%3DMcNair%26aufirst%3DL.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DMuir%26aufirst%3DA.%2BJ.%26aulast%3DAfdhal%26aufirst%3DN.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBalan%26aufirst%3DV.%26aulast%3DVargas%26aufirst%3DH.%26aulast%3DBernstein%26aufirst%3DD.%26aulast%3DBlack%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DBzowej%26aufirst%3DN.%26aulast%3DDavis%26aufirst%3DG.%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%26aulast%3DDienstag%26aufirst%3DJ.%26aulast%3DEverson%26aufirst%3DG.%26aulast%3DFaruqui%26aufirst%3DS.%26aulast%3DFranco%26aufirst%3DJ.%26aulast%3DFried%26aufirst%3DM.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DJensen%26aufirst%3DD.%26aulast%3DKugelmas%26aufirst%3DM.%26aulast%3DKwo%26aufirst%3DP.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DNelson%26aufirst%3DD.%26aulast%3DNorthup%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DPoordad%26aufirst%3DF.%26aulast%3DReddy%26aufirst%3DR.%2BK.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DSchiff%26aufirst%3DE.%26aulast%3DSherman%26aufirst%3DK.%26aulast%3DShiffman%26aufirst%3DM.%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DSzabol%26aufirst%3DG.%26aulast%3DYounossi%26aufirst%3DZ.%26atitle%3DTelaprevir%2520with%2520peginterferon%2520and%2520ribavirin%2520for%2520chronic%2520HCV%2520genotype%25201%2520infection%26jtitle%3DN.%2520Eng.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D1827%26epage%3D1838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kwo, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vierling, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pound, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galati, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravendhran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koury, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedicone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=705-716&author=P.+Y.+Kwoauthor=E.+J.+Lawitzauthor=J.+McConeauthor=E.+R.+Schiffauthor=J.+M.+Vierlingauthor=D.+Poundauthor=M.+N.+Davisauthor=J.+S.+Galatiauthor=S.+C.+Gordonauthor=N.+Ravendhranauthor=L.+Rossaroauthor=F.+H.+Andersonauthor=I.+M.+Jacobsonauthor=R.+Rubinauthor=K.+Kouryauthor=L.+D.+Pediconeauthor=C.+A.+Brassauthor=E.+Chaudhriauthor=J.+K.+Albrecht&title=Efficacy+of+boceprevir%2C+an+NS3+protease+inhibitor%2C+in+combination+with+peginterferon+alfa-2b+and+ribavirin+in+treatment-naive+patients+with+genotype+1+hepatitis+C+infection+%28SPRINT-1%29%3A+an+open-label%2C+randomised%2C+multicentre+phase+2+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwo%26aufirst%3DP.%2BY.%26aulast%3DLawitz%26aufirst%3DE.%2BJ.%26aulast%3DMcCone%26aufirst%3DJ.%26aulast%3DSchiff%26aufirst%3DE.%2BR.%26aulast%3DVierling%26aufirst%3DJ.%2BM.%26aulast%3DPound%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DM.%2BN.%26aulast%3DGalati%26aufirst%3DJ.%2BS.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DRavendhran%26aufirst%3DN.%26aulast%3DRossaro%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DF.%2BH.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DRubin%26aufirst%3DR.%26aulast%3DKoury%26aufirst%3DK.%26aulast%3DPedicone%26aufirst%3DL.%2BD.%26aulast%3DBrass%26aufirst%3DC.%2BA.%26aulast%3DChaudhri%26aufirst%3DE.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DEfficacy%2520of%2520boceprevir%252C%2520an%2520NS3%2520protease%2520inhibitor%252C%2520in%2520combination%2520with%2520peginterferon%2520alfa-2b%2520and%2520ribavirin%2520in%2520treatment-naive%2520patients%2520with%2520genotype%25201%2520hepatitis%2520C%2520infection%2520%2528SPRINT-1%2529%253A%2520an%2520open-label%252C%2520randomised%252C%2520multicentre%2520phase%25202%2520trial%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D705%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally, bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally%2C+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%252C%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J. J.</span><span> </span><span class="NLM_article-title">Challenges in modern drug discovery: A case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar700109k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=50-59&author=F.+G.+Njorogeauthor=K.+X.+Chenauthor=N.-Y.+Shihauthor=J.+J.+Piwinski&title=Challenges+in+modern+drug+discovery%3A+A+case+study+of+boceprevir%2C+an+HCV+protease+inhibitor+for+the+treatment+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Far700109k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far700109k%26sid%3Dliteratum%253Aachs%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26atitle%3DChallenges%2520in%2520modern%2520drug%2520discovery%253A%2520A%2520case%2520study%2520of%2520boceprevir%252C%2520an%2520HCV%2520protease%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D50%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogonowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudence, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-amino-1-(cyclobutylmethyl)-2–3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a selective, potent, orally bioavailable, hepatitis C virus NS3 protease inhibitor: A potential therapeutic agent for the treatment of hepatitis C infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agarwalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=B.+L.+Madisonauthor=X.+Cuiauthor=K.-C.+Chengauthor=T.+Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Kormacherauthor=R.+Whiteauthor=S.+Bogonowich-Knippauthor=A.+Pavlovskyauthor=B.+Prudenceauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-amino-1-%28cyclobutylmethyl%29-2%E2%80%933-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable%2C+hepatitis+C+virus+NS3+protease+inhibitor%3A+A+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DB.%2BL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DT.%2BY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKormacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogonowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DPrudence%26aufirst%3DB.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-amino-1-%2528cyclobutylmethyl%2529-2%25E2%2580%25933-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%252C%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520A%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Behrens, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span> </span><span class="NLM_article-title">Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=12-22&author=S.+E.+Behrensauthor=L.+Tomeiauthor=R.+De+Francesco&title=Identification+and+properties+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBehrens%26aufirst%3DS.%2BE.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520properties%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D12%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Biochemical properties of hepatitis c virus ns5b RNAdependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">8416</span><span class="NLM_x">–</span> <span class="NLM_lpage">8428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=9343198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaK2sXmvV2hs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=8416-8428&author=V.+Lohmannauthor=F.+Kornerauthor=U.+Herianauthor=R.+Bartenschlager&title=Biochemical+properties+of+hepatitis+c+virus+ns5b+RNAdependent+RNA+polymerase+and+identification+of+amino+acid+sequence+motifs+essential+for+enzymatic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymic activity</span></div><div class="casAuthors">Lohmann, Volker; Korner, Frank; Herian, Ulrike; Bartenschlager, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8416-8428</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The NS5B protein of the hepatitis C virus (HCV) is an RNA-dependent RNA polymerase (RdRp) (S.-E. Behrens, L. Tomei, and R. De Francesco, EMBO J. 15:12-22, 1996) that is assumed to be required for replication of the viral genome.  To further study the biochem. and structural properties of this enzyme, an NS5B-hexahistidine fusion protein was expressed with recombinant baculoviruses in insect cells and purified to near homogeneity.  The enzyme was found to have a primer-dependent RdRp activity that was able to copy a complete in vitro-transcribed HCV genome in the absence of addnl. viral or cellular factors.  Filter binding assays and competition expts. showed that the purified enzyme binds RNA with no clear preference for HCV 3'-end sequences.  Binding to homopolymeric RNAs was also examd., and the following order of specificity was obsd.: poly(U) > poly(G) > poly(A) > poly(C).  An inverse order was found for the RdRp activity, which used poly(C) most efficiently as a template but was inactive on poly(U) and poly(G), suggesting that a high binding affinity between polymerase and template interferes with processivity.  By using a mutational anal., four amino acid sequence motifs crucial for RdRp activity were identified.  While most substitutions of conserved residues within these motifs severely reduced the enzymic activities, a single substitution in motif D which enhanced the RdRp activity by about 50% was found.  Deletion studies indicate that amino acid residues at the very termini, in particular the amino terminus, are important for RdRp activity but not for RNA binding.  Finally, we found a terminal transferase activity assocd. with the purified enzyme.  However, this activity was also detected with NS5B proteins with an inactive RdRp, with an NS4B protein purified in the same way, and with wild-type baculovirus, suggesting that it is not an inherent activity of NS5B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdCeTDzvlRArVg90H21EOLACvtfcHk0lh0ybVJuLvilA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvV2hs7s%253D&md5=98640d185270f0b331db0fa0624865cd</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DBiochemical%2520properties%2520of%2520hepatitis%2520c%2520virus%2520ns5b%2520RNAdependent%2520RNA%2520polymerase%2520and%2520identification%2520of%2520amino%2520acid%2520sequence%2520motifs%2520essential%2520for%2520enzymatic%2520activity%26jtitle%3DJ.%2520Virol.%26date%3D1997%26volume%3D71%26spage%3D8416%26epage%3D8428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Quinkert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, V.</span><span> </span><span class="NLM_article-title">Quantitative analysis of the hepatitis C virus replication complex</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">13594</span><span class="NLM_x">–</span> <span class="NLM_lpage">13605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1128%2FJVI.79.21.13594-13605.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=16227280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKjtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=13594-13605&author=D.+Quinkertauthor=R.+Bartenschlagerauthor=V.+Lohmann&title=Quantitative+analysis+of+the+hepatitis+C+virus+replication+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative analysis of the hepatitis C virus replication complex</span></div><div class="casAuthors">Quinkert, Doris; Bartenschlager, Ralf; Lohmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13594-13605</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) encodes a large polyprotein; therefore, all viral proteins are produced in equimolar amts. regardless of their function.  The aim of our study was to det. the ratio of nonstructural proteins to RNA that is required for HCV RNA replication.  We analyzed Huh-7 cells harboring full-length HCV genomes or subgenomic replicons and found in all cases a >1000-fold excess of HCV proteins over pos.- and neg.-strand RNA.  To examine whether all nonstructural protein copies are involved in RNA synthesis, we isolated active HCV replication complexes from replicon cells and examd. them for their content of viral RNA and proteins before and after treatment with protease and/or nuclease.  In vitro replicase activity, as well as almost the entire neg.- and pos.-strand RNA, was resistant to nuclease treatment, whereas <5% of the nonstructural proteins were protected from protease digest but accounted for the full in vitro replicase activity.  In consequence, only a minor fraction of the HCV nonstructural proteins was actively involved in RNA synthesis at a given time point but, due to the high amts. present in replicon cells, still representing a huge excess compared to the viral RNA.  Based on the comparison of nuclease-resistant viral RNA to protease-resistant viral proteins, we est. that an active HCV replicase complex consists of one neg.-strand RNA, two to ten pos.-strand RNAs, and several hundred nonstructural protein copies, which might be required as structural components of the vesicular compartments that are the site of HCV replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogSsRsSfAAvLVg90H21EOLACvtfcHk0lh0ybVJuLvilA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKjtr%252FJ&md5=c5060858a84ac062a62d2bfa0a5ca926</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.21.13594-13605.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.21.13594-13605.2005%26sid%3Dliteratum%253Aachs%26aulast%3DQuinkert%26aufirst%3DD.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DLohmann%26aufirst%3DV.%26atitle%3DQuantitative%2520analysis%2520of%2520the%2520hepatitis%2520C%2520virus%2520replication%2520complex%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D13594%26epage%3D13605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cable, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannarino, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=937-943&author=C.+A.+Lesburgauthor=M.+B.+Cableauthor=E.+Ferrariauthor=Z.+Hongauthor=A.+F.+Mannarinoauthor=P.+C.+Weber&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+from+hepatitis+C+virus+reveals+a+fully+encircled+active+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DCable%26aufirst%3DM.%2BB.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DMannarino%26aufirst%3DA.%2BF.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520hepatitis%2520C%2520virus%2520reveals%2520a%2520fully%2520encircled%2520active%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D937%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ago, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatsunami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, M.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1016%2FS0969-2126%2800%2980031-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=10574802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=1417-1426&author=H.+Agoauthor=T.+Adachiauthor=A.+Yoshidaauthor=M.+Yamamotoauthor=N.+Habukaauthor=K.+Yatsunamiauthor=M.+Miyano&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Ago, Hideo; Adachi, Tsuyoshi; Yoshida, Atsuhito; Yamamoto, Masaki; Habuka, Noriyuki; Yatsunami, Kimio; Miyano, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1417-1426</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is the major etiol. agent of hepatocellular carcinoma, and HCV RNA-dependent RNA polymerase (RNA replicase) (I) is one of the main potential targets for anti-HCV agents.  HCV I performs run-off copying replication in an RNA-selective manner for the template-primer duplex and the substrate, but the structural basis of this reaction mechanism has still to be elucidated.  Here, the 3-dimensional structure of HCV I was detd. by x-ray crystallog. at 2.5 Å resoln.  The compact HCV I structure resembled a right hand, but had more complicated fingers and thumb domains than those of the other known polymerases, with a novel α-helix-rich subdomain (α fingers) as an addn. to the fingers domain.  The other fingers subdomain (β fingers) was folded in the same manner as the fingers domain of HIV virus reverse transcriptase, another RNA-dependent polymerase.  The ribose-recognition site of HCV I was constructed of hydrophilic residues, unlike those of DNA polymerases.  The C-terminal region of HCV I occupied the putative RNA-duplex-binding cleft.  The structural basis of the RNA selectivity of HCV I was elucidated from its crystal structure.  The putative substrate-binding site with a shallow hydrophilic cavity should have ribonucleoside triphosphate as the preferred substrate.  The authors propose that the unique α fingers might represent a common structural discriminator of the template-primer duplex that distinguishes between RNA and DNA during the replication of pos. single-stranded RNA by viral I enzymes.  The C-terminal region might exert a regulatory function on the initiation and activity of HCV I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKp1aOmXjMKLVg90H21EOLACvtfcHk0lh0ybVJuLvilA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D&md5=95fcc20ce2f28dab4d76d8dfac0aa4ee</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2800%2980031-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252800%252980031-3%26sid%3Dliteratum%253Aachs%26aulast%3DAgo%26aufirst%3DH.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DYatsunami%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D1417%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">Reviews of non-nucleoside HCV NS5B polymerase inhibitors: </p></div><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, Y.; He, Y.; Molla, A.</span><span> </span><span class="NLM_article-title">Hepatitis C virus polymerase as a target for antiviral drug intervention: Non-nucleoside inhibitors</span>. In  <span class="citation_source-book">Antiviral Research: Strategies in Antiviral Drug Discovery</span>; <span class="NLM_contrib-group">LaFemina, R. L.</span>, Ed.; <span class="NLM_publisher-name">ASM Press</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1128%2F9781555815493.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=137-151&author=Y.+Liu&author=Y.+He&author=A.+Mollaauthor=R.+L.+LaFemina&title=Antiviral+Research%3A+Strategies+in+Antiviral+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1128%2F9781555815493.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1128%252F9781555815493.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DHepatitis%2520C%2520virus%2520polymerase%2520as%2520a%2520target%2520for%2520antiviral%2520drug%2520intervention%253A%2520Non-nucleoside%2520inhibitors%26btitle%3DAntiviral%2520Research%253A%2520Strategies%2520in%2520Antiviral%2520Drug%2520Discovery%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26pub%3DASM%2520Press%26date%3D2009%26spage%3D137%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the hcv ns5b polymerase: Progress in the discovery and development of novel agents for the treatment of hcv infections</span> <span class="citation_source-journal">Curr. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=17668364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=614-634&author=P.+L.+Beaulieu&title=Non-nucleoside+inhibitors+of+the+hcv+ns5b+polymerase%3A+Progress+in+the+discovery+and+development+of+novel+agents+for+the+treatment+of+hcv+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">614-634</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The severe health conditions assocd. with chronic HCV infection remain a global concern.  Small-mol. drugs that specifically target essential virally encoded enzymes have not yet progressed to market, and the current std. of care continues to rely on a combination of pegylated IFN with ribavirin.  This therapy has serious side effects and a significant proportion of patients infected with HCV genotype 1 (the major genotype in industrialized countries) have an unsatisfactory outcome with this therapy.  Major advances have been realized in the development of specific non-nucleoside inhibitors of the viral NS5B RNA-dependent RNA polymerase.  This well-characterized replicative enzyme is a highly drugable target that, in addn. to its active site, features at least three known allosteric binding pockets that regulate RNA synthesis and are suitable for inhibitor design.  Clin. proof-of-concept for allosteric non-nucleoside HCV polymerase inhibitors has been reported and several compds. have progressed into preclin. studies.  It is likely that in the future NS5B inhibitors will form an integral part of more effective anti-HCV therapies, combining the use of small-mol. antiviral drugs with or without the assistance of immune modulators such as IFNs in order to minimize the emergence of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTl5U1TLVJ57Vg90H21EOLACvtfcHk0liGij2k-rm6mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK&md5=347a7983497b1b50bba61a455783f302</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520hcv%2520ns5b%2520polymerase%253A%2520Progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520agents%2520for%2520the%2520treatment%2520of%2520hcv%2520infections%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D614%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">Reviews of HCV NS5B polymerase inhibitors: </p></div><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Legrand-Abravanel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">New NS5B polymerase inhibitors for hepatitis C</span> <span class="citation_source-journal">Expert Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=963-975&author=F.+Legrand-Abravanelauthor=F.+Nicotauthor=J.+Izopet&title=New+NS5B+polymerase+inhibitors+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegrand-Abravanel%26aufirst%3DF.%26aulast%3DNicot%26aufirst%3DF.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DNew%2520NS5B%2520polymerase%2520inhibitors%2520for%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Investig.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D963%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1517%2F13543770802672598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=145-164&author=P.+L.+Beaulieu&title=Recent+advances+in+the+development+of+NS5B+polymerase+inhibitors+for+the+treatment+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-164</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  170 To 200 million people worldwide are believed to suffer from chronic hepatitis C virus (HCV) infection, a blood-born disease that targets the liver and progresses to organ cirrhosis and primary cancer in a significant proportion of patients.  The currently available treatment has limited efficacy and suffers from restricting side effects.  HCV infection is the principal cause of liver transplant in industrialized nations and between 8000 and 10,000 deaths result annually from the disease in the United States alone.  Virus-specific, more efficacious, and better-tolerated anti-HCV therapies are thus required to address the unmet medical need.  Objective: To review progress achieved since 2005 in the development of HCV NS5B polymerase inhibitors as potential therapy for the treatment of HCV infection with a primary focus on available patent and medical literature.  Results/conclusion: Several classes of small-mol. inhibitors of HCV NS5B have progressed into clin. development and demonstrated efficacy in reducing viral load in infected patients.  The results so far provide an encouraging foundation for the development of novel, more tolerable therapies and addressing emergence of resistance through combination of antiviral agents with complementary mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo8VVFJs4oSbVg90H21EOLACvtfcHk0liGij2k-rm6mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D&md5=64b78562e2b4e3e8a166fdabf14f7efe</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1517%2F13543770802672598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802672598%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520NS5B%2520polymerase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D145%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Witte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendricks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span> </span><span class="NLM_article-title">Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2005&pages=8-15&author=H.+Maauthor=V.+Levequeauthor=A.+De+Witteauthor=W.+Liauthor=T.+Hendricksauthor=S.+M.+Clausenauthor=N.+Cammackauthor=K.+Klumpp&title=Inhibition+of+native+hepatitis+C+virus+replicase+by+nucleotide+and+non-nucleoside+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DDe%2BWitte%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHendricks%26aufirst%3DT.%26aulast%3DClausen%26aufirst%3DS.%2BM.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DKlumpp%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520native%2520hepatitis%2520C%2520virus%2520replicase%2520by%2520nucleotide%2520and%2520non-nucleoside%2520inhibitors%26jtitle%3DVirology%26date%3D2005%26volume%3D332%26spage%3D8%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockstroh, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulim, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">The way forward in hcv treatment--finding the right path</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=991-1000&author=M.+P.+Mannsauthor=G.+R.+Fosterauthor=J.+K.+Rockstrohauthor=S.+Zeuzemauthor=F.+Zoulimauthor=M.+Houghton&title=The+way+forward+in+hcv+treatment%2D%2Dfinding+the+right+path"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DFoster%26aufirst%3DG.%2BR.%26aulast%3DRockstroh%26aufirst%3DJ.%2BK.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DZoulim%26aufirst%3DF.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DThe%2520way%2520forward%2520in%2520hcv%2520treatment--finding%2520the%2520right%2520path%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D991%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amours, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammadossi, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 20-C-methylcytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6614</span><span class="NLM_x">–</span> <span class="NLM_lpage">6620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6614-6620&author=C.+Pierraauthor=A.+Amadorauthor=S.+Benzariaauthor=E.+Cretton-Scottauthor=M.+D%E2%80%99Amoursauthor=J.+Maoauthor=S.+Mathieuauthor=A.+Moussaauthor=E.+G.+Bridgesauthor=D.+M.+Standringauthor=J.-P.+Sammadossiauthor=R.+Storerauthor=G.+Gosselin&title=Synthesis+and+pharmacokinetics+of+valopicitabine+%28NM283%29%2C+an+efficient+prodrug+of+the+potent+anti-HCV+agent+20-C-methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm0603623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603623%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amours%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DBridges%26aufirst%3DE.%2BG.%26aulast%3DStandring%26aufirst%3DD.%2BM.%26aulast%3DSammadossi%26aufirst%3DJ.-P.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520pharmacokinetics%2520of%2520valopicitabine%2520%2528NM283%2529%252C%2520an%2520efficient%2520prodrug%2520of%2520the%2520potent%2520anti-HCV%2520agent%252020-C-methylcytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6614%26epage%3D6620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> R1626:</p></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalayanov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltseva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V. J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyagurr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span> </span><span class="NLM_article-title">The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 40-azidocytidine against hepatitis C virus replication: The discovery of 40-azido-20-deoxy-20-fluorocytidine and 40-azido-20-dideoxy-20,20-difluorocytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2971</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801595c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2971-2978&author=D.+B.+Smithauthor=G.+Kalayanovauthor=G.+Sundauthor=A.+Winqvistauthor=T.+Maltsevaauthor=V.+J.-P.+Levequeauthor=S.+Rajyagurrauthor=S.+Le+Pogamauthor=I.+Najerauthor=K.+Benkestockauthor=X.-X.+Zhouauthor=A.+C.+Kaiserauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+G.+Johannssonauthor=K.+Klumppauthor=M.+Smith&title=The+design%2C+synthesis%2C+and+antiviral+activity+of+monofluoro+and+difluoro+analogues+of+40-azidocytidine+against+hepatitis+C+virus+replication%3A+The+discovery+of+40-azido-20-deoxy-20-fluorocytidine+and+40-azido-20-dideoxy-20%2C20-difluorocytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm801595c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801595c%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalayanov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DG.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DLeveque%26aufirst%3DV.%2BJ.-P.%26aulast%3DRajyagurr%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajer%26aufirst%3DI.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DKaiser%26aufirst%3DA.%2BC.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DJohannsson%26aufirst%3DN.%2BG.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520design%252C%2520synthesis%252C%2520and%2520antiviral%2520activity%2520of%2520monofluoro%2520and%2520difluoro%2520analogues%2520of%252040-azidocytidine%2520against%2520hepatitis%2520C%2520virus%2520replication%253A%2520The%2520discovery%2520of%252040-azido-20-deoxy-20-fluorocytidine%2520and%252040-azido-20-dideoxy-20%252C20-difluorocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2971%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> PSI-6130:</p></div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Clark, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollecker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankiewicz, K. W.</span><span> </span><span class="NLM_article-title">Design, synthesis, and antiviral activity of 20-deoxy-20-fluoro-20-c-methylcytidine, a potent inhibitor of hepatitis C virus replication</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5504</span><span class="NLM_x">–</span> <span class="NLM_lpage">5508</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5504-5508&author=J.+L.+Clarkauthor=L.+Holleckerauthor=J.+C.+Masonauthor=L.+J.+Stuyverauthor=P.+M.+Tharnishauthor=S.+Lostiaauthor=T.+R.+McBrayerauthor=R.+Schinaziauthor=K.+A.+Watanabeauthor=M.+J.+Ottoauthor=P.+A.+Furmanauthor=W.+J.+Stecauthor=S.+E.+Pattersonauthor=K.+W.+Pankiewicz&title=Design%2C+synthesis%2C+and+antiviral+activity+of+20-deoxy-20-fluoro-20-c-methylcytidine%2C+a+potent+inhibitor+of+hepatitis+C+virus+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjm0502788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502788%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BL.%26aulast%3DHollecker%26aufirst%3DL.%26aulast%3DMason%26aufirst%3DJ.%2BC.%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DSchinazi%26aufirst%3DR.%26aulast%3DWatanabe%26aufirst%3DK.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DStec%26aufirst%3DW.%2BJ.%26aulast%3DPatterson%26aufirst%3DS.%2BE.%26aulast%3DPankiewicz%26aufirst%3DK.%2BW.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antiviral%2520activity%2520of%252020-deoxy-20-fluoro-20-c-methylcytidine%252C%2520a%2520potent%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520replication%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5504%26epage%3D5508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarathnam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Discovery of a β-<span class="smallcaps smallerCapital">d</span>-2′-deoxy-2′-α-fluoro-2′-β-<i>C</i>-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7202</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100863x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7202-18&author=M.+J.+Sofiaauthor=D.+Baoauthor=W.+Changauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=P.+G.+Reddyauthor=B.+S.+Rossauthor=P.+Wangauthor=H.+R.+Zhangauthor=S.+Bansalauthor=C.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=H.+M.+Steuerauthor=C.+Niuauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Discovery+of+a+%CE%B2-d-2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B1-fluoro-2%E2%80%B2-%CE%B2-C-methyluridine+nucleotide+prodrug+%28PSI-7977%29+for+the+treatment+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span></div><div class="casAuthors">Sofia, Michael J.; Bao, Donghui; Chang, Wonsuk; Du, Jinfa; Nagarathnam, Dhanapalan; Rachakonda, Suguna; Reddy, P. Ganapati; Ross, Bruce S.; Wang, Peiyuan; Zhang, Hai-Ren; Bansal, Shalini; Espiritu, Christine; Keilman, Meg; Lam, Angela M.; Steuer, Holly M. Micolochick; Niu, Congrong; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7202-7218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.  The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies.  β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-Me nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic.  Phosphoramidate prodrugs of the 5'-phosphate deriv. of the β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleoside were prepd. and showed significant potency in the HCV subgenomic replicon assay (<1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo.  The single diastereomer 51 of diastereomeric mixt. 14 was crystd., and an X-ray structure was detd. establishing the phosphoramidate stereochem. as Sp, thus correlating for the first time the stereochem. of a phosphoramidate prodrug with biol. activity.  51 (PSI-7977) was selected as a clin. development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAkLi9-odWbVg90H21EOLACvtfcHk0lhKxIPxRbcyNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO&md5=33d371e557e9d70562a326f97798f45c</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1021%2Fjm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100863x%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%2BR.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520%25CE%25B2-d-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-2%25E2%2580%25B2-%25CE%25B2-C-methyluridine%2520nucleotide%2520prodrug%2520%2528PSI-7977%2529%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7202%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Reddy, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, B.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarathnam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofia, M. J.</span><span> </span><span class="NLM_article-title">20-Deoxy-20-a-fluoro-20-b-C-methyl 30,50-cyclic phosphate nucleotide prodrug analogues as inhibitors of HCV NS5B polymerase: Discovery of PSI-352938</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7376</span><span class="NLM_x">–</span> <span class="NLM_lpage">7380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7376-7380&author=P.+G.+Reddyauthor=D.+Baoauthor=W.+Changauthor=B.-K.+Chunauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=B.+S.+Rossauthor=H.-R.+Zhangauthor=S.+Bansalauthor=C.+L.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=C.+Niuauthor=H.+M.+Steuerauthor=P.+A.+Furmanauthor=M.+J.+Ottoauthor=M.+J.+Sofia&title=20-Deoxy-20-a-fluoro-20-b-C-methyl+30%2C50-cyclic+phosphate+nucleotide+prodrug+analogues+as+inhibitors+of+HCV+NS5B+polymerase%3A+Discovery+of+PSI-352938"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DB.-K.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%2BL.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3D20-Deoxy-20-a-fluoro-20-b-C-methyl%252030%252C50-cyclic%2520phosphate%2520nucleotide%2520prodrug%2520analogues%2520as%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520Discovery%2520of%2520PSI-352938%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7376%26epage%3D7380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perigaud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrottes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licklider, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camire, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Colla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hildebrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilello, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarville, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badaroux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. N.</span><span> </span><span class="NLM_article-title">In vitro antiviral activity and pharmacology of IDX184, a novel and potent inhibitor of HCV replication</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">S220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=S220&author=E.+Cretton-Scottauthor=C.+Perigaudauthor=S.+Peyrottesauthor=L.+Lickliderauthor=M.+Camireauthor=M.+Larssonauthor=M.+La+Collaauthor=E.+Hildebrandauthor=L.+Lallosauthor=J.+Bilelloauthor=J.+McCarvilleauthor=M.+Seiferauthor=M.+Liuzziauthor=C.+Pierraauthor=E.+Badarouxauthor=G.+Gosselinauthor=D.+Surlerauxauthor=D.+N.+Standring&title=In+vitro+antiviral+activity+and+pharmacology+of+IDX184%2C+a+novel+and+potent+inhibitor+of+HCV+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DPerigaud%26aufirst%3DC.%26aulast%3DPeyrottes%26aufirst%3DS.%26aulast%3DLicklider%26aufirst%3DL.%26aulast%3DCamire%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DM.%26aulast%3DLa%2BColla%26aufirst%3DM.%26aulast%3DHildebrand%26aufirst%3DE.%26aulast%3DLallos%26aufirst%3DL.%26aulast%3DBilello%26aufirst%3DJ.%26aulast%3DMcCarville%26aufirst%3DJ.%26aulast%3DSeifer%26aufirst%3DM.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DBadaroux%26aufirst%3DE.%26aulast%3DGosselin%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DStandring%26aufirst%3DD.%2BN.%26atitle%3DIn%2520vitro%2520antiviral%2520activity%2520and%2520pharmacology%2520of%2520IDX184%252C%2520a%2520novel%2520and%2520potent%2520inhibitor%2520of%2520HCV%2520replication%26jtitle%3DJ.%2520Hepatol.%26date%3D2008%26volume%3D48%26spage%3DS220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madela, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aljarah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernachio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorovits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolykhalov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammadb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4850</span><span class="NLM_x">–</span> <span class="NLM_lpage">4854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1016%2Fj.bmcl.2010.06.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=20637609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlagurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4850-4854&author=C.+McGuiganauthor=K.+Madelaauthor=M.+Aljarahauthor=A.+Gillesauthor=A.+Brancaleauthor=N.+Zontaauthor=S.+Chamberlainauthor=J.+Vernachioauthor=J.+Hutchinsauthor=A.+Hallauthor=B.+Amesauthor=E.+Gorovitsauthor=B.+Gangulyauthor=A.+Kolykhalovauthor=J.+Wangauthor=J.+Muhammadbauthor=J.+M.+Pattiauthor=G.+Henson&title=Design%2C+synthesis+and+evaluation+of+a+novel+double+pro-drug%3A+INX-08189.+A+new+clinical+candidate+for+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16gR"><div class="casContent"><span class="casTitleNuber">16g</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of a novel double prodrug: INX-08189. A new clinical candidate for hepatitis C virus</span></div><div class="casAuthors">McGuigan, Christopher; Madela, Karolina; Aljarah, Mohamed; Gilles, Arnaud; Brancale, Andrea; Zonta, Nicola; Chamberlain, Stanley; Vernachio, John; Hutchins, Jeff; Hall, Andrea; Ames, Brenda; Gorovits, Elena; Ganguly, Babita; Kolykhalov, Alexander; Wang, Jin; Muhammad, Jerry; Patti, Joseph M.; Henson, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4850-4854</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We herein report a novel double prodrug approach applied to the anti-HCV agent 2'-β-C-Me guanosine.  A phosphoramidate ProTide motif and a 6-O-methoxy base prodrug moiety are combined to generate lipophilic prodrugs of the monophosphate of the guanine nucleoside.  Modification of the ester and amino acid moieties lead to a compd. INX-08189 that exhibits 10 nM potency in the HCV genotype 1b sub-genomic replicon, thus being 500 times more potent than the parent nucleoside.  The potency of the lead compd. INX-08189 was shown to be consistent with intracellular 2'-C-Me guanosine triphosphate levels in primary human hepatocytes.  The sepd. diastereomers of INX-08189 were shown to have similar activity in the replicon assay and were also shown to be similar substrates for enzyme processing.  INX-08189 has completed investigational new drug enabling studies and has been progressed into human clin. trials for the treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRKJa0VtEVwrVg90H21EOLACvtfcHk0lhMHF9b020KAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlagurs%253D&md5=20d10847a850ddf681fe8accc4ed49db</span></div><a href="/servlet/linkout?suffix=cit16g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.094%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DMadela%26aufirst%3DK.%26aulast%3DAljarah%26aufirst%3DM.%26aulast%3DGilles%26aufirst%3DA.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DZonta%26aufirst%3DN.%26aulast%3DChamberlain%26aufirst%3DS.%26aulast%3DVernachio%26aufirst%3DJ.%26aulast%3DHutchins%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DAmes%26aufirst%3DB.%26aulast%3DGorovits%26aufirst%3DE.%26aulast%3DGanguly%26aufirst%3DB.%26aulast%3DKolykhalov%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMuhammadb%26aufirst%3DJ.%26aulast%3DPatti%26aufirst%3DJ.%2BM.%26aulast%3DHenson%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520a%2520novel%2520double%2520pro-drug%253A%2520INX-08189.%2520A%2520new%2520clinical%2520candidate%2520for%2520hepatitis%2520C%2520virus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4850%26epage%3D4854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immermann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villano, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M.</span><span> </span><span class="NLM_article-title">HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1002%2Fhep.22717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=19072827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=745-52&author=N.+M.+Knetemanauthor=A.+Y.+Howeauthor=T.+Gaoauthor=J.+Lewisauthor=D.+Pevearauthor=G.+Lundauthor=D.+Douglasauthor=D.+F.+Mercerauthor=D.+L.+Tyrrellauthor=F.+Immermannauthor=I.+Chaudharyauthor=J.+Spethauthor=S.+A.+Villanoauthor=J.+O%E2%80%99Connellauthor=M.+Collett&title=HCV796%3A+A+selective+nonstructural+protein+5B+polymerase+inhibitor+with+potent+anti-hepatitis+C+virus+activity+in+vitro%2C+in+mice+with+chimeric+human+livers%2C+and+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">HCCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span></div><div class="casAuthors">Kneteman, Norman M.; Howe, Anita Y. M.; Gao, Tiejun; Lewis, Jamie; Pevear, Dan; Lund, Gary; Douglas, Donna; Mercer, David F.; Tyrrell, D. Lorne J.; Immermann, Frederick; Chaudhary, Inder; Speth, John; Villano, Stephen A.; O'Connell, John; Collett, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Anti-hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clin. study.  This manuscript outlines activity and correlation across such a spectrum of models and into clin. trials with a novel selective nonstructural protein 5B (NS5B) polymerase inhibitor, HCV796.  Enzyme assays yielded median inhibitory concn. (IC50) values of 0.01 to 0.14 μM for genotype 1, with half maximal effective concn. (EC50s) of 5 nM and 9 nM against genotype 1a and 1b replicons.  In the chimeric mouse model, a 2.02 ± 0.55 log redn. in HCV titer was seen with monotherapy, whereas a suboptimal dose of 30 mg/kg three times per day in combination with interferon demonstrated a 2.44 log redn. (P = 0.001 vs. interferon alone) Clin. outcomes in combination with pegylated interferon and ribavirin have revealed additive efficacy in treatment naive patients.  Abnormal liver function test results were obsd. in 8% of HCV-796 patients treated for over 8 wk, resulting in suspension of further trial activity.  Conclusion: The RNA-dependent RNA polymerase inhibitor HCV796 demonstrated potent anti-HCV activity consistently through enzyme inhibition assays, subgenomic replicon, and chimeric mouse studies.  Strong correlations of outcomes in the mouse model were seen with subsequent clin. trials, including a plateau in dose-related antiviral activity and additive impact from combination therapy with interferon.  These outcomes demonstrate the utility of the range of in vitro and in vivo models now available for anti-HCV drug development and support the potential utility of polymerase inhibitors in future combination therapies for HCV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ZCtNeI0RLLVg90H21EOLACvtfcHk0lhMHF9b020KAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D&md5=0dcebc9c1e93051ad46eae43b352e7cf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fhep.22717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22717%26sid%3Dliteratum%253Aachs%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DHowe%26aufirst%3DA.%2BY.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DPevear%26aufirst%3DD.%26aulast%3DLund%26aufirst%3DG.%26aulast%3DDouglas%26aufirst%3DD.%26aulast%3DMercer%26aufirst%3DD.%2BF.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%26aulast%3DImmermann%26aufirst%3DF.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DSpeth%26aufirst%3DJ.%26aulast%3DVillano%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DCollett%26aufirst%3DM.%26atitle%3DHCV796%253A%2520A%2520selective%2520nonstructural%2520protein%25205B%2520polymerase%2520inhibitor%2520with%2520potent%2520anti-hepatitis%2520C%2520virus%2520activity%2520in%2520vitro%252C%2520in%2520mice%2520with%2520chimeric%2520human%2520livers%252C%2520and%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D745%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludlum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drowns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlihy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parge, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1255-1258&author=H.+Liauthor=J.+Tatlockauthor=A.+Lintonauthor=J.+Gonzalezauthor=T.+Jewellauthor=L.+Patelauthor=S.+Ludlumauthor=M.+Drownsauthor=S.+V.+Rahavendranauthor=H.+Skorauthor=R.+Hunterauthor=S.+T.+Shiauthor=K.+J.+Herlihyauthor=H.+Pargeauthor=M.+Hickeyauthor=X.+Yuauthor=F.+Chauauthor=J.+Nonomiyaauthor=C.+Lewis&title=Discovery+of+%28R%29-6-cyclopentyl-6-%282-%282%2C6-diethylpyridin-4-yl%29ethyl%29-3-%28%285%2C7-dimethyl-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyrimidin-2-yl%29methyl%29-4-hydroxy-5%2C6-dihydropyran-2-one+%28PF-00868554%29+as+a+potent+and+orally+available+hepatitis+C+virus+polymerase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm8014537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014537%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DJewell%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DLudlum%26aufirst%3DS.%26aulast%3DDrowns%26aufirst%3DM.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DSkor%26aufirst%3DH.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DS.%2BT.%26aulast%3DHerlihy%26aufirst%3DK.%2BJ.%26aulast%3DParge%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DChau%26aufirst%3DF.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520%2528R%2529-6-cyclopentyl-6-%25282-%25282%252C6-diethylpyridin-4-yl%2529ethyl%2529-3-%2528%25285%252C7-dimethyl-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyrimidin-2-yl%2529methyl%2529-4-hydroxy-5%252C6-dihydropyran-2-one%2520%2528PF-00868554%2529%2520as%2520a%2520potent%2520and%2520orally%2520available%2520hepatitis%2520C%2520virus%2520polymerase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1255%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrover, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span> </span><span class="NLM_article-title">Safety and antiviral activity of the non-nucleoside polymerase inhibitor VX-222 in treatment naïve genotype 1 HCV infected patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">S14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2010&pages=S14&author=M.+Rodriguez-Torresauthor=E.+Lawitzauthor=B.+Conwayauthor=K.+Kaitaauthor=A.+M.+Sheikhauthor=R.+Ghalibauthor=R.+Adroverauthor=C.+Cooperauthor=M.+Silvaauthor=M.+Rosarioauthor=B.+Bourgaultauthor=L.+Proulxauthor=J.+G.+McHutchison&title=Safety+and+antiviral+activity+of+the+non-nucleoside+polymerase+inhibitor+VX-222+in+treatment+na%C3%AFve+genotype+1+HCV+infected+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DConway%26aufirst%3DB.%26aulast%3DKaita%26aufirst%3DK.%26aulast%3DSheikh%26aufirst%3DA.%2BM.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DAdrover%26aufirst%3DR.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DM.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DBourgault%26aufirst%3DB.%26aulast%3DProulx%26aufirst%3DL.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26atitle%3DSafety%2520and%2520antiviral%2520activity%2520of%2520the%2520non-nucleoside%2520polymerase%2520inhibitor%2520VX-222%2520in%2520treatment%2520na%25C3%25AFve%2520genotype%25201%2520HCV%2520infected%2520patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2010%26volume%3D52%26spage%3DS14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMicco, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godofsky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freddo, J.</span><span> </span><span class="NLM_article-title">Antiviral activity of ANA598, a potent non-nucleoside polymerase inhibitor, in chronic hepatitis C patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">S384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=S384&author=E.+Lawitzauthor=M.+Rodrigues-Torresauthor=T.+DeMiccoauthor=T.+Nguyenauthor=E.+Godofskyauthor=J.+Applemanauthor=M.+Rahimyauthor=C.+Crowleyauthor=J.+Freddo&title=Antiviral+activity+of+ANA598%2C+a+potent+non-nucleoside+polymerase+inhibitor%2C+in+chronic+hepatitis+C+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DRodrigues-Torres%26aufirst%3DM.%26aulast%3DDeMicco%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DGodofsky%26aufirst%3DE.%26aulast%3DAppleman%26aufirst%3DJ.%26aulast%3DRahimy%26aufirst%3DM.%26aulast%3DCrowley%26aufirst%3DC.%26aulast%3DFreddo%26aufirst%3DJ.%26atitle%3DAntiviral%2520activity%2520of%2520ANA598%252C%2520a%2520potent%2520non-nucleoside%2520polymerase%2520inhibitor%252C%2520in%2520chronic%2520hepatitis%2520C%2520patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D50%26spage%3DS384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Larrey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moelleken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronowicki, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arastéh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarski, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourlière, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enríquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdallah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boecher, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffgen, J.</span><span> </span><span class="NLM_article-title">BI 207127 is a potent HCV RNA polymerase inhibitor during 5 days monotherapy in patients with chronic hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1044A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=1044A&author=D.+Larreyauthor=Y.+Benhamouauthor=A.+W.+Lohseauthor=C.+Trepoauthor=C.+Moellekenauthor=J.-P.+Bronowickiauthor=M.+H.+Heimauthor=K.+Arast%C3%A9hauthor=J.-P.+Zarskiauthor=M.+Bourli%C3%A8reauthor=R.+Wiestauthor=J.+L.+Callejaauthor=J.+Enr%C3%ADquezauthor=A.+Erhardtauthor=H.+Wedemeyerauthor=T.+Gerlachauthor=T.+Bergauthor=J.+O.+Sternauthor=K.+Wuauthor=N.+Abdallahauthor=G.+Nehmizauthor=W.+O.+Boecherauthor=F.+M.+Bergerauthor=J.+Steffgen&title=BI+207127+is+a+potent+HCV+RNA+polymerase+inhibitor+during+5+days+monotherapy+in+patients+with+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarrey%26aufirst%3DD.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DLohse%26aufirst%3DA.%2BW.%26aulast%3DTrepo%26aufirst%3DC.%26aulast%3DMoelleken%26aufirst%3DC.%26aulast%3DBronowicki%26aufirst%3DJ.-P.%26aulast%3DHeim%26aufirst%3DM.%2BH.%26aulast%3DArast%25C3%25A9h%26aufirst%3DK.%26aulast%3DZarski%26aufirst%3DJ.-P.%26aulast%3DBourli%25C3%25A8re%26aufirst%3DM.%26aulast%3DWiest%26aufirst%3DR.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DEnr%25C3%25ADquez%26aufirst%3DJ.%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DGerlach%26aufirst%3DT.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DStern%26aufirst%3DJ.%2BO.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DAbdallah%26aufirst%3DN.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DBoecher%26aufirst%3DW.%2BO.%26aulast%3DBerger%26aufirst%3DF.%2BM.%26aulast%3DSteffgen%26aufirst%3DJ.%26atitle%3DBI%2520207127%2520is%2520a%2520potent%2520HCV%2520RNA%2520polymerase%2520inhibitor%2520during%25205%2520days%2520monotherapy%2520in%2520patients%2520with%2520chronic%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2009%26volume%3D50%26spage%3D1044A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><a href="http://clinicaltrials.gov/ct2/show/NCT01193361?term=bms-791325&amp;rank=4" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01193361?term=bms-791325&rank=4</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01193361%3Fterm%3Dbms-791325%26rank%3D4."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Anilkumar, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selyutin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavalas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannigrahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feld, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcmonagle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, J. A.</span><span> </span><span class="NLM_article-title">Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5336</span><span class="NLM_x">–</span> <span class="NLM_lpage">5341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1016%2Fj.bmcl.2011.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=21840715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKis7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5336-5341&author=G.+N.+Anilkumarauthor=C.+A.+Lesburgauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=Q.+Zengauthor=Y.+Jiangauthor=T.-Y.+Chanauthor=H.+Puauthor=H.+Vaccaroauthor=L.+Wangauthor=F.+Bennettauthor=K.+X.+Chenauthor=J.+Ducaauthor=S.+Gavalasauthor=Y.+Huangauthor=P.+Pintoauthor=M.+Sannigrahiauthor=F.+Velazquezauthor=S.+Venkatramanauthor=B.+Vibulbhanauthor=S.+Agrawalauthor=N.+Butkiewiczauthor=B.+Feldauthor=E.+Ferrariauthor=Z.+Heauthor=C.-K.+Jiangauthor=R.+E.+Palermoauthor=P.+Mcmonagleauthor=H.-C.+Huangauthor=N.-Y.+Shihauthor=G.+Njorogeauthor=J.+A.+Kozlowski&title=Novel+HCV+NS5B+polymerase+inhibitors%3A+Discovery+of+indole+2-carboxylic+acids+with+C3-heterocycles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles</span></div><div class="casAuthors">Anilkumar, Gopinadhan N.; Lesburg, Charles A.; Selyutin, Oleg; Rosenblum, Stuart B.; Zeng, Qingbei; Jiang, Yueheng; Chan, Tin-Yau; Pu, Haiyan; Vaccaro, Henry; Wang, Li; Bennett, Frank; Chen, Kevin X.; Duca, Jose; Gavalas, Stephen; Huang, Yuhua; Pinto, Patrick; Sannigrahi, Mousumi; Velazquez, Francisco; Venkatraman, Srikanth; Vibulbhan, Bancha; Agrawal, Sony; Butkiewicz, Nancy; Feld, Boris; Ferrari, Eric; He, Zhiqing; Jiang, Chuan-kui; Palermo, Robert E.; McMonagle, Patricia; Huang, H.-C.; Shih, Neng-Yang; Njoroge, George; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5336-5341</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">SAR development of indole-based palm site inhibitors of HCV NS5B polymerase exemplified by initial indole lead I (NS5B IC50 = 0.9 μM, replicon EC50 >100 μM) is described.  Structure-based drug design led to the incorporation of novel heterocyclic moieties at the indole C3-position which formed a bidentate interaction with the protein backbone.  SAR development resulted in lead carboxyindoles II (NS5B IC50 = 0.032 μM, replicon EC50 = 1.4 μM) and III (NS5B IC50 = 0.017 μM, replicon EC50 = 0.3 μM) with improved enzyme and replicon activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok2tI0MuqRU7Vg90H21EOLACvtfcHk0li89pQgAMuytg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKis7zO&md5=0934657e3c8029bab0a01ea2c5113832</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DAnilkumar%26aufirst%3DG.%2BN.%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DT.-Y.%26aulast%3DPu%26aufirst%3DH.%26aulast%3DVaccaro%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DDuca%26aufirst%3DJ.%26aulast%3DGavalas%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DSannigrahi%26aufirst%3DM.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DFeld%26aufirst%3DB.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DC.-K.%26aulast%3DPalermo%26aufirst%3DR.%2BE.%26aulast%3DMcmonagle%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DNjoroge%26aufirst%3DG.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DNovel%2520HCV%2520NS5B%2520polymerase%2520inhibitors%253A%2520Discovery%2520of%2520indole%25202-carboxylic%2520acids%2520with%2520C3-heterocycles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5336%26epage%3D5341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS5B polymerase exhibits distinct nucleotide requirements for initiation and elongation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">33893</span><span class="NLM_x">–</span> <span class="NLM_lpage">33901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=33893-33901&author=E.+Ferrariauthor=Z.+Heauthor=R.+E.+Palermoauthor=H.-C.+Huang&title=Hepatitis+C+virus+NS5B+polymerase+exhibits+distinct+nucleotide+requirements+for+initiation+and+elongation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DPalermo%26aufirst%3DR.%2BE.%26aulast%3DHuang%26aufirst%3DH.-C.%26atitle%3DHepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520exhibits%2520distinct%2520nucleotide%2520requirements%2520for%2520initiation%2520and%2520elongation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D33893%26epage%3D33901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Körner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+K%C3%B6rnerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0li89pQgAMuytg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DK%25C3%25B6rner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Chen, K. X.; Vibulbhan, B.; Yang, W.; Sannigrahi, M.; Velazquez, F.; Chan, T. Y.; Venkatraman, S.; Anilkumar, G. N.; Zeng, Q.; Bennet, F.; Jiang, Y.; Lesburg, C. A.; Duca, J.; Pinto, P.; Gavalas, S.; Huang, Y.; Wu, W.; Selyutin, O.; Agrawal, S.; Feld, B.; Huang, H. C.; Li, C.; Cheng, K. C.; Shih, N. Y.; Kozlowski, J. A.; Rosenblum, S. B.; Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Structure–activity relationship development and discovery of potent indole-based inhibitors of the hepatitis C virus NS5B polymerase</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm201258k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=754-765&author=K.+X.+Chen&author=B.+Vibulbhan&author=W.+Yang&author=M.+Sannigrahi&author=F.+Velazquez&author=T.+Y.+Chan&author=S.+Venkatraman&author=G.+N.+Anilkumar&author=Q.+Zeng&author=F.+Bennet&author=Y.+Jiang&author=C.+A.+Lesburg&author=J.+Duca&author=P.+Pinto&author=S.+Gavalas&author=Y.+Huang&author=W.+Wu&author=O.+Selyutin&author=S.+Agrawal&author=B.+Feld&author=H.+C.+Huang&author=C.+Li&author=K.+C.+Cheng&author=N.+Y.+Shih&author=J.+A.+Kozlowski&author=S.+B.+Rosenblum&author=F.+G.+Njoroge&title=Structure%E2%80%93activity+relationship+development+and+discovery+of+potent+indole-based+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm201258k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201258k%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520development%2520and%2520discovery%2520of%2520potent%2520indole-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D754%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaura, N.</span><span> </span><span class="NLM_article-title">Palladium(0)-catalyzed cross-coupling reaction of alkoxydiboron with haloarenes: A direct procedure for arylboronic esters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7508</span><span class="NLM_x">–</span> <span class="NLM_lpage">7510</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00128a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7508-7510&author=T.+Ishiyamaauthor=M.+Murataauthor=N.+Miyaura&title=Palladium%280%29-catalyzed+cross-coupling+reaction+of+alkoxydiboron+with+haloarenes%3A+A+direct+procedure+for+arylboronic+esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span></div><div class="casAuthors">Ishiyama, Tatsuo; Murata, Miki; Miyaura, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7508-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed cross-coupling reaction of the pinacol ester of diboronic acid I with haloarenes gave a direct procedure for arylboronic esters II (Ar = aryl) from aryl halides in a range of 60-98%.  The reaction was catalyzed by PdCl2(dppf) (3 mol %) at 80° in the presence of KOAc (3 equiv) in DMSO and available with various functional groups such as nitrile, cyanide, ester, and carbonyl groups.  The trans-ArPd(II)(OAc)(PPh3)2 intermediate was isolated and characterized to propose the catalytic cycle involving the transmetalation between the phenylpalladium(II) acetate complex and I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobehJBGFjDH7Vg90H21EOLACvtfcHk0li89pQgAMuytg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D&md5=2666902270ec1efc5742480b133f1255</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo00128a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00128a024%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-catalyzed%2520cross-coupling%2520reaction%2520of%2520alkoxydiboron%2520with%2520haloarenes%253A%2520A%2520direct%2520procedure%2520for%2520arylboronic%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7508%26epage%3D7510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Jansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span> </span><span class="NLM_article-title">Variations of acidic functions at position 2 and substituents at positions 4, 5 and 6 of the indole moiety and their effect on NMDA-glycine site affinity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">865</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=855-865&author=M.+Jansenauthor=G.+Dannhardt&title=Variations+of+acidic+functions+at+position+2+and+substituents+at+positions+4%2C+5+and+6+of+the+indole+moiety+and+their+effect+on+NMDA-glycine+site+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3DVariations%2520of%2520acidic%2520functions%2520at%2520position%25202%2520and%2520substituents%2520at%2520positions%25204%252C%25205%2520and%25206%2520of%2520the%2520indole%2520moiety%2520and%2520their%2520effect%2520on%2520NMDA-glycine%2520site%2520affinity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D855%26epage%3D865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hughes, D. L.</span><span> </span><span class="NLM_article-title">The Mitsunobu Reaction</span> <span class="citation_source-journal">Org. Reactions</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1002%2F0471264180.or042.02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaK2cXkvVajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=335&author=D.+L.+Hughes&title=The+Mitsunobu+Reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">The Mitsunobu reaction</span></div><div class="casAuthors">Hughes, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Reactions (New York)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">335-656</span>CODEN:
                <span class="NLM_cas:coden">ORREAW</span>;
        ISSN:<span class="NLM_cas:issn">0078-6179</span>.
    </div><div class="casAbstract">A review with 887 refs., mainly covering the di-Et azodicarboxylate/triphenylphosphine redox system with emphasis on the literature between 1981 and 1988.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKenjnWCm_GLVg90H21EOLACvtfcHk0lg39FN-3UiVTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvVajtb4%253D&md5=b863281e19bd0a84a975ba0824dbf42a</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1002%2F0471264180.or042.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471264180.or042.02%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Mitsunobu%2520Reaction%26jtitle%3DOrg.%2520Reactions%26date%3D1992%26volume%3D42%26spage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mitsunobu, O.</span><span> </span><span class="NLM_article-title">The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1055%2Fs-1981-29317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaL3MXht1Sgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1981&pages=1-28&author=O.+Mitsunobu&title=The+use+of+diethyl+azodicarboxylate+and+triphenylphosphine+in+synthesis+and+transformation+of+natural+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products</span></div><div class="casAuthors">Mitsunobu, Oyo</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-28</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">A review with 100 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0srI3PCMfHrVg90H21EOLACvtfcHk0lg39FN-3UiVTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXht1Sgsrk%253D&md5=01d75d554d76b7c094691a7465648db2</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1055%2Fs-1981-29317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1981-29317%26sid%3Dliteratum%253Aachs%26aulast%3DMitsunobu%26aufirst%3DO.%26atitle%3DThe%2520use%2520of%2520diethyl%2520azodicarboxylate%2520and%2520triphenylphosphine%2520in%2520synthesis%2520and%2520transformation%2520of%2520natural%2520products%26jtitle%3DSynthesis%26date%3D1981%26spage%3D1%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Powers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayorga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzola, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonn, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. P. C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1034</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050859x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD28XksV2ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1034-1046&author=J.+P.+Powersauthor=D.+E.+Piperauthor=Y.+Liauthor=V.+Mayorgaauthor=J.+Anzolaauthor=J.+M.+Chenauthor=J.+C.+Jaenauthor=G.+Leeauthor=J.+Liuauthor=M.+G.+Petersonauthor=G.+R.+Tonnauthor=Q.+Yeauthor=M.+P.+C+Walkerauthor=Z.+Wang&title=SAR+and+mode+of+action+of+novel+non-nucleoside+inhibitors+of+hepatitis+C+NS5b+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase</span></div><div class="casAuthors">Powers, Jay P.; Piper, Derek E.; Li, Yang; Mayorga, Veronica; Anzola, John; Chen, James M.; Jaen, Juan C.; Lee, Gary; Liu, Jinqian; Peterson, M. Greg; Tonn, George R.; Ye, Qiuping; Walker, Nigel P. C.; Wang, Zhulun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1034-1046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel non-nucleoside inhibitors of the HCV RNA polymerase (NS5b) with sub-micromolar biochem. potency have been identified which are selective for the inhibition of HCV NS5b over other polymerases.  The structures of the complexes formed between several of these inhibitors and HCV NS5b were detd. by x-ray crystallog., and the inhibitors were found to bind in an allosteric binding site sep. from the active site.  Structure-activity relationships and structural studies have identified the mechanism of action for compds. in this series, several of which possess drug-like properties, as unique, reversible, covalent inhibitors of HCV NS5b.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQXM5YE5fcYLVg90H21EOLACvtfcHk0lg39FN-3UiVTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksV2ltA%253D%253D&md5=722ac0edb5dabb720e30475ef5925d5f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm050859x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050859x%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DPiper%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMayorga%26aufirst%3DV.%26aulast%3DAnzola%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DM.%2BG.%26aulast%3DTonn%26aufirst%3DG.%2BR.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DWalker%26aufirst%3DM.%2BP.%2BC%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DSAR%2520and%2520mode%2520of%2520action%2520of%2520novel%2520non-nucleoside%2520inhibitors%2520of%2520hepatitis%2520C%2520NS5b%2520RNA%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1034%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> was generated using the program PyMOL (The PyMOL Molecular Graphics System, Version 1.2r1, Schrödinger, LLC.).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">X-Ray crystal structure data of HCV NS5B in complex with <b>47</b> have been deposited in the Protein Data Bank with access code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYQ">3TYQ</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Covalent Modifiers: An Orthogonal Approach to Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8008597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1231-1246&author=M.+H.+Potashmanauthor=M.+E.+Duggan&title=Covalent+Modifiers%3A+An+Orthogonal+Approach+to+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modifiers: An Orthogonal Approach to Drug Design</span></div><div class="casAuthors">Potashman, Michele H.; Duggan, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1231-1246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this article we review a variety of examples in which therapeutic targets are covalently bound by small-mol. drugs or by compds. in advanced clin. development.  The covalent interactions can be either reversible or irreversible, depending on the reaction partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6BO6g9_F717Vg90H21EOLACvtfcHk0ljrPRC8UpbLnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D&md5=f8380d5a1cdd8638ad2a1e0405d25267</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1021%2Fjm8008597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008597%26sid%3Dliteratum%253Aachs%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DCovalent%2520Modifiers%253A%2520An%2520Orthogonal%2520Approach%2520to%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1231%26epage%3D1246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Powers, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asgian, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekici, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K. E.</span><span> </span><span class="NLM_article-title">Irreversible inhibitors of serine, cysteine, and threonine proteases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4639</span><span class="NLM_x">–</span> <span class="NLM_lpage">4750</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010182v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFSnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4639-4750&author=J.+C.+Powersauthor=J.+L.+Asgianauthor=O.+D.+Ekiciauthor=K.+E.+James&title=Irreversible+inhibitors+of+serine%2C+cysteine%2C+and+threonine+proteases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Irreversible inhibitors of serine, cysteine, and threonine proteases</span></div><div class="casAuthors">Powers, James C.; Asgian, Juliana L.; Ekici, Oezlem Dogan; James, Karen Ellis</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4639-4750</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include alkylating, acylating, phosphonylating, and sulfonylating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorivaxGhmhirVg90H21EOLACvtfcHk0ljrPRC8UpbLnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFSnsr4%253D&md5=eb21ff0297b87537a7d459c92f13c75d</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Fcr010182v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010182v%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26aulast%3DAsgian%26aufirst%3DJ.%2BL.%26aulast%3DEkici%26aufirst%3DO.%2BD.%26aulast%3DJames%26aufirst%3DK.%2BE.%26atitle%3DIrreversible%2520inhibitors%2520of%2520serine%252C%2520cysteine%252C%2520and%2520threonine%2520proteases%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4639%26epage%3D4750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Huth, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black-Schaefer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladror, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Toxicological evaluation of thiol-reactive compounds identified using a La assay to detect reactive molecules by nuclear magnetic resonance</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1752</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700319t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1752-1759&author=J.+R.+Huthauthor=D.+Songauthor=R.+R.+Mendozaauthor=C.+L.+Black-Schaeferauthor=J.+C.+Mackauthor=S.+A.+Dorwinauthor=U.+S.+Ladrorauthor=J.+M.+Severinauthor=K.+A.+Walterauthor=D.+M.+Bartleyauthor=P.+J.+Hajduk&title=Toxicological+evaluation+of+thiol-reactive+compounds+identified+using+a+La+assay+to+detect+reactive+molecules+by+nuclear+magnetic+resonance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Ftx700319t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700319t%26sid%3Dliteratum%253Aachs%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DMendoza%26aufirst%3DR.%2BR.%26aulast%3DBlack-Schaefer%26aufirst%3DC.%2BL.%26aulast%3DMack%26aufirst%3DJ.%2BC.%26aulast%3DDorwin%26aufirst%3DS.%2BA.%26aulast%3DLadror%26aufirst%3DU.%2BS.%26aulast%3DSeverin%26aufirst%3DJ.%2BM.%26aulast%3DWalter%26aufirst%3DK.%2BA.%26aulast%3DBartley%26aufirst%3DD.%2BM.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DToxicological%2520evaluation%2520of%2520thiol-reactive%2520compounds%2520identified%2520using%2520a%2520La%2520assay%2520to%2520detect%2520reactive%2520molecules%2520by%2520nuclear%2520magnetic%2520resonance%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1752%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Boelsterli, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leow, K. Y.</span><span> </span><span class="NLM_article-title">Bioactivation and hepatotoxicity of nitroaromatic drugs</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.2174%2F138920006778520606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=17073576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWgt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=715-727&author=U.+A.+Boelsterliauthor=H.+K.+Hoauthor=S.+Zhouauthor=K.+Y.+Leow&title=Bioactivation+and+hepatotoxicity+of+nitroaromatic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation and hepatotoxicity of nitroaromatic drugs</span></div><div class="casAuthors">Boelsterli, Urs A.; Ho, Han Kiat; Zhou, Shufeng; Leow, Koon Yeow</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">715-727</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Certain drugs contg. a nitroarom. moiety (e.g., tolcapone, nimesulide, nilutamide, flutamide, nitrofurantoin) have been assocd. with organ-selective toxicity including rare cases of idiosyncratic liver injury.  What they have in common is the potential for multistep nitroreductive bioactivation (6-electron transfer) that produces the potentially hazardous nitroanion radical, nitroso intermediate, and N-hydroxy deriv.  These intermediates have been assocd. with increased oxidant stress and targeting of nucleophilic residues on proteins and nucleic acids.  However, other mechanisms including the formation of oxidative metabolites and mitochondrial liability, as well as inherent toxicokinetic properties, also det. the drugs' overall potency.  Therefore, structural modification not only of the nitro moiety but also of ring substituents can greatly reduced toxicity.  Novel concepts have revealed that, besides the classical microsomal nitroreductases, cytosolic and mitochondrial enzymes including nitric oxide synthase can also bioactivate certain nitroarenes (nilutamide).  Furthermore, animal models of silent mitochondrial dysfunction have demonstrated that a mitochondrial oxidant stress posed by certain nitroarom. drugs (nimesulide) can produce significant mitochondrial injury if superimposed on a genetic mitochondrial abnormality.  Finally, there may be mechanisms for all nitroarom. drugs that do not involve bioactivation of the nitro group, e.g., AHR interactions with flutamide.  Taken together, the focus of research on the hepatic toxicity of nitroarene-contg. drugs has shifted over the past years from the identification of the reactive intermediates generated during the bioreductive pathway to the underlying biomechanisms of liver injury.  Most likely one of the next paradigm shifts will include the identification of determinants of susceptibility to nitroarom. drug-induced hepatotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbZw5d9MZTE7Vg90H21EOLACvtfcHk0ljrPRC8UpbLnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWgt7rF&md5=21e155ba17d1ad097e7652a5d22728b3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F138920006778520606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920006778520606%26sid%3Dliteratum%253Aachs%26aulast%3DBoelsterli%26aufirst%3DU.%2BA.%26aulast%3DHo%26aufirst%3DH.%2BK.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DLeow%26aufirst%3DK.%2BY.%26atitle%3DBioactivation%2520and%2520hepatotoxicity%2520of%2520nitroaromatic%2520drugs%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2006%26volume%3D7%26spage%3D715%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a','cit16b','cit16c','cit16d','cit16e','cit16f','cit16g'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':[],'ref32':[],'ref33':['cit33a','cit33b'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Matthias Gehringer, <span class="NLM_string-name hlFld-ContribAuthor">Stefan A. Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5673-5724. <a href="https://doi.org/10.1021/acs.jmedchem.8b01153" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01153%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEmerging%252Band%252BRe-Emerging%252BWarheads%252Bfor%252BTargeted%252BCovalent%252BInhibitors%25253A%252BApplications%252Bin%252BMedicinal%252BChemistry%252Band%252BChemical%252BBiology%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D23072018%26date%3D25012019%26date%3D19122018%26volume%3D62%26issue%3D12%26spage%3D5673%26epage%3D5724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanou  Yang</span>, <span class="hlFld-ContribAuthor ">Yue-Zhong  Shu</span>, and <span class="hlFld-ContribAuthor ">W. Griffith  Humphreys</span>  . </span><span class="cited-content_cbyCitation_article-title">Label-Free Bottom-Up Proteomic Workflow for Simultaneously Assessing the Target Specificity of Covalent Drug Candidates and Their Off-Target Reactivity to Selected Proteins. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Toxicology</span><span> <strong>2016,</strong> <em>29 </em>
                                    (1)
                                     , 109-116. <a href="https://doi.org/10.1021/acs.chemrestox.5b00460" title="DOI URL">https://doi.org/10.1021/acs.chemrestox.5b00460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrestox.5b00460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrestox.5b00460%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Toxicology%26atitle%3DLabel-Free%252BBottom-Up%252BProteomic%252BWorkflow%252Bfor%252BSimultaneously%252BAssessing%252Bthe%252BTarget%252BSpecificity%252Bof%252BCovalent%252BDrug%252BCandidates%252Band%252BTheir%252BOff-Target%252BReactivity%252Bto%252BSelected%252BProteins%26aulast%3DYang%26aufirst%3DYanou%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D08112015%26date%3D29122015%26date%3D19012016%26date%3D16122015%26volume%3D29%26issue%3D1%26spage%3D109%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Letizia  Barreca</span>, <span class="hlFld-ContribAuthor ">Nunzio  Iraci</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Manfroni</span>, <span class="hlFld-ContribAuthor ">Rosy  Gaetani</span>, <span class="hlFld-ContribAuthor ">Chiara  Guercini</span>, <span class="hlFld-ContribAuthor ">Stefano  Sabatini</span>, <span class="hlFld-ContribAuthor ">Oriana  Tabarrini</span>, and <span class="hlFld-ContribAuthor ">Violetta  Cecchetti</span>  . </span><span class="cited-content_cbyCitation_article-title">Accounting for Target Flexibility and Water Molecules by Docking to Ensembles of Target Structures: The HCV NS5B Palm Site I Inhibitors Case Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (2)
                                     , 481-497. <a href="https://doi.org/10.1021/ci400367m" title="DOI URL">https://doi.org/10.1021/ci400367m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400367m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400367m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAccounting%252Bfor%252BTarget%252BFlexibility%252Band%252BWater%252BMolecules%252Bby%252BDocking%252Bto%252BEnsembles%252Bof%252BTarget%252BStructures%25253A%252BThe%252BHCV%252BNS5B%252BPalm%252BSite%252BI%252BInhibitors%252BCase%252BStudy%26aulast%3DBarreca%26aufirst%3DMaria%2BLetizia%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D25062013%26date%3D05092013%26date%3D24022014%26date%3D18082013%26volume%3D54%26issue%3D2%26spage%3D481%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdalla E.  Hassan</span>, <span class="hlFld-ContribAuthor ">Reham A. I.  Abou-elkhair</span>, <span class="hlFld-ContribAuthor ">Samar M.  Mohamed</span>, <span class="hlFld-ContribAuthor ">Ahmed H.  Moustafa</span>, <span class="hlFld-ContribAuthor ">Reda M.  Fikry</span>, <span class="hlFld-ContribAuthor ">Fathy A.  Yassen</span>. </span><span class="cited-content_cbyCitation_article-title">Glycoside- and acyclic nucleoside-based 6-cyclohexyl-4-aryl-2-oxonicotinonitrile: synthesis and antimicrobial evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2019,</strong> <em>16 </em>
                                    (9)
                                     , 1891-1902. <a href="https://doi.org/10.1007/s13738-019-01662-x" title="DOI URL">https://doi.org/10.1007/s13738-019-01662-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-019-01662-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-019-01662-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DGlycoside-%252Band%252Bacyclic%252Bnucleoside-based%252B6-cyclohexyl-4-aryl-2-oxonicotinonitrile%25253A%252Bsynthesis%252Band%252Bantimicrobial%252Bevaluation%26aulast%3DHassan%26aufirst%3DAbdalla%2BE.%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D9%26spage%3D1891%26epage%3D1902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdalla E.  Hassan</span>, <span class="hlFld-ContribAuthor ">Samar M.  Mohammed</span>, <span class="hlFld-ContribAuthor ">Reham A. I.  Abou‐Elkhair</span>, <span class="hlFld-ContribAuthor ">Ahmed H.  Moustafa</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Glycosides and Acyclic Nucleosides Derived 2‐Oxonicotinonitriles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2019,</strong> <em>56 </em>
                                    (7)
                                     , 1885-1897. <a href="https://doi.org/10.1002/jhet.3563" title="DOI URL">https://doi.org/10.1002/jhet.3563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3563%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BGlycosides%252Band%252BAcyclic%252BNucleosides%252BDerived%252B2%2525E2%252580%252590Oxonicotinonitriles%26aulast%3DHassan%26aufirst%3DAbdalla%2BE.%26date%3D2019%26date%3D2019%26volume%3D56%26issue%3D7%26spage%3D1885%26epage%3D1897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Narayana Murthy  Ganta</span>, <span class="hlFld-ContribAuthor ">Gangaraju  Gedda</span>, <span class="hlFld-ContribAuthor ">Bethi  Rathnakar</span>, <span class="hlFld-ContribAuthor ">Mavurapu  Satyanarayana</span>, <span class="hlFld-ContribAuthor ">Bhaskar  Yamajala</span>, <span class="hlFld-ContribAuthor ">Mohamed Jawed  Ahsan</span>, <span class="hlFld-ContribAuthor ">Surender Singh  Jadav</span>, <span class="hlFld-ContribAuthor ">Tuniki  Balaraju</span>. </span><span class="cited-content_cbyCitation_article-title">A review on HCV inhibitors: Significance of non-structural polyproteins. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 576-601. <a href="https://doi.org/10.1016/j.ejmech.2018.12.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Breview%252Bon%252BHCV%252Binhibitors%25253A%252BSignificance%252Bof%252Bnon-structural%252Bpolyproteins%26aulast%3DGanta%26aufirst%3DNarayana%2BMurthy%26date%3D2019%26volume%3D164%26spage%3D576%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Letitia  Shunmugam</span>, <span class="hlFld-ContribAuthor ">Mahmoud E. S.  Soliman</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting HCV polymerase: a structural and dynamic perspective into the mechanism of selective covalent inhibition. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (73)
                                     , 42210-42222. <a href="https://doi.org/10.1039/C8RA07346E" title="DOI URL">https://doi.org/10.1039/C8RA07346E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA07346E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA07346E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DTargeting%252BHCV%252Bpolymerase%25253A%252Ba%252Bstructural%252Band%252Bdynamic%252Bperspective%252Binto%252Bthe%252Bmechanism%252Bof%252Bselective%252Bcovalent%252Binhibition%26aulast%3DShunmugam%26aufirst%3DLetitia%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D73%26spage%3D42210%26epage%3D42222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weijie  Hou</span>, <span class="hlFld-ContribAuthor ">Yan  Ren</span>, <span class="hlFld-ContribAuthor ">Zhenhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Huan  Sun</span>, <span class="hlFld-ContribAuthor ">Yongfen  Ma</span>, <span class="hlFld-ContribAuthor ">Bo  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Novel quinazoline derivatives bearing various 6-benzamide moieties as highly selective and potent EGFR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (8)
                                     , 1740-1750. <a href="https://doi.org/10.1016/j.bmc.2018.02.022" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.02.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.02.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bquinazoline%252Bderivatives%252Bbearing%252Bvarious%252B6-benzamide%252Bmoieties%252Bas%252Bhighly%252Bselective%252Band%252Bpotent%252BEGFR%252Binhibitors%26aulast%3DHou%26aufirst%3DWeijie%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D1740%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satya P.  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">The Medicinal Chemistry of Antihepatitis Agents III. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 133-210. <a href="https://doi.org/10.1016/B978-0-12-813330-9.00007-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-813330-9.00007-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-813330-9.00007-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-813330-9.00007-7%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BMedicinal%252BChemistry%252Bof%252BAntihepatitis%252BAgents%252BIII%26aulast%3DGupta%26aufirst%3DSatya%2BP.%26date%3D2018%26spage%3D133%26epage%3D210%26pub%3DElsevier%26atitle%3DStudies%252Bon%252BHepatitis%252BViruses%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 553-627. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12406-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12406-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12406-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12406-0%26sid%3Dliteratum%253Aachs%26atitle%3DDirect-Acting%252BAntiviral%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DMeanwell%26aufirst%3DN.A.%26date%3D2017%26spage%3D553%26epage%3D627%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robin A.  Fairhurst</span>, <span class="hlFld-ContribAuthor ">Thomas  Knoepfel</span>, <span class="hlFld-ContribAuthor ">Catherine  Leblanc</span>, <span class="hlFld-ContribAuthor ">Nicole  Buschmann</span>, <span class="hlFld-ContribAuthor ">Christoph  Gaul</span>, <span class="hlFld-ContribAuthor ">Jutta  Blank</span>, <span class="hlFld-ContribAuthor ">Inga  Galuba</span>, <span class="hlFld-ContribAuthor ">Jörg  Trappe</span>, <span class="hlFld-ContribAuthor ">Chao  Zou</span>, <span class="hlFld-ContribAuthor ">Johannes  Voshol</span>, <span class="hlFld-ContribAuthor ">Christine  Genick</span>, <span class="hlFld-ContribAuthor ">Peggy  Brunet-Lefeuvre</span>, <span class="hlFld-ContribAuthor ">Francis  Bitsch</span>, <span class="hlFld-ContribAuthor ">Diana  Graus-Porta</span>, <span class="hlFld-ContribAuthor ">Pascal  Furet</span>. </span><span class="cited-content_cbyCitation_article-title">Approaches to selective fibroblast growth factor receptor 4 inhibition through targeting the ATP-pocket middle-hinge region. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 1604-1613. <a href="https://doi.org/10.1039/C7MD00213K" title="DOI URL">https://doi.org/10.1039/C7MD00213K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00213K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00213K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DApproaches%252Bto%252Bselective%252Bfibroblast%252Bgrowth%252Bfactor%252Breceptor%252B4%252Binhibition%252Bthrough%252Btargeting%252Bthe%252BATP-pocket%252Bmiddle-hinge%252Bregion%26aulast%3DFairhurst%26aufirst%3DRobin%2BA.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D8%26spage%3D1604%26epage%3D1613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jahan B.  Ghasemi</span>, <span class="hlFld-ContribAuthor ">Elmira  Nazarshodeh</span>, <span class="hlFld-ContribAuthor ">H.  Abedi</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking, 2D and 3D-QSAR studies of new indole-based derivatives as HCV-NS5B polymerase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2015,</strong> <em>12 </em>
                                    (10)
                                     , 1789-1799. <a href="https://doi.org/10.1007/s13738-015-0654-4" title="DOI URL">https://doi.org/10.1007/s13738-015-0654-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-015-0654-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-015-0654-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3DMolecular%252Bdocking%25252C%252B2D%252Band%252B3D-QSAR%252Bstudies%252Bof%252Bnew%252Bindole-based%252Bderivatives%252Bas%252BHCV-NS5B%252Bpolymerase%252Binhibitors%26aulast%3DGhasemi%26aufirst%3DJahan%2BB.%26date%3D2015%26date%3D2015%26volume%3D12%26issue%3D10%26spage%3D1789%26epage%3D1799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Can  Zhao</span>, <span class="hlFld-ContribAuthor ">Yinhu  Wang</span>, <span class="hlFld-ContribAuthor ">Shutao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 188-214. <a href="https://doi.org/10.1016/j.ejmech.2015.07.046" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.07.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.07.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.07.046%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bon%252Bthe%252Bsynthesis%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS5B%252BRNA-dependent%252BRNA-polymerase%252Binhibitors%26aulast%3DZhao%26aufirst%3DCan%26date%3D2015%26volume%3D102%26spage%3D188%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrienne D.  Cox</span>, <span class="hlFld-ContribAuthor ">Stephen W.  Fesik</span>, <span class="hlFld-ContribAuthor ">Alec C.  Kimmelman</span>, <span class="hlFld-ContribAuthor ">Ji  Luo</span>, <span class="hlFld-ContribAuthor ">Channing J.  Der</span>. </span><span class="cited-content_cbyCitation_article-title">Drugging the undruggable RAS: Mission Possible?. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2014,</strong> <em>13 </em>
                                    (11)
                                     , 828-851. <a href="https://doi.org/10.1038/nrd4389" title="DOI URL">https://doi.org/10.1038/nrd4389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4389%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DDrugging%252Bthe%252Bundruggable%252BRAS%25253A%252BMission%252BPossible%25253F%26aulast%3DCox%26aufirst%3DAdrienne%2BD.%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D11%26spage%3D828%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Wang</span>, <span class="hlFld-ContribAuthor ">M.  Zhong</span>, <span class="hlFld-ContribAuthor ">A.  Yan</span>, <span class="hlFld-ContribAuthor ">L.  Li</span>, <span class="hlFld-ContribAuthor ">C.  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative structure and bioactivity relationship study on HCV NS5B polymerase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2014,</strong> <em>25 </em>
                                    (1)
                                     , 1-15. <a href="https://doi.org/10.1080/1062936X.2013.820790" title="DOI URL">https://doi.org/10.1080/1062936X.2013.820790</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2013.820790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2013.820790%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DQuantitative%252Bstructure%252Band%252Bbioactivity%252Brelationship%252Bstudy%252Bon%252BHCV%252BNS5B%252Bpolymerase%252Binhibitors%26aulast%3DWang%26aufirst%3DM.%26date%3D2014%26date%3D2013%26volume%3D25%26issue%3D1%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingbei  Zeng</span>, <span class="hlFld-ContribAuthor ">Anilkumar G.  Nair</span>, <span class="hlFld-ContribAuthor ">Stuart B.  Rosenblum</span>, <span class="hlFld-ContribAuthor ">Hsueh-Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Yueheng  Jiang</span>, <span class="hlFld-ContribAuthor ">Oleg  Selyutin</span>, <span class="hlFld-ContribAuthor ">Tin-Yau  Chan</span>, <span class="hlFld-ContribAuthor ">Frank  Bennett</span>, <span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Srikanth  Venkatraman</span>, <span class="hlFld-ContribAuthor ">Mousumi  Sannigrahi</span>, <span class="hlFld-ContribAuthor ">Francisco  Velazquez</span>, <span class="hlFld-ContribAuthor ">Jose S.  Duca</span>, <span class="hlFld-ContribAuthor ">Stephen  Gavalas</span>, <span class="hlFld-ContribAuthor ">Yuhua  Huang</span>, <span class="hlFld-ContribAuthor ">Haiyan  Pu</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Patrick  Pinto</span>, <span class="hlFld-ContribAuthor ">Bancha  Vibulbhan</span>, <span class="hlFld-ContribAuthor ">Sony  Agrawal</span>, <span class="hlFld-ContribAuthor ">Eric  Ferrari</span>, <span class="hlFld-ContribAuthor ">Chuan-kui  Jiang</span>, <span class="hlFld-ContribAuthor ">Cheng  Li</span>, <span class="hlFld-ContribAuthor ">David  Hesk</span>, <span class="hlFld-ContribAuthor ">Jennifer  Gesell</span>, <span class="hlFld-ContribAuthor ">Steve  Sorota</span>, <span class="hlFld-ContribAuthor ">Neng-Yang  Shih</span>, <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>, <span class="hlFld-ContribAuthor ">Joseph A.  Kozlowski</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an irreversible HCV NS5B polymerase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (24)
                                     , 6585-6587. <a href="https://doi.org/10.1016/j.bmcl.2013.10.060" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.10.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.10.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ban%252Birreversible%252BHCV%252BNS5B%252Bpolymerase%252Binhibitor%26aulast%3DZeng%26aufirst%3DQingbei%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6585%26epage%3D6587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romain  Haudecoeur</span>, <span class="hlFld-ContribAuthor ">Marine  Peuchmaur</span>, <span class="hlFld-ContribAuthor ">Abdelhakim  Ahmed-Belkacem</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Pawlotsky</span>, <span class="hlFld-ContribAuthor ">Ahcène  Boumendjel</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Activity Relationships in the Development of Allosteric Hepatitis C Virus RNA-Dependent RNA Polymerase Inhibitors: Ten Years of Research. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2013,</strong> <em>33 </em>
                                    (5)
                                     , 934-984. <a href="https://doi.org/10.1002/med.21271" title="DOI URL">https://doi.org/10.1002/med.21271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21271%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DStructure-Activity%252BRelationships%252Bin%252Bthe%252BDevelopment%252Bof%252BAllosteric%252BHepatitis%252BC%252BVirus%252BRNA-Dependent%252BRNA%252BPolymerase%252BInhibitors%25253A%252BTen%252BYears%252Bof%252BResearch%26aulast%3DHaudecoeur%26aufirst%3DRomain%26date%3D2013%26date%3D2012%26volume%3D33%26issue%3D5%26spage%3D934%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric  Ferrari</span>, <span class="hlFld-ContribAuthor ">Hsueh-Cheng  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Hepatitis C Virus NS5B Polymerase Assay of De Novo Initiated RNA Synthesis Directed from a Heteropolymeric RNA Template. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 81-92. <a href="https://doi.org/10.1007/978-1-62703-484-5_7" title="DOI URL">https://doi.org/10.1007/978-1-62703-484-5_7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-62703-484-5_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-62703-484-5_7%26sid%3Dliteratum%253Aachs%26atitle%3DA%252BNovel%252BHepatitis%252BC%252BVirus%252BNS5B%252BPolymerase%252BAssay%252Bof%252BDe%252BNovo%252BInitiated%252BRNA%252BSynthesis%252BDirected%252Bfrom%252Ba%252BHeteropolymeric%252BRNA%252BTemplate%26aulast%3DFerrari%26aufirst%3DEric%26date%3D2013%26date%3D2013%26spage%3D81%26epage%3D92%26pub%3DHumana%2520Press%26atitle%3DAntiviral%252BMethods%252Band%252BProtocols%26aulast%3DGong%26aufirst%3DEdwin%2BYunhao%26date%3D2013%26volume%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit S  Kalgutkar</span>, <span class="hlFld-ContribAuthor ">Deepak K  Dalvie</span>. </span><span class="cited-content_cbyCitation_article-title">Drug discovery for a new generation of covalent drugs. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2012,</strong> <em>7 </em>
                                    (7)
                                     , 561-581. <a href="https://doi.org/10.1517/17460441.2012.688744" title="DOI URL">https://doi.org/10.1517/17460441.2012.688744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2012.688744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2012.688744%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DDrug%252Bdiscovery%252Bfor%252Ba%252Bnew%252Bgeneration%252Bof%252Bcovalent%252Bdrugs%26aulast%3DKalgutkar%26aufirst%3DAmit%2BS%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D7%26spage%3D561%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maolin  Wang</span>, <span class="hlFld-ContribAuthor ">Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>, <span class="hlFld-ContribAuthor ">Changyuan  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Classification of HCV NS5B Polymerase Inhibitors Using Support Vector Machine. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2012,</strong> <em>13 </em>
                                    (4)
                                     , 4033-4047. <a href="https://doi.org/10.3390/ijms13044033" title="DOI URL">https://doi.org/10.3390/ijms13044033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms13044033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms13044033%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DClassification%252Bof%252BHCV%252BNS5B%252BPolymerase%252BInhibitors%252BUsing%252BSupport%252BVector%252BMachine%26aulast%3DWang%26aufirst%3DMaolin%26date%3D2012%26date%3D2012%26volume%3D13%26issue%3D4%26spage%3D4033%26epage%3D4047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201322r&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead compounds from early SAR studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201322r&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201322r&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) NIS, CHCl<sub>3</sub>; (b) 2-methoxy-3-pyridineboronic acid, PdCl<sub>2</sub>(dppf)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,2-dimethoxyethane, 50–85% (two steps); (c) ArCH<sub>2</sub>Br (or ArCH<sub>2</sub>Cl), Cs<sub>2</sub>CO<sub>3</sub>, DMF, 40–90%; (d) LiOH, THF/H<sub>2</sub>O, 60–90%; (e) CDI, then RSO<sub>2</sub>NH<sub>2</sub>, DBU, THF, 50–80%; (f) 4 M HCl, dioxane, 30–60%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201322r&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) 4 M HCl, dioxane; (b) LiOH, THF/H<sub>2</sub>O; (c) EDC, NEt<sub>3</sub>, DMF, 60–90%; (d) ArCH<sub>2</sub>Br (or ArCH<sub>2</sub>Cl), Cs<sub>2</sub>CO<sub>3</sub>, DMF; or ArCH<sub>2</sub>OH, DIAD, PPh<sub>3</sub>, THF, 60–90%; (e) RSO<sub>2</sub>NH<sub>2</sub>, DBU, DMF, 30–60%; (f) LiOH, THF/H<sub>2</sub>O, 20–60%.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/medium/jm-2011-01322r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structure of compound <b>47</b> bound to the palm site of HCV NS5B polymerase. The compound (yellow) is covalently attached to the protein (cyan) via a bond between the side chain sulfur of Cys-366 (depicted as a small sphere) and the 5′-position of the compound. The electron density for the compound and residue Cys-366 is best modeled as two alternate conformations and are included as such in the deposited PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYQ">3TYQ</a>. A single conformation is shown here for clarity. The compound makes identical interactions as observed in the complex between inhibitor <b>1</b> and NS5B,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> with a pair of hydrogen bonds from the C3-pyridone group to the backbone of residues Ile-447 and Tyr-448. Furthermore, the interaction of the C2-carboxylate group with the protein is mediated by a pair of water molecules, shown as red spheres. Besides the backbone atoms of Ile-447 and Tyr-448, all side-chain atoms within 5 Å of the ligand are depicted as sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201322r/production/images/large/jm-2011-01322r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201322r&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cohen, J.</span><span> </span><span class="NLM_article-title">The scientific challenge of hepatitis C</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=26-30&author=J.+Cohen&title=The+scientific+challenge+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DJ.%26atitle%3DThe%2520scientific%2520challenge%2520of%2520hepatitis%2520C%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D26%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruszon-Moran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nainan, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQuillan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaslow, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, H. S.</span><span> </span><span class="NLM_article-title">The prevalence of hepatitis C virus infection in the United States, 1988 through 1994</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">556</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1056%2FNEJM199908193410802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=10451460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=556-562&author=M.+J.+Alterauthor=D.+Kruszon-Moranauthor=O.+V.+Nainanauthor=G.+M.+McQuillanauthor=F.+Gaoauthor=L.+A.+Moyerauthor=R.+A.+Kaslowauthor=H.+S.+Margolis&title=The+prevalence+of+hepatitis+C+virus+infection+in+the+United+States%2C+1988+through+1994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The prevalence of hepatitis C virus infection in the United States, 1988 through 1994</span></div><div class="casAuthors">Alter M J; Kruszon-Moran D; Nainan O V; McQuillan G M; Gao F; Moyer L A; Kaslow R A; Margolis H S</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">556-62</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Because many persons with chronic hepatitis C virus (HCV) infection are asymptomatic, population-based serologic studies are needed to estimate the prevalence of the infection and to develop and evaluate prevention efforts.  METHODS:  We performed tests for antibody to HCV (anti-HCV) on serum samples from 21,241 persons six years old or older who participated in the third National Health and Nutrition Examination Survey, conducted during 1988 through 1994.  We determined the prevalence of HCV RNA by means of nucleic acid amplification and the genotype by means of sequencing.  RESULTS:  The overall prevalence of anti-HCV was 1.8 percent, corresponding to an estimated 3.9 million persons nationwide (95 percent confidence interval, 3.1 million to 4.8 million) with HCV infection.  Sixty-five percent of the persons with HCV infection were 30 to 49 years old.  Seventy-four percent were positive for HCV RNA, indicating that an estimated 2.7 million persons in the United States (95 percent confidence interval, 2.4 million to 3.0 million) were chronically infected, of whom 73.7 percent were infected with genotype 1 (56.7 percent with genotype 1a, and 17.0 percent with genotype 1b).  Among subjects 17 to 59 years of age, the strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior.  Other factors independently associated with infection included poverty, having had 12 or fewer years of education, and having been divorced or separated.  Neither sex nor racial-ethnic group was independently associated with HCV infection.  CONCLUSIONS:  In the United States, about 2.7 million persons are chronically infected with HCV.  People who use illegal drugs or engage in high-risk sexual behavior account for most persons with HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRTwajewlRkP_tos8R3JUhXfW6udTcc2eYCjVzWVKwWtrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1Mzmt1Whsw%253D%253D&md5=d36f80ca56095fcd3cb19271f9e80dca</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1056%2FNEJM199908193410802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199908193410802%26sid%3Dliteratum%253Aachs%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26aulast%3DKruszon-Moran%26aufirst%3DD.%26aulast%3DNainan%26aufirst%3DO.%2BV.%26aulast%3DMcQuillan%26aufirst%3DG.%2BM.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DMoyer%26aufirst%3DL.%2BA.%26aulast%3DKaslow%26aufirst%3DR.%2BA.%26aulast%3DMargolis%26aufirst%3DH.%2BS.%26atitle%3DThe%2520prevalence%2520of%2520hepatitis%2520C%2520virus%2520infection%2520in%2520the%2520United%2520States%252C%25201988%2520through%25201994%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D556%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cuthbert, J. A.</span><span> </span><span class="NLM_article-title">Hepatitis C: Progress and problems</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=7834603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1994&pages=505-532&author=J.+A.+Cuthbert&title=Hepatitis+C%3A+Progress+and+problems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C: progress and problems</span></div><div class="casAuthors">Cuthbert J A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-32</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">The hepatitis C virus (HCV), a single-stranded RNA virus, is the major cause of posttransfusion hepatitis.  HCV isolates differ in nucleotide and amino acid sequences.  Nucleotide changes are concentrated in hypervariable regions and may be related to immune selection.  In most immunocompetent persons, HCV infection is diagnosed serologically, using antigens from conserved regions.  Amplification of RNA may be necessary to detect infection in immunosuppressed patients.  Transmission by known parenteral routes is frequent; other means of spread are less common and may represent inapparent, percutaneous dissemination.  Infection can lead to classical acute hepatitis, but most infected persons have no history of acute disease.  Once infected, most individuals apparently remain carriers of the virus, with varying degrees of hepatocyte damage and fibrosis ensuing.  Chronic hepatitis may lead to cirrhosis and hepatocellular carcinoma.  However, disease progression varies widely, from less than 2 years to cirrhosis in some patients to more than 30 years with only chronic hepatitis in others.  Determinants important in deciding outcome are unknown.  Alpha interferon, which results in sustained remission in selected patients, is the only available therapy.  Long-term benefits from such therapy have not been demonstrated.  Prevention of HCV infection by vaccination is likely to be challenging if ongoing viral mutation results in escape from neutralization and clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXDQuuyW-2sDEC-75aqa5AfW6udTcc2ebSyRpHtZyul7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7js1ajtA%253D%253D&md5=b4434f7061f607052197da39e1916b0a</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuthbert%26aufirst%3DJ.%2BA.%26atitle%3DHepatitis%2520C%253A%2520Progress%2520and%2520problems%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D1994%26volume%3D7%26spage%3D505%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shepard, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Global epidemiology of hepatitis C virus infection</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1016%2FS1473-3099%2805%2970216-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=16122679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=558-567&author=C.+W.+Shepardauthor=L.+Finelliauthor=M.+J.+Alter&title=Global+epidemiology+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Global epidemiology of hepatitis C virus infection</span></div><div class="casAuthors">Shepard Colin W; Finelli Lyn; Alter Miriam J</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">558-67</span>
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    </div><div class="casAbstract">Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future.  The complexity and uncertainty related to the geographic distribution of HCV infection and chronic hepatitis C, determination of its associated risk factors, and evaluation of cofactors that accelerate its progression, underscore the difficulties in global prevention and control of HCV.  Because there is no vaccine and no post-exposure prophylaxis for HCV, the focus of primary prevention efforts should be safer blood supply in the developing world, safe injection practices in health care and other settings, and decreasing the number of people who initiate injection drug use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyQ65qEM2alVm8bhe6roZYfW6udTcc2ebSyRpHtZyul7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D&md5=4d5f81fa0c2191b8c32b328e39933fad</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2805%2970216-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252805%252970216-4%26sid%3Dliteratum%253Aachs%26aulast%3DShepard%26aufirst%3DC.%2BW.%26aulast%3DFinelli%26aufirst%3DL.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DGlobal%2520epidemiology%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2005%26volume%3D5%26spage%3D558%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Monto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, T. L.</span><span> </span><span class="NLM_article-title">The epidemiology and prevention of hepatocellular carcinoma</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1016%2FS0093-7754%2801%2990137-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=11685737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A280%3ADC%252BD3MngvVOhtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=441-449&author=A.+Montoauthor=T.+L.+Wright&title=The+epidemiology+and+prevention+of+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">The epidemiology and prevention of hepatocellular carcinoma</span></div><div class="casAuthors">Monto A; Wright T L</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in oncology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">441-9</span>
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    </div><div class="casAbstract">Hepatocellular carcinoma (HCC) is a common cancer.  Its incidence is higher in countries where hepatitis B is endemic.  HCC is substantially a complication of liver cirrhosis.  Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the predominant causes of cirrhosis, and as such, HCC.  The link between HCC and alcoholic cirrhosis is less strong.  Other less common forms of chronic liver disease can also lead to HCC.  HBV is the HCC-determining disease worldwide.  In endemic regions, it tends to be acquired early in life.  The largest strides in prevention of HCC have been made with the HBV vaccine.  HCV has a lower global prevalence than HBV, but HCV causes the most HCC in economically developed regions.  In these areas, where the incidence of HCC is low, HCV now accounts for more than 50% of HCCs.  There is no vaccine for HCV, so prevention of HCV-associated HCC will focus on prevention of initial infection and elimination of infection through antiviral therapies.  HBV-HCV coinfection, and the combination of either with alcohol abuse or aflatoxin exposure seems to raise the risk of HCC development further.  Liver transplantation and other adjuvant therapies may offer better options for secondary prevention of HCC than resection alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuq0Don9pfEtTiMd2aNQVUfW6udTcc2ebSyRpHtZyul7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MngvVOhtw%253D%253D&md5=1b421c8469c206780be4d03eafb412e2</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2FS0093-7754%2801%2990137-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0093-7754%252801%252990137-X%26sid%3Dliteratum%253Aachs%26aulast%3DMonto%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DT.%2BL.%26atitle%3DThe%2520epidemiology%2520and%2520prevention%2520of%2520hepatocellular%2520carcinoma%26jtitle%3DSemin.%2520Oncol.%26date%3D2001%26volume%3D28%26spage%3D441%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sheridan, C.</span><span> </span><span class="NLM_article-title">New Merck and Vertex drugs raise standard of care in hepatitis C</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">554</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=553-554&author=C.+Sheridan&title=New+Merck+and+Vertex+drugs+raise+standard+of+care+in+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheridan%26aufirst%3DC.%26atitle%3DNew%2520Merck%2520and%2520Vertex%2520drugs%2520raise%2520standard%2520of%2520care%2520in%2520hepatitis%2520C%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D553%26epage%3D554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fried, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, D. K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonçales, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häussinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diago, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhumeaux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craxi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, J.</span><span> </span><span class="NLM_article-title">PEGinterferon-α-2a plus ribavirin for chronic hepatitis C virus infection</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1056%2FNEJMoa020047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=12324553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=975-982&author=M.+W.+Friedauthor=M.+L.+Shiffmanauthor=D.+K.+R.+Reddyauthor=C.+Smithauthor=G.+Marinosauthor=F.+L.+Gon%C3%A7alesauthor=D.+H%C3%A4ussingerauthor=M.+Diagoauthor=G.+Carosiauthor=D.+Dhumeauxauthor=A.+Craxiauthor=A.+Linauthor=J.+Hoffmanauthor=J.+Yu&title=PEGinterferon-%CE%B1-2a+plus+ribavirin+for+chronic+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</span></div><div class="casAuthors">Fried, Michael W.; Shiffman, Mitchell L.; Reddy, K. Rajender; Smith, Coleman; Marinos, George; Goncales, Fernando L., Jr.; Haussinger, Dieter; Diago, Moises; Carosi, Giampiero; Dhumeaux, Daniel; Craxi, Antonio; Lin, Amy; Hoffman, Joseph; Yu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">975-982</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Treatment with peginterferon alfa-2a alone produces significantly higher sustained virol. responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection.  We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in the initial treatment of chronic hepatitis C.  Methods: A total of 1121 patients were randomly assigned to treatment and received at least one dose of study medication, consisting of 180 μg of peginterferon alfa-2a once weekly plus daily ribavirin (1000 or 1200 mg, depending on body wt.), weekly peginterferon alfa-2a plus daily placebo, or 3 million units of interferon alfa-2b thrice weekly plus daily ribavirin for 48 wk.  Results: A significantly higher proportion of patients who received peginterferon alfa-2a plus ribavirin had a sustained virol. response (defined as the absence of detectable HCV RNA 24 wk after cessation of therapy) than of patients who received interferon alfa-2b plus ribavirin (56 % vs. 44 %, P<0.001) or peginterferon alfa-2a alone (56 % vs. 29 %, P<0.001).  The proportions of patients with HCV genotype 1 who had sustained virol. responses were 46 %, 36 %, and 21 %, resp., for the three regimens.  Among patients with HCV genotype 1 and high base-line levels of HCV RNA, the proportions of those with sustained virol. responses were 41 %, 33 %, and 13 %, resp.  The overall safety profiles of the three treatment regimens were similar; the incidence of influenza-like symptoms and depression was lower in the groups receiving peginterferon alfa-2a than in the group receiving interferon alfa-2b plus ribavirin.  Conclusions: In patients with chronic hepatitis C, once-weekly peginterferon alfa-2a plus ribavirin was tolerated as well as interferon alfa-2b plus ribavirin and produced significant improvements in the rate of sustained virol. response, as compared with interferon alfa-2b plus ribavirin or peginterferon alfa-2a alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqblwkeNXWJzbVg90H21EOLACvtfcHk0ljvniuhNv_I2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt12rtb0%253D&md5=2fd959d790b9505384fbd26ef44b2963</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa020047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa020047%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DReddy%26aufirst%3DD.%2BK.%2BR.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DMarinos%26aufirst%3DG.%26aulast%3DGon%25C3%25A7ales%26aufirst%3DF.%2BL.%26aulast%3DH%25C3%25A4ussinger%26aufirst%3DD.%26aulast%3DDiago%26aufirst%3DM.%26aulast%3DCarosi%26aufirst%3DG.%26aulast%3DDhumeaux%26aufirst%3DD.%26aulast%3DCraxi%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DPEGinterferon-%25CE%25B1-2a%2520plus%2520ribavirin%2520for%2520chronic%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D975%26epage%3D982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Di Bisceglie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">New therapeutic strategies for hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">224</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2002&pages=224-231&author=A.+M.+Di+Bisceglieauthor=J.+McHutchisonauthor=C.+M.+Rice&title=New+therapeutic+strategies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%2BM.%26aulast%3DMcHutchison%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DNew%2520therapeutic%2520strategies%2520for%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2002%26volume%3D35%26spage%3D224%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Choo, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=2523562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.+L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=A.+J.+Weinerauthor=L.+R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood-borne+non-A%2C+non-B+viral+hepatitis+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span></div><div class="casAuthors">Choo, Qui Lim; Kuo, George; Weiner, Amy J.; Overby, Lacy R.; Bradley, Daniel W.; Houghton, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4902</span>),
    <span class="NLM_cas:pages">359-62</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A random-primed cDNA library was constructed from plasma contg. the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH.  A cDNA clone was isolated that was shown to encode an antigen assocd. specifically with NANBH infections.  This clone is not derived from host DNA but from an RNA mol. present in NANBH infections that consists of ≥10,000 nucleotides, and that is pos.-stranded with respect to the encoded NANBH antigen.  These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae.  This mol. approach should be of great value in the isolation and characterization of other unidentified infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpVFx7nEkrVg90H21EOLACvtfcHk0ljvniuhNv_I2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D&md5=25161cf212790856dd29d3aaf78f20b8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.%2BL.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL.%2BR.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood-borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">A review of HCV protease inhibitors</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=821-837&author=K.+X.+Chenauthor=F.+G.+Njoroge&title=A+review+of+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DA%2520review%2520of%2520HCV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D821%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Legrand-Abravanel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">New NS5B polymerase inhibitors for hepatitis C</span> <span class="citation_source-journal">Expert Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=963-975&author=F.+Legrand-Abravanelauthor=F.+Nicotauthor=J.+Izopet&title=New+NS5B+polymerase+inhibitors+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegrand-Abravanel%26aufirst%3DF.%26aulast%3DNicot%26aufirst%3DF.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DNew%2520NS5B%2520polymerase%2520inhibitors%2520for%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Investig.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D963%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettles, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belema, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridell, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serrano-Wu, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Boyle, D. R.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemm, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knipe, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasela, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">465</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1038%2Fnature08960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=20410884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=465&publication_year=2010&pages=96-100&author=M.+Gaoauthor=R.+E.+Nettlesauthor=M.+Belemaauthor=L.+B.+Snyderauthor=V.+N.+Nguyenauthor=R.+A.+Fridellauthor=M.+H.+Serrano-Wuauthor=D.+R.+Langleyauthor=J.-H.+Sunauthor=D.+R.+O%E2%80%99Boyleauthor=J.+A.+Lemmauthor=C.+Wangauthor=J.+O.+Knipeauthor=C.+Chienauthor=R.+J.+Colonnoauthor=D.+M.+Graselaauthor=N.+A.+Meanwellauthor=L.+G.+Hamann&title=Chemical+genetics+strategy+identifies+an+HCV+NS5A+inhibitor+with+a+potent+clinical+effect"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect</span></div><div class="casAuthors">Gao, Min; Nettles, Richard E.; Belema, Makonen; Snyder, Lawrence B.; Nguyen, Van N.; Fridell, Robert A.; Serrano-Wu, Michael H.; Langley, David R.; Sun, Jin-Hua; O'Boyle, Donald R., II; Lemm, Julie A.; Wang, Chunfu; Knipe, Jay O.; Chien, Caly; Colonno, Richard J.; Grasela, Dennis M.; Meanwell, Nicholas A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">465</span>
        (<span class="NLM_cas:issue">7294</span>),
    <span class="NLM_cas:pages">96-100</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The worldwide prevalence of chronic hepatitis C virus (HCV) infection is estd. to be approaching 200 million people.  Current therapy relies upon a combination of pegylated interferon-α and ribavirin, a poorly tolerated regimen typically assocd. with less than 50% sustained virol. response rate in those infected with genotype 1 virus.  The development of direct-acting antiviral agents to treat HCV has focused predominantly on inhibitors of the viral enzymes NS3 protease and the RNA-dependent RNA polymerase NS5B.  Here we describe the profile of BMS-790052, a small mol. inhibitor of the HCV NS5A protein that exhibits picomolar half-max. effective concns. (EC50) towards replicons expressing a broad range of HCV genotypes and the JFH-1 genotype 2a infectious virus in cell culture.  In a phase I clin. trial in patients chronically infected with HCV, administration of a single 100-mg dose of BMS-790052 was assocd. with a 3.3 log10 redn. in mean viral load measured 24 h post-dose that was sustained for an addnl. 120 h in two patients infected with genotype 1b virus.  Genotypic anal. of samples taken at baseline, 24 and 144 h post-dose revealed that the major HCV variants obsd. had substitutions at amino-acid positions identified using the in vitro replicon system.  These results provide the first clin. validation of an inhibitor of HCV NS5A, a protein with no known enzymic function, as an approach to the suppression of virus replication that offers potential as part of a therapeutic regimen based on combinations of HCV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAY7Lig0xT9LVg90H21EOLACvtfcHk0liVhu4qv9Q25Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltVGhtbo%253D&md5=620427e987f2bccd153270cde2ef5027</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1038%2Fnature08960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08960%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DM.%26aulast%3DNettles%26aufirst%3DR.%2BE.%26aulast%3DBelema%26aufirst%3DM.%26aulast%3DSnyder%26aufirst%3DL.%2BB.%26aulast%3DNguyen%26aufirst%3DV.%2BN.%26aulast%3DFridell%26aufirst%3DR.%2BA.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DSun%26aufirst%3DJ.-H.%26aulast%3DO%25E2%2580%2599Boyle%26aufirst%3DD.%2BR.%26aulast%3DLemm%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DChemical%2520genetics%2520strategy%2520identifies%2520an%2520HCV%2520NS5A%2520inhibitor%2520with%2520a%2520potent%2520clinical%2520effect%26jtitle%3DNature%26date%3D2010%26volume%3D465%26spage%3D96%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muir, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afdhal, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzowej, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bisceglie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dienstag, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faruqui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fried, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugelmas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northup, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poordad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younossi, Z.</span><span> </span><span class="NLM_article-title">Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection</span> <span class="citation_source-journal">N. Eng. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">1827</span><span class="NLM_x">–</span> <span class="NLM_lpage">1838</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1056%2FNEJMoa0806104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=19403902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVGmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=1827-1838&author=J.+G.+McHutchisonauthor=G.+T.+Eversonauthor=S.+C.+Gordonauthor=I.+M.+Jacobsonauthor=M.+Sulkowskiauthor=R.+Kauffmanauthor=L.+McNairauthor=J.+Alamauthor=A.+J.+Muirauthor=N.+Afdhalauthor=S.+Aroraauthor=V.+Balanauthor=H.+Vargasauthor=D.+Bernsteinauthor=M.+Blackauthor=R.+Brownauthor=N.+Bzowejauthor=G.+Davisauthor=A.+Di+Bisceglieauthor=J.+Dienstagauthor=G.+Eversonauthor=S.+Faruquiauthor=J.+Francoauthor=M.+Friedauthor=R.+Ghalibauthor=S.+C.+Gordonauthor=J.+Grossauthor=I.+M.+Jacobsonauthor=D.+Jensenauthor=M.+Kugelmasauthor=P.+Kwoauthor=E.+Lawitzauthor=W.+Leeauthor=P.+Martinauthor=D.+Nelsonauthor=P.+Northupauthor=K.+Patelauthor=F.+Poordadauthor=R.+K.+Reddyauthor=M.+Rodriguez-Torresauthor=V.+Rustgiauthor=E.+Schiffauthor=K.+Shermanauthor=M.+Shiffmanauthor=M.+Sulkowskiauthor=G.+Szabolauthor=Z.+Younossi&title=Telaprevir+with+peginterferon+and+ribavirin+for+chronic+HCV+genotype+1+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection</span></div><div class="casAuthors">McHutchison, John G.; Everson, Gregory T.; Gordon, Stuart C.; Jacobson, Ira M.; Sulkowski, Mark; Kauffman, Robert; McNair, Lindsay; Alam, John; Muir, Andrew J.; Afdhal, N.; Arora, S.; Balan, V.; Vargas, H.; Bernstein, D.; Black, M.; Brown, R.; Bzowej, N.; Davis, G.; Di Bisceglie, A.; Dienstag, J.; Everson, G.; Faruqui, S.; Franco, J.; Fried, M.; Ghalib, R.; Gordon, S. C.; Gross, J.; Jacobson, I. M.; Jensen, D.; Kugelmas, M.; Kwo, P.; Lawitz, E.; Lee, W.; Martin, P.; Nelson, D.; Northup, P.; Patel, K.; Poordad, F.; Reddy, R. K.; Rodriguez-Torres, M.; Rustgi, V.; Schiff, E.; Sherman, K.; Shiffman, M.; Sulkowski, M.; Szabol, G.; Younossi, Z.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1827-1838</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Current therapy for chronic hepatitis C virus (HCV) infection is effective in less than 50% of patients infected with HCV genotype 1.  Telaprevir, a protease inhibitor specific to the HCV nonstructural 3/4A serine protease, rapidly reduced HCV RNA levels in early studies.  METHODS We randomly assigned patients infected with HCV genotype 1 to one of three telaprevir groups or to the control group.  The control group (called the PR48 group) received peginterferon alfa-2a (180 μg per wk) and ribavirin (1000 or 1200 mg per day, according to body wt.) for 48 wk, plus telaprevir-matched placebo for the first 12 wk (75 patients).  The telaprevir groups received telaprevir (1250 mg on day 1 and 750 mg every 8 h thereafter) for 12 wk, as well as peginterferon alfa-2a and ribavirin (at the same doses as in the PR48 group) for the same 12 wk (the T12PR12 group, 17 patients) or for a total of 24 wk (the T12PR24 group, 79 patients) or 48 wk (the T12PR48 group, 79 patients).  The primary outcome was a sustained virol. response (an undetectable HCV RNA level 24 wk after the end of therapy).  RESULTS The rate of sustained virol. response was 41% (31 of 75 patients) in the PR48 group, as compared with 61% (48 of 79 patients) in the T12PR24 group (P = 0.02), 67% (53 of 79 patients) in the T12PR48 group (P = 0.002), and 35% (6 of 17 patients) in the T12PR12 group (this group was exploratory and not compared with the control group).  Viral breakthrough occurred in 7% of patients receiving telaprevir.  The rate of discontinuation because of adverse events was higher in the three telaprevir-based groups (21%, vs. 11% in the PR48 group), with rash the most common reason for discontinuation.  CONCLUSIONS Treatment with a telaprevir-based regimen significantly improved sustained virol. response rates in patients with genotype 1 HCV, albeit with higher rates of discontinuation because of adverse events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnK2pWAKIzM7Vg90H21EOLACvtfcHk0liVhu4qv9Q25Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVGmtrc%253D&md5=574eed8a6bd101631bb1e3d904a072b5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0806104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0806104%26sid%3Dliteratum%253Aachs%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DEverson%26aufirst%3DG.%2BT.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DR.%26aulast%3DMcNair%26aufirst%3DL.%26aulast%3DAlam%26aufirst%3DJ.%26aulast%3DMuir%26aufirst%3DA.%2BJ.%26aulast%3DAfdhal%26aufirst%3DN.%26aulast%3DArora%26aufirst%3DS.%26aulast%3DBalan%26aufirst%3DV.%26aulast%3DVargas%26aufirst%3DH.%26aulast%3DBernstein%26aufirst%3DD.%26aulast%3DBlack%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DR.%26aulast%3DBzowej%26aufirst%3DN.%26aulast%3DDavis%26aufirst%3DG.%26aulast%3DDi%2BBisceglie%26aufirst%3DA.%26aulast%3DDienstag%26aufirst%3DJ.%26aulast%3DEverson%26aufirst%3DG.%26aulast%3DFaruqui%26aufirst%3DS.%26aulast%3DFranco%26aufirst%3DJ.%26aulast%3DFried%26aufirst%3DM.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DGross%26aufirst%3DJ.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DJensen%26aufirst%3DD.%26aulast%3DKugelmas%26aufirst%3DM.%26aulast%3DKwo%26aufirst%3DP.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DW.%26aulast%3DMartin%26aufirst%3DP.%26aulast%3DNelson%26aufirst%3DD.%26aulast%3DNorthup%26aufirst%3DP.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DPoordad%26aufirst%3DF.%26aulast%3DReddy%26aufirst%3DR.%2BK.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DRustgi%26aufirst%3DV.%26aulast%3DSchiff%26aufirst%3DE.%26aulast%3DSherman%26aufirst%3DK.%26aulast%3DShiffman%26aufirst%3DM.%26aulast%3DSulkowski%26aufirst%3DM.%26aulast%3DSzabol%26aufirst%3DG.%26aulast%3DYounossi%26aufirst%3DZ.%26atitle%3DTelaprevir%2520with%2520peginterferon%2520and%2520ribavirin%2520for%2520chronic%2520HCV%2520genotype%25201%2520infection%26jtitle%3DN.%2520Eng.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D1827%26epage%3D1838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kwo, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCone, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vierling, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pound, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galati, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravendhran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koury, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedicone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">716</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=705-716&author=P.+Y.+Kwoauthor=E.+J.+Lawitzauthor=J.+McConeauthor=E.+R.+Schiffauthor=J.+M.+Vierlingauthor=D.+Poundauthor=M.+N.+Davisauthor=J.+S.+Galatiauthor=S.+C.+Gordonauthor=N.+Ravendhranauthor=L.+Rossaroauthor=F.+H.+Andersonauthor=I.+M.+Jacobsonauthor=R.+Rubinauthor=K.+Kouryauthor=L.+D.+Pediconeauthor=C.+A.+Brassauthor=E.+Chaudhriauthor=J.+K.+Albrecht&title=Efficacy+of+boceprevir%2C+an+NS3+protease+inhibitor%2C+in+combination+with+peginterferon+alfa-2b+and+ribavirin+in+treatment-naive+patients+with+genotype+1+hepatitis+C+infection+%28SPRINT-1%29%3A+an+open-label%2C+randomised%2C+multicentre+phase+2+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwo%26aufirst%3DP.%2BY.%26aulast%3DLawitz%26aufirst%3DE.%2BJ.%26aulast%3DMcCone%26aufirst%3DJ.%26aulast%3DSchiff%26aufirst%3DE.%2BR.%26aulast%3DVierling%26aufirst%3DJ.%2BM.%26aulast%3DPound%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DM.%2BN.%26aulast%3DGalati%26aufirst%3DJ.%2BS.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DRavendhran%26aufirst%3DN.%26aulast%3DRossaro%26aufirst%3DL.%26aulast%3DAnderson%26aufirst%3DF.%2BH.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DRubin%26aufirst%3DR.%26aulast%3DKoury%26aufirst%3DK.%26aulast%3DPedicone%26aufirst%3DL.%2BD.%26aulast%3DBrass%26aufirst%3DC.%2BA.%26aulast%3DChaudhri%26aufirst%3DE.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DEfficacy%2520of%2520boceprevir%252C%2520an%2520NS3%2520protease%2520inhibitor%252C%2520in%2520combination%2520with%2520peginterferon%2520alfa-2b%2520and%2520ribavirin%2520in%2520treatment-naive%2520patients%2520with%2520genotype%25201%2520hepatitis%2520C%2520infection%2520%2528SPRINT-1%2529%253A%2520an%2520open-label%252C%2520randomised%252C%2520multicentre%2520phase%25202%2520trial%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D705%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally, bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally%2C+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%252C%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J. J.</span><span> </span><span class="NLM_article-title">Challenges in modern drug discovery: A case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar700109k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=50-59&author=F.+G.+Njorogeauthor=K.+X.+Chenauthor=N.-Y.+Shihauthor=J.+J.+Piwinski&title=Challenges+in+modern+drug+discovery%3A+A+case+study+of+boceprevir%2C+an+HCV+protease+inhibitor+for+the+treatment+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Far700109k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far700109k%26sid%3Dliteratum%253Aachs%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DPiwinski%26aufirst%3DJ.%2BJ.%26atitle%3DChallenges%2520in%2520modern%2520drug%2520discovery%253A%2520A%2520case%2520study%2520of%2520boceprevir%252C%2520an%2520HCV%2520protease%2520inhibitor%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D50%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kormacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogonowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prudence, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-amino-1-(cyclobutylmethyl)-2–3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a selective, potent, orally bioavailable, hepatitis C virus NS3 protease inhibitor: A potential therapeutic agent for the treatment of hepatitis C infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agarwalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=B.+L.+Madisonauthor=X.+Cuiauthor=K.-C.+Chengauthor=T.+Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Kormacherauthor=R.+Whiteauthor=S.+Bogonowich-Knippauthor=A.+Pavlovskyauthor=B.+Prudenceauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-amino-1-%28cyclobutylmethyl%29-2%E2%80%933-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+selective%2C+potent%2C+orally+bioavailable%2C+hepatitis+C+virus+NS3+protease+inhibitor%3A+A+potential+therapeutic+agent+for+the+treatment+of+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DB.%2BL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DT.%2BY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKormacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogonowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DPrudence%26aufirst%3DB.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-amino-1-%2528cyclobutylmethyl%2529-2%25E2%2580%25933-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520selective%252C%2520potent%252C%2520orally%2520bioavailable%252C%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitor%253A%2520A%2520potential%2520therapeutic%2520agent%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Behrens, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span> </span><span class="NLM_article-title">Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=12-22&author=S.+E.+Behrensauthor=L.+Tomeiauthor=R.+De+Francesco&title=Identification+and+properties+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBehrens%26aufirst%3DS.%2BE.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26atitle%3DIdentification%2520and%2520properties%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D12%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Biochemical properties of hepatitis c virus ns5b RNAdependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">8416</span><span class="NLM_x">–</span> <span class="NLM_lpage">8428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=9343198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaK2sXmvV2hs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1997&pages=8416-8428&author=V.+Lohmannauthor=F.+Kornerauthor=U.+Herianauthor=R.+Bartenschlager&title=Biochemical+properties+of+hepatitis+c+virus+ns5b+RNAdependent+RNA+polymerase+and+identification+of+amino+acid+sequence+motifs+essential+for+enzymatic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymic activity</span></div><div class="casAuthors">Lohmann, Volker; Korner, Frank; Herian, Ulrike; Bartenschlager, Ralf</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8416-8428</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The NS5B protein of the hepatitis C virus (HCV) is an RNA-dependent RNA polymerase (RdRp) (S.-E. Behrens, L. Tomei, and R. De Francesco, EMBO J. 15:12-22, 1996) that is assumed to be required for replication of the viral genome.  To further study the biochem. and structural properties of this enzyme, an NS5B-hexahistidine fusion protein was expressed with recombinant baculoviruses in insect cells and purified to near homogeneity.  The enzyme was found to have a primer-dependent RdRp activity that was able to copy a complete in vitro-transcribed HCV genome in the absence of addnl. viral or cellular factors.  Filter binding assays and competition expts. showed that the purified enzyme binds RNA with no clear preference for HCV 3'-end sequences.  Binding to homopolymeric RNAs was also examd., and the following order of specificity was obsd.: poly(U) > poly(G) > poly(A) > poly(C).  An inverse order was found for the RdRp activity, which used poly(C) most efficiently as a template but was inactive on poly(U) and poly(G), suggesting that a high binding affinity between polymerase and template interferes with processivity.  By using a mutational anal., four amino acid sequence motifs crucial for RdRp activity were identified.  While most substitutions of conserved residues within these motifs severely reduced the enzymic activities, a single substitution in motif D which enhanced the RdRp activity by about 50% was found.  Deletion studies indicate that amino acid residues at the very termini, in particular the amino terminus, are important for RdRp activity but not for RNA binding.  Finally, we found a terminal transferase activity assocd. with the purified enzyme.  However, this activity was also detected with NS5B proteins with an inactive RdRp, with an NS4B protein purified in the same way, and with wild-type baculovirus, suggesting that it is not an inherent activity of NS5B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdCeTDzvlRArVg90H21EOLACvtfcHk0lhQDWHkEN_PrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvV2hs7s%253D&md5=98640d185270f0b331db0fa0624865cd</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DBiochemical%2520properties%2520of%2520hepatitis%2520c%2520virus%2520ns5b%2520RNAdependent%2520RNA%2520polymerase%2520and%2520identification%2520of%2520amino%2520acid%2520sequence%2520motifs%2520essential%2520for%2520enzymatic%2520activity%26jtitle%3DJ.%2520Virol.%26date%3D1997%26volume%3D71%26spage%3D8416%26epage%3D8428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Quinkert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, V.</span><span> </span><span class="NLM_article-title">Quantitative analysis of the hepatitis C virus replication complex</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">13594</span><span class="NLM_x">–</span> <span class="NLM_lpage">13605</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1128%2FJVI.79.21.13594-13605.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=16227280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKjtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=13594-13605&author=D.+Quinkertauthor=R.+Bartenschlagerauthor=V.+Lohmann&title=Quantitative+analysis+of+the+hepatitis+C+virus+replication+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative analysis of the hepatitis C virus replication complex</span></div><div class="casAuthors">Quinkert, Doris; Bartenschlager, Ralf; Lohmann, Volker</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">13594-13605</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) encodes a large polyprotein; therefore, all viral proteins are produced in equimolar amts. regardless of their function.  The aim of our study was to det. the ratio of nonstructural proteins to RNA that is required for HCV RNA replication.  We analyzed Huh-7 cells harboring full-length HCV genomes or subgenomic replicons and found in all cases a >1000-fold excess of HCV proteins over pos.- and neg.-strand RNA.  To examine whether all nonstructural protein copies are involved in RNA synthesis, we isolated active HCV replication complexes from replicon cells and examd. them for their content of viral RNA and proteins before and after treatment with protease and/or nuclease.  In vitro replicase activity, as well as almost the entire neg.- and pos.-strand RNA, was resistant to nuclease treatment, whereas <5% of the nonstructural proteins were protected from protease digest but accounted for the full in vitro replicase activity.  In consequence, only a minor fraction of the HCV nonstructural proteins was actively involved in RNA synthesis at a given time point but, due to the high amts. present in replicon cells, still representing a huge excess compared to the viral RNA.  Based on the comparison of nuclease-resistant viral RNA to protease-resistant viral proteins, we est. that an active HCV replicase complex consists of one neg.-strand RNA, two to ten pos.-strand RNAs, and several hundred nonstructural protein copies, which might be required as structural components of the vesicular compartments that are the site of HCV replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogSsRsSfAAvLVg90H21EOLACvtfcHk0lhQDWHkEN_PrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKjtr%252FJ&md5=c5060858a84ac062a62d2bfa0a5ca926</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.21.13594-13605.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.21.13594-13605.2005%26sid%3Dliteratum%253Aachs%26aulast%3DQuinkert%26aufirst%3DD.%26aulast%3DBartenschlager%26aufirst%3DR.%26aulast%3DLohmann%26aufirst%3DV.%26atitle%3DQuantitative%2520analysis%2520of%2520the%2520hepatitis%2520C%2520virus%2520replication%2520complex%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D13594%26epage%3D13605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cable, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannarino, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">937</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=937-943&author=C.+A.+Lesburgauthor=M.+B.+Cableauthor=E.+Ferrariauthor=Z.+Hongauthor=A.+F.+Mannarinoauthor=P.+C.+Weber&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+from+hepatitis+C+virus+reveals+a+fully+encircled+active+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DCable%26aufirst%3DM.%2BB.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DMannarino%26aufirst%3DA.%2BF.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520from%2520hepatitis%2520C%2520virus%2520reveals%2520a%2520fully%2520encircled%2520active%2520site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D937%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ago, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habuka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yatsunami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano, M.</span><span> </span><span class="NLM_article-title">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1417</span><span class="NLM_x">–</span> <span class="NLM_lpage">1426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1016%2FS0969-2126%2800%2980031-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=10574802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=1417-1426&author=H.+Agoauthor=T.+Adachiauthor=A.+Yoshidaauthor=M.+Yamamotoauthor=N.+Habukaauthor=K.+Yatsunamiauthor=M.+Miyano&title=Crystal+structure+of+the+RNA-dependent+RNA+polymerase+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus</span></div><div class="casAuthors">Ago, Hideo; Adachi, Tsuyoshi; Yoshida, Atsuhito; Yamamoto, Masaki; Habuka, Noriyuki; Yatsunami, Kimio; Miyano, Masashi</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1417-1426</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is the major etiol. agent of hepatocellular carcinoma, and HCV RNA-dependent RNA polymerase (RNA replicase) (I) is one of the main potential targets for anti-HCV agents.  HCV I performs run-off copying replication in an RNA-selective manner for the template-primer duplex and the substrate, but the structural basis of this reaction mechanism has still to be elucidated.  Here, the 3-dimensional structure of HCV I was detd. by x-ray crystallog. at 2.5 Å resoln.  The compact HCV I structure resembled a right hand, but had more complicated fingers and thumb domains than those of the other known polymerases, with a novel α-helix-rich subdomain (α fingers) as an addn. to the fingers domain.  The other fingers subdomain (β fingers) was folded in the same manner as the fingers domain of HIV virus reverse transcriptase, another RNA-dependent polymerase.  The ribose-recognition site of HCV I was constructed of hydrophilic residues, unlike those of DNA polymerases.  The C-terminal region of HCV I occupied the putative RNA-duplex-binding cleft.  The structural basis of the RNA selectivity of HCV I was elucidated from its crystal structure.  The putative substrate-binding site with a shallow hydrophilic cavity should have ribonucleoside triphosphate as the preferred substrate.  The authors propose that the unique α fingers might represent a common structural discriminator of the template-primer duplex that distinguishes between RNA and DNA during the replication of pos. single-stranded RNA by viral I enzymes.  The C-terminal region might exert a regulatory function on the initiation and activity of HCV I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKp1aOmXjMKLVg90H21EOLACvtfcHk0lhQDWHkEN_PrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslOit7o%253D&md5=95fcc20ce2f28dab4d76d8dfac0aa4ee</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2800%2980031-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252800%252980031-3%26sid%3Dliteratum%253Aachs%26aulast%3DAgo%26aufirst%3DH.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DHabuka%26aufirst%3DN.%26aulast%3DYatsunami%26aufirst%3DK.%26aulast%3DMiyano%26aufirst%3DM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D1417%26epage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">Reviews of non-nucleoside HCV NS5B polymerase inhibitors: </p></div><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, Y.; He, Y.; Molla, A.</span><span> </span><span class="NLM_article-title">Hepatitis C virus polymerase as a target for antiviral drug intervention: Non-nucleoside inhibitors</span>. In  <span class="citation_source-book">Antiviral Research: Strategies in Antiviral Drug Discovery</span>; <span class="NLM_contrib-group">LaFemina, R. L.</span>, Ed.; <span class="NLM_publisher-name">ASM Press</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1128%2F9781555815493.ch8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=137-151&author=Y.+Liu&author=Y.+He&author=A.+Mollaauthor=R.+L.+LaFemina&title=Antiviral+Research%3A+Strategies+in+Antiviral+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1128%2F9781555815493.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1128%252F9781555815493.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DHepatitis%2520C%2520virus%2520polymerase%2520as%2520a%2520target%2520for%2520antiviral%2520drug%2520intervention%253A%2520Non-nucleoside%2520inhibitors%26btitle%3DAntiviral%2520Research%253A%2520Strategies%2520in%2520Antiviral%2520Drug%2520Discovery%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26pub%3DASM%2520Press%26date%3D2009%26spage%3D137%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Non-nucleoside inhibitors of the hcv ns5b polymerase: Progress in the discovery and development of novel agents for the treatment of hcv infections</span> <span class="citation_source-journal">Curr. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=17668364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=614-634&author=P.+L.+Beaulieu&title=Non-nucleoside+inhibitors+of+the+hcv+ns5b+polymerase%3A+Progress+in+the+discovery+and+development+of+novel+agents+for+the+treatment+of+hcv+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Non-nucleoside inhibitors of the HCV NS5B polymerase: progress in the discovery and development of novel agents for the treatment of HCV infections</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">614-634</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The severe health conditions assocd. with chronic HCV infection remain a global concern.  Small-mol. drugs that specifically target essential virally encoded enzymes have not yet progressed to market, and the current std. of care continues to rely on a combination of pegylated IFN with ribavirin.  This therapy has serious side effects and a significant proportion of patients infected with HCV genotype 1 (the major genotype in industrialized countries) have an unsatisfactory outcome with this therapy.  Major advances have been realized in the development of specific non-nucleoside inhibitors of the viral NS5B RNA-dependent RNA polymerase.  This well-characterized replicative enzyme is a highly drugable target that, in addn. to its active site, features at least three known allosteric binding pockets that regulate RNA synthesis and are suitable for inhibitor design.  Clin. proof-of-concept for allosteric non-nucleoside HCV polymerase inhibitors has been reported and several compds. have progressed into preclin. studies.  It is likely that in the future NS5B inhibitors will form an integral part of more effective anti-HCV therapies, combining the use of small-mol. antiviral drugs with or without the assistance of immune modulators such as IFNs in order to minimize the emergence of resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTl5U1TLVJ57Vg90H21EOLACvtfcHk0lhlh11kzbySpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKgsbvK&md5=347a7983497b1b50bba61a455783f302</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DNon-nucleoside%2520inhibitors%2520of%2520the%2520hcv%2520ns5b%2520polymerase%253A%2520Progress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520agents%2520for%2520the%2520treatment%2520of%2520hcv%2520infections%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2007%26volume%3D8%26spage%3D614%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">Reviews of HCV NS5B polymerase inhibitors: </p></div><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Watkins, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, L. S.</span><span> </span><span class="NLM_article-title">HCV NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=441-465&author=W.+J.+Watkinsauthor=A.+S.+Rayauthor=L.+S.+Chong&title=HCV+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatkins%26aufirst%3DW.%2BJ.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DChong%26aufirst%3DL.%2BS.%26atitle%3DHCV%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D441%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Legrand-Abravanel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izopet, J.</span><span> </span><span class="NLM_article-title">New NS5B polymerase inhibitors for hepatitis C</span> <span class="citation_source-journal">Expert Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">963</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=963-975&author=F.+Legrand-Abravanelauthor=F.+Nicotauthor=J.+Izopet&title=New+NS5B+polymerase+inhibitors+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLegrand-Abravanel%26aufirst%3DF.%26aulast%3DNicot%26aufirst%3DF.%26aulast%3DIzopet%26aufirst%3DJ.%26atitle%3DNew%2520NS5B%2520polymerase%2520inhibitors%2520for%2520hepatitis%2520C%26jtitle%3DExpert%2520Opin.%2520Investig.%2520Drugs%26date%3D2010%26volume%3D19%26spage%3D963%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1517%2F13543770802672598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=145-164&author=P.+L.+Beaulieu&title=Recent+advances+in+the+development+of+NS5B+polymerase+inhibitors+for+the+treatment+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection</span></div><div class="casAuthors">Beaulieu, Pierre L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-164</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  170 To 200 million people worldwide are believed to suffer from chronic hepatitis C virus (HCV) infection, a blood-born disease that targets the liver and progresses to organ cirrhosis and primary cancer in a significant proportion of patients.  The currently available treatment has limited efficacy and suffers from restricting side effects.  HCV infection is the principal cause of liver transplant in industrialized nations and between 8000 and 10,000 deaths result annually from the disease in the United States alone.  Virus-specific, more efficacious, and better-tolerated anti-HCV therapies are thus required to address the unmet medical need.  Objective: To review progress achieved since 2005 in the development of HCV NS5B polymerase inhibitors as potential therapy for the treatment of HCV infection with a primary focus on available patent and medical literature.  Results/conclusion: Several classes of small-mol. inhibitors of HCV NS5B have progressed into clin. development and demonstrated efficacy in reducing viral load in infected patients.  The results so far provide an encouraging foundation for the development of novel, more tolerable therapies and addressing emergence of resistance through combination of antiviral agents with complementary mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo8VVFJs4oSbVg90H21EOLACvtfcHk0lhlh11kzbySpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVCks74%253D&md5=64b78562e2b4e3e8a166fdabf14f7efe</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1517%2F13543770802672598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802672598%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520NS5B%2520polymerase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D145%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Witte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendricks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clausen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span> </span><span class="NLM_article-title">Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2005&pages=8-15&author=H.+Maauthor=V.+Levequeauthor=A.+De+Witteauthor=W.+Liauthor=T.+Hendricksauthor=S.+M.+Clausenauthor=N.+Cammackauthor=K.+Klumpp&title=Inhibition+of+native+hepatitis+C+virus+replicase+by+nucleotide+and+non-nucleoside+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DH.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DDe%2BWitte%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DHendricks%26aufirst%3DT.%26aulast%3DClausen%26aufirst%3DS.%2BM.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DKlumpp%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520native%2520hepatitis%2520C%2520virus%2520replicase%2520by%2520nucleotide%2520and%2520non-nucleoside%2520inhibitors%26jtitle%3DVirology%26date%3D2005%26volume%3D332%26spage%3D8%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockstroh, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeuzem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulim, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">The way forward in hcv treatment--finding the right path</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=991-1000&author=M.+P.+Mannsauthor=G.+R.+Fosterauthor=J.+K.+Rockstrohauthor=S.+Zeuzemauthor=F.+Zoulimauthor=M.+Houghton&title=The+way+forward+in+hcv+treatment%2D%2Dfinding+the+right+path"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DFoster%26aufirst%3DG.%2BR.%26aulast%3DRockstroh%26aufirst%3DJ.%2BK.%26aulast%3DZeuzem%26aufirst%3DS.%26aulast%3DZoulim%26aufirst%3DF.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DThe%2520way%2520forward%2520in%2520hcv%2520treatment--finding%2520the%2520right%2520path%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D991%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amours, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammadossi, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 20-C-methylcytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6614</span><span class="NLM_x">–</span> <span class="NLM_lpage">6620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6614-6620&author=C.+Pierraauthor=A.+Amadorauthor=S.+Benzariaauthor=E.+Cretton-Scottauthor=M.+D%E2%80%99Amoursauthor=J.+Maoauthor=S.+Mathieuauthor=A.+Moussaauthor=E.+G.+Bridgesauthor=D.+M.+Standringauthor=J.-P.+Sammadossiauthor=R.+Storerauthor=G.+Gosselin&title=Synthesis+and+pharmacokinetics+of+valopicitabine+%28NM283%29%2C+an+efficient+prodrug+of+the+potent+anti-HCV+agent+20-C-methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fjm0603623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603623%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DD%25E2%2580%2599Amours%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DBridges%26aufirst%3DE.%2BG.%26aulast%3DStandring%26aufirst%3DD.%2BM.%26aulast%3DSammadossi%26aufirst%3DJ.-P.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520pharmacokinetics%2520of%2520valopicitabine%2520%2528NM283%2529%252C%2520an%2520efficient%2520prodrug%2520of%2520the%2520potent%2520anti-HCV%2520agent%252020-C-methylcytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6614%26epage%3D6620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> R1626:</p></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalayanov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winqvist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltseva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V. J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyagurr, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benkestock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, X.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaiser, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swallow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsson, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span> </span><span class="NLM_article-title">The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 40-azidocytidine against hepatitis C virus replication: The discovery of 40-azido-20-deoxy-20-fluorocytidine and 40-azido-20-dideoxy-20,20-difluorocytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2971</span><span class="NLM_x">–</span> <span class="NLM_lpage">2978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801595c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=2971-2978&author=D.+B.+Smithauthor=G.+Kalayanovauthor=G.+Sundauthor=A.+Winqvistauthor=T.+Maltsevaauthor=V.+J.-P.+Levequeauthor=S.+Rajyagurrauthor=S.+Le+Pogamauthor=I.+Najerauthor=K.+Benkestockauthor=X.-X.+Zhouauthor=A.+C.+Kaiserauthor=H.+Maagauthor=N.+Cammackauthor=J.+A.+Martinauthor=S.+Swallowauthor=N.+G.+Johannssonauthor=K.+Klumppauthor=M.+Smith&title=The+design%2C+synthesis%2C+and+antiviral+activity+of+monofluoro+and+difluoro+analogues+of+40-azidocytidine+against+hepatitis+C+virus+replication%3A+The+discovery+of+40-azido-20-deoxy-20-fluorocytidine+and+40-azido-20-dideoxy-20%2C20-difluorocytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fjm801595c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801595c%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DKalayanov%26aufirst%3DG.%26aulast%3DSund%26aufirst%3DG.%26aulast%3DWinqvist%26aufirst%3DA.%26aulast%3DMaltseva%26aufirst%3DT.%26aulast%3DLeveque%26aufirst%3DV.%2BJ.-P.%26aulast%3DRajyagurr%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajer%26aufirst%3DI.%26aulast%3DBenkestock%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.-X.%26aulast%3DKaiser%26aufirst%3DA.%2BC.%26aulast%3DMaag%26aufirst%3DH.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DJohannsson%26aufirst%3DN.%2BG.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DM.%26atitle%3DThe%2520design%252C%2520synthesis%252C%2520and%2520antiviral%2520activity%2520of%2520monofluoro%2520and%2520difluoro%2520analogues%2520of%252040-azidocytidine%2520against%2520hepatitis%2520C%2520virus%2520replication%253A%2520The%2520discovery%2520of%252040-azido-20-deoxy-20-fluorocytidine%2520and%252040-azido-20-dideoxy-20%252C20-difluorocytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D2971%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> PSI-6130:</p></div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Clark, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollecker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tharnish, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lostia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stec, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pankiewicz, K. W.</span><span> </span><span class="NLM_article-title">Design, synthesis, and antiviral activity of 20-deoxy-20-fluoro-20-c-methylcytidine, a potent inhibitor of hepatitis C virus replication</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5504</span><span class="NLM_x">–</span> <span class="NLM_lpage">5508</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5504-5508&author=J.+L.+Clarkauthor=L.+Holleckerauthor=J.+C.+Masonauthor=L.+J.+Stuyverauthor=P.+M.+Tharnishauthor=S.+Lostiaauthor=T.+R.+McBrayerauthor=R.+Schinaziauthor=K.+A.+Watanabeauthor=M.+J.+Ottoauthor=P.+A.+Furmanauthor=W.+J.+Stecauthor=S.+E.+Pattersonauthor=K.+W.+Pankiewicz&title=Design%2C+synthesis%2C+and+antiviral+activity+of+20-deoxy-20-fluoro-20-c-methylcytidine%2C+a+potent+inhibitor+of+hepatitis+C+virus+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1021%2Fjm0502788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502788%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BL.%26aulast%3DHollecker%26aufirst%3DL.%26aulast%3DMason%26aufirst%3DJ.%2BC.%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DTharnish%26aufirst%3DP.%2BM.%26aulast%3DLostia%26aufirst%3DS.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DSchinazi%26aufirst%3DR.%26aulast%3DWatanabe%26aufirst%3DK.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DStec%26aufirst%3DW.%2BJ.%26aulast%3DPatterson%26aufirst%3DS.%2BE.%26aulast%3DPankiewicz%26aufirst%3DK.%2BW.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antiviral%2520activity%2520of%252020-deoxy-20-fluoro-20-c-methylcytidine%252C%2520a%2520potent%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520replication%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5504%26epage%3D5508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sofia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarathnam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Discovery of a β-<span class="smallcaps smallerCapital">d</span>-2′-deoxy-2′-α-fluoro-2′-β-<i>C</i>-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7202</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100863x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7202-18&author=M.+J.+Sofiaauthor=D.+Baoauthor=W.+Changauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=P.+G.+Reddyauthor=B.+S.+Rossauthor=P.+Wangauthor=H.+R.+Zhangauthor=S.+Bansalauthor=C.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=H.+M.+Steuerauthor=C.+Niuauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Discovery+of+a+%CE%B2-d-2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B1-fluoro-2%E2%80%B2-%CE%B2-C-methyluridine+nucleotide+prodrug+%28PSI-7977%29+for+the+treatment+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus</span></div><div class="casAuthors">Sofia, Michael J.; Bao, Donghui; Chang, Wonsuk; Du, Jinfa; Nagarathnam, Dhanapalan; Rachakonda, Suguna; Reddy, P. Ganapati; Ross, Bruce S.; Wang, Peiyuan; Zhang, Hai-Ren; Bansal, Shalini; Espiritu, Christine; Keilman, Meg; Lam, Angela M.; Steuer, Holly M. Micolochick; Niu, Congrong; Otto, Michael J.; Furman, Phillip A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7202-7218</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) is a global health problem requiring novel approaches for effective treatment of this disease.  The HCV NS5B polymerase has been demonstrated to be a viable target for the development of HCV therapies.  β-D-2'-Deoxy-2'-α-fluoro-2'-β-C-Me nucleosides are selective inhibitors of the HCV NS5B polymerase and have demonstrated potent activity in the clinic.  Phosphoramidate prodrugs of the 5'-phosphate deriv. of the β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine nucleoside were prepd. and showed significant potency in the HCV subgenomic replicon assay (<1 μM) and produced high levels of triphosphate 6 in primary hepatocytes and in the livers of rats, dogs, and monkeys when administered in vivo.  The single diastereomer 51 of diastereomeric mixt. 14 was crystd., and an X-ray structure was detd. establishing the phosphoramidate stereochem. as Sp, thus correlating for the first time the stereochem. of a phosphoramidate prodrug with biol. activity.  51 (PSI-7977) was selected as a clin. development candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWAkLi9-odWbVg90H21EOLACvtfcHk0ljTlosxEAeQIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKmtb%252FO&md5=33d371e557e9d70562a326f97798f45c</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1021%2Fjm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100863x%26sid%3Dliteratum%253Aachs%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%2BR.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520%25CE%25B2-d-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B1-fluoro-2%25E2%2580%25B2-%25CE%25B2-C-methyluridine%2520nucleotide%2520prodrug%2520%2528PSI-7977%2529%2520for%2520the%2520treatment%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7202%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Reddy, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, B.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagarathnam, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachakonda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bansal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espiritu, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steuer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sofia, M. J.</span><span> </span><span class="NLM_article-title">20-Deoxy-20-a-fluoro-20-b-C-methyl 30,50-cyclic phosphate nucleotide prodrug analogues as inhibitors of HCV NS5B polymerase: Discovery of PSI-352938</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7376</span><span class="NLM_x">–</span> <span class="NLM_lpage">7380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7376-7380&author=P.+G.+Reddyauthor=D.+Baoauthor=W.+Changauthor=B.-K.+Chunauthor=J.+Duauthor=D.+Nagarathnamauthor=S.+Rachakondaauthor=B.+S.+Rossauthor=H.-R.+Zhangauthor=S.+Bansalauthor=C.+L.+Espirituauthor=M.+Keilmanauthor=A.+M.+Lamauthor=C.+Niuauthor=H.+M.+Steuerauthor=P.+A.+Furmanauthor=M.+J.+Ottoauthor=M.+J.+Sofia&title=20-Deoxy-20-a-fluoro-20-b-C-methyl+30%2C50-cyclic+phosphate+nucleotide+prodrug+analogues+as+inhibitors+of+HCV+NS5B+polymerase%3A+Discovery+of+PSI-352938"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DP.%2BG.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DB.-K.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DNagarathnam%26aufirst%3DD.%26aulast%3DRachakonda%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DB.%2BS.%26aulast%3DZhang%26aufirst%3DH.-R.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DEspiritu%26aufirst%3DC.%2BL.%26aulast%3DKeilman%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DA.%2BM.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DSteuer%26aufirst%3DH.%2BM.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DSofia%26aufirst%3DM.%2BJ.%26atitle%3D20-Deoxy-20-a-fluoro-20-b-C-methyl%252030%252C50-cyclic%2520phosphate%2520nucleotide%2520prodrug%2520analogues%2520as%2520inhibitors%2520of%2520HCV%2520NS5B%2520polymerase%253A%2520Discovery%2520of%2520PSI-352938%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7376%26epage%3D7380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perigaud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyrottes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licklider, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camire, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Colla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hildebrand, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilello, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarville, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badaroux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. N.</span><span> </span><span class="NLM_article-title">In vitro antiviral activity and pharmacology of IDX184, a novel and potent inhibitor of HCV replication</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">S220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=S220&author=E.+Cretton-Scottauthor=C.+Perigaudauthor=S.+Peyrottesauthor=L.+Lickliderauthor=M.+Camireauthor=M.+Larssonauthor=M.+La+Collaauthor=E.+Hildebrandauthor=L.+Lallosauthor=J.+Bilelloauthor=J.+McCarvilleauthor=M.+Seiferauthor=M.+Liuzziauthor=C.+Pierraauthor=E.+Badarouxauthor=G.+Gosselinauthor=D.+Surlerauxauthor=D.+N.+Standring&title=In+vitro+antiviral+activity+and+pharmacology+of+IDX184%2C+a+novel+and+potent+inhibitor+of+HCV+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DPerigaud%26aufirst%3DC.%26aulast%3DPeyrottes%26aufirst%3DS.%26aulast%3DLicklider%26aufirst%3DL.%26aulast%3DCamire%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DM.%26aulast%3DLa%2BColla%26aufirst%3DM.%26aulast%3DHildebrand%26aufirst%3DE.%26aulast%3DLallos%26aufirst%3DL.%26aulast%3DBilello%26aufirst%3DJ.%26aulast%3DMcCarville%26aufirst%3DJ.%26aulast%3DSeifer%26aufirst%3DM.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DBadaroux%26aufirst%3DE.%26aulast%3DGosselin%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DStandring%26aufirst%3DD.%2BN.%26atitle%3DIn%2520vitro%2520antiviral%2520activity%2520and%2520pharmacology%2520of%2520IDX184%252C%2520a%2520novel%2520and%2520potent%2520inhibitor%2520of%2520HCV%2520replication%26jtitle%3DJ.%2520Hepatol.%26date%3D2008%26volume%3D48%26spage%3DS220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madela, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aljarah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamberlain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernachio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ames, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorovits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolykhalov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammadb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span> </span><span class="NLM_article-title">Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4850</span><span class="NLM_x">–</span> <span class="NLM_lpage">4854</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1016%2Fj.bmcl.2010.06.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=20637609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16g&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlagurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4850-4854&author=C.+McGuiganauthor=K.+Madelaauthor=M.+Aljarahauthor=A.+Gillesauthor=A.+Brancaleauthor=N.+Zontaauthor=S.+Chamberlainauthor=J.+Vernachioauthor=J.+Hutchinsauthor=A.+Hallauthor=B.+Amesauthor=E.+Gorovitsauthor=B.+Gangulyauthor=A.+Kolykhalovauthor=J.+Wangauthor=J.+Muhammadbauthor=J.+M.+Pattiauthor=G.+Henson&title=Design%2C+synthesis+and+evaluation+of+a+novel+double+pro-drug%3A+INX-08189.+A+new+clinical+candidate+for+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16gR"><div class="casContent"><span class="casTitleNuber">16g</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of a novel double prodrug: INX-08189. A new clinical candidate for hepatitis C virus</span></div><div class="casAuthors">McGuigan, Christopher; Madela, Karolina; Aljarah, Mohamed; Gilles, Arnaud; Brancale, Andrea; Zonta, Nicola; Chamberlain, Stanley; Vernachio, John; Hutchins, Jeff; Hall, Andrea; Ames, Brenda; Gorovits, Elena; Ganguly, Babita; Kolykhalov, Alexander; Wang, Jin; Muhammad, Jerry; Patti, Joseph M.; Henson, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4850-4854</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We herein report a novel double prodrug approach applied to the anti-HCV agent 2'-β-C-Me guanosine.  A phosphoramidate ProTide motif and a 6-O-methoxy base prodrug moiety are combined to generate lipophilic prodrugs of the monophosphate of the guanine nucleoside.  Modification of the ester and amino acid moieties lead to a compd. INX-08189 that exhibits 10 nM potency in the HCV genotype 1b sub-genomic replicon, thus being 500 times more potent than the parent nucleoside.  The potency of the lead compd. INX-08189 was shown to be consistent with intracellular 2'-C-Me guanosine triphosphate levels in primary human hepatocytes.  The sepd. diastereomers of INX-08189 were shown to have similar activity in the replicon assay and were also shown to be similar substrates for enzyme processing.  INX-08189 has completed investigational new drug enabling studies and has been progressed into human clin. trials for the treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRKJa0VtEVwrVg90H21EOLACvtfcHk0lj6zDXbJH0Yiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlagurs%253D&md5=20d10847a850ddf681fe8accc4ed49db</span></div><a href="/servlet/linkout?suffix=cit16g&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.06.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.06.094%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DMadela%26aufirst%3DK.%26aulast%3DAljarah%26aufirst%3DM.%26aulast%3DGilles%26aufirst%3DA.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DZonta%26aufirst%3DN.%26aulast%3DChamberlain%26aufirst%3DS.%26aulast%3DVernachio%26aufirst%3DJ.%26aulast%3DHutchins%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DAmes%26aufirst%3DB.%26aulast%3DGorovits%26aufirst%3DE.%26aulast%3DGanguly%26aufirst%3DB.%26aulast%3DKolykhalov%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMuhammadb%26aufirst%3DJ.%26aulast%3DPatti%26aufirst%3DJ.%2BM.%26aulast%3DHenson%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520a%2520novel%2520double%2520pro-drug%253A%2520INX-08189.%2520A%2520new%2520clinical%2520candidate%2520for%2520hepatitis%2520C%2520virus%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4850%26epage%3D4854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kneteman, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pevear, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douglas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercer, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyrrell, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immermann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villano, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collett, M.</span><span> </span><span class="NLM_article-title">HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1002%2Fhep.22717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=19072827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=745-52&author=N.+M.+Knetemanauthor=A.+Y.+Howeauthor=T.+Gaoauthor=J.+Lewisauthor=D.+Pevearauthor=G.+Lundauthor=D.+Douglasauthor=D.+F.+Mercerauthor=D.+L.+Tyrrellauthor=F.+Immermannauthor=I.+Chaudharyauthor=J.+Spethauthor=S.+A.+Villanoauthor=J.+O%E2%80%99Connellauthor=M.+Collett&title=HCV796%3A+A+selective+nonstructural+protein+5B+polymerase+inhibitor+with+potent+anti-hepatitis+C+virus+activity+in+vitro%2C+in+mice+with+chimeric+human+livers%2C+and+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">HCCV796: a selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus</span></div><div class="casAuthors">Kneteman, Norman M.; Howe, Anita Y. M.; Gao, Tiejun; Lewis, Jamie; Pevear, Dan; Lund, Gary; Douglas, Donna; Mercer, David F.; Tyrrell, D. Lorne J.; Immermann, Frederick; Chaudhary, Inder; Speth, John; Villano, Stephen A.; O'Connell, John; Collett, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">745-752</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Anti-hepatitis C virus (HCV) drug development has been challenged by a lack of experience with inhibitors inclusive of in vitro, animal model, and clin. study.  This manuscript outlines activity and correlation across such a spectrum of models and into clin. trials with a novel selective nonstructural protein 5B (NS5B) polymerase inhibitor, HCV796.  Enzyme assays yielded median inhibitory concn. (IC50) values of 0.01 to 0.14 μM for genotype 1, with half maximal effective concn. (EC50s) of 5 nM and 9 nM against genotype 1a and 1b replicons.  In the chimeric mouse model, a 2.02 ± 0.55 log redn. in HCV titer was seen with monotherapy, whereas a suboptimal dose of 30 mg/kg three times per day in combination with interferon demonstrated a 2.44 log redn. (P = 0.001 vs. interferon alone) Clin. outcomes in combination with pegylated interferon and ribavirin have revealed additive efficacy in treatment naive patients.  Abnormal liver function test results were obsd. in 8% of HCV-796 patients treated for over 8 wk, resulting in suspension of further trial activity.  Conclusion: The RNA-dependent RNA polymerase inhibitor HCV796 demonstrated potent anti-HCV activity consistently through enzyme inhibition assays, subgenomic replicon, and chimeric mouse studies.  Strong correlations of outcomes in the mouse model were seen with subsequent clin. trials, including a plateau in dose-related antiviral activity and additive impact from combination therapy with interferon.  These outcomes demonstrate the utility of the range of in vitro and in vivo models now available for anti-HCV drug development and support the potential utility of polymerase inhibitors in future combination therapies for HCV treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7ZCtNeI0RLLVg90H21EOLACvtfcHk0ligQ7PcIDrQag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvFOnu70%253D&md5=0dcebc9c1e93051ad46eae43b352e7cf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fhep.22717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22717%26sid%3Dliteratum%253Aachs%26aulast%3DKneteman%26aufirst%3DN.%2BM.%26aulast%3DHowe%26aufirst%3DA.%2BY.%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DPevear%26aufirst%3DD.%26aulast%3DLund%26aufirst%3DG.%26aulast%3DDouglas%26aufirst%3DD.%26aulast%3DMercer%26aufirst%3DD.%2BF.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%26aulast%3DImmermann%26aufirst%3DF.%26aulast%3DChaudhary%26aufirst%3DI.%26aulast%3DSpeth%26aufirst%3DJ.%26aulast%3DVillano%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DJ.%26aulast%3DCollett%26aufirst%3DM.%26atitle%3DHCV796%253A%2520A%2520selective%2520nonstructural%2520protein%25205B%2520polymerase%2520inhibitor%2520with%2520potent%2520anti-hepatitis%2520C%2520virus%2520activity%2520in%2520vitro%252C%2520in%2520mice%2520with%2520chimeric%2520human%2520livers%252C%2520and%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D745%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatlock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludlum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drowns, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahavendran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skor, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlihy, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parge, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomiya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, C.</span><span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8014537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1255-1258&author=H.+Liauthor=J.+Tatlockauthor=A.+Lintonauthor=J.+Gonzalezauthor=T.+Jewellauthor=L.+Patelauthor=S.+Ludlumauthor=M.+Drownsauthor=S.+V.+Rahavendranauthor=H.+Skorauthor=R.+Hunterauthor=S.+T.+Shiauthor=K.+J.+Herlihyauthor=H.+Pargeauthor=M.+Hickeyauthor=X.+Yuauthor=F.+Chauauthor=J.+Nonomiyaauthor=C.+Lewis&title=Discovery+of+%28R%29-6-cyclopentyl-6-%282-%282%2C6-diethylpyridin-4-yl%29ethyl%29-3-%28%285%2C7-dimethyl-%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5Dpyrimidin-2-yl%29methyl%29-4-hydroxy-5%2C6-dihydropyran-2-one+%28PF-00868554%29+as+a+potent+and+orally+available+hepatitis+C+virus+polymerase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm8014537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014537%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DH.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DLinton%26aufirst%3DA.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DJewell%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DL.%26aulast%3DLudlum%26aufirst%3DS.%26aulast%3DDrowns%26aufirst%3DM.%26aulast%3DRahavendran%26aufirst%3DS.%2BV.%26aulast%3DSkor%26aufirst%3DH.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DS.%2BT.%26aulast%3DHerlihy%26aufirst%3DK.%2BJ.%26aulast%3DParge%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DChau%26aufirst%3DF.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DLewis%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520%2528R%2529-6-cyclopentyl-6-%25282-%25282%252C6-diethylpyridin-4-yl%2529ethyl%2529-3-%2528%25285%252C7-dimethyl-%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255Dpyrimidin-2-yl%2529methyl%2529-4-hydroxy-5%252C6-dihydropyran-2-one%2520%2528PF-00868554%2529%2520as%2520a%2520potent%2520and%2520orally%2520available%2520hepatitis%2520C%2520virus%2520polymerase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1255%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghalib, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrover, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgault, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span> </span><span class="NLM_article-title">Safety and antiviral activity of the non-nucleoside polymerase inhibitor VX-222 in treatment naïve genotype 1 HCV infected patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">S14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2010&pages=S14&author=M.+Rodriguez-Torresauthor=E.+Lawitzauthor=B.+Conwayauthor=K.+Kaitaauthor=A.+M.+Sheikhauthor=R.+Ghalibauthor=R.+Adroverauthor=C.+Cooperauthor=M.+Silvaauthor=M.+Rosarioauthor=B.+Bourgaultauthor=L.+Proulxauthor=J.+G.+McHutchison&title=Safety+and+antiviral+activity+of+the+non-nucleoside+polymerase+inhibitor+VX-222+in+treatment+na%C3%AFve+genotype+1+HCV+infected+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DConway%26aufirst%3DB.%26aulast%3DKaita%26aufirst%3DK.%26aulast%3DSheikh%26aufirst%3DA.%2BM.%26aulast%3DGhalib%26aufirst%3DR.%26aulast%3DAdrover%26aufirst%3DR.%26aulast%3DCooper%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DM.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DBourgault%26aufirst%3DB.%26aulast%3DProulx%26aufirst%3DL.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26atitle%3DSafety%2520and%2520antiviral%2520activity%2520of%2520the%2520non-nucleoside%2520polymerase%2520inhibitor%2520VX-222%2520in%2520treatment%2520na%25C3%25AFve%2520genotype%25201%2520HCV%2520infected%2520patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2010%26volume%3D52%26spage%3DS14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lawitz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigues-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMicco, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godofsky, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahimy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freddo, J.</span><span> </span><span class="NLM_article-title">Antiviral activity of ANA598, a potent non-nucleoside polymerase inhibitor, in chronic hepatitis C patients</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">S384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=S384&author=E.+Lawitzauthor=M.+Rodrigues-Torresauthor=T.+DeMiccoauthor=T.+Nguyenauthor=E.+Godofskyauthor=J.+Applemanauthor=M.+Rahimyauthor=C.+Crowleyauthor=J.+Freddo&title=Antiviral+activity+of+ANA598%2C+a+potent+non-nucleoside+polymerase+inhibitor%2C+in+chronic+hepatitis+C+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawitz%26aufirst%3DE.%26aulast%3DRodrigues-Torres%26aufirst%3DM.%26aulast%3DDeMicco%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DGodofsky%26aufirst%3DE.%26aulast%3DAppleman%26aufirst%3DJ.%26aulast%3DRahimy%26aufirst%3DM.%26aulast%3DCrowley%26aufirst%3DC.%26aulast%3DFreddo%26aufirst%3DJ.%26atitle%3DAntiviral%2520activity%2520of%2520ANA598%252C%2520a%2520potent%2520non-nucleoside%2520polymerase%2520inhibitor%252C%2520in%2520chronic%2520hepatitis%2520C%2520patients%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D50%26spage%3DS384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Larrey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trepo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moelleken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronowicki, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arastéh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarski, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourlière, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enríquez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdallah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boecher, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffgen, J.</span><span> </span><span class="NLM_article-title">BI 207127 is a potent HCV RNA polymerase inhibitor during 5 days monotherapy in patients with chronic hepatitis C</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1044A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=1044A&author=D.+Larreyauthor=Y.+Benhamouauthor=A.+W.+Lohseauthor=C.+Trepoauthor=C.+Moellekenauthor=J.-P.+Bronowickiauthor=M.+H.+Heimauthor=K.+Arast%C3%A9hauthor=J.-P.+Zarskiauthor=M.+Bourli%C3%A8reauthor=R.+Wiestauthor=J.+L.+Callejaauthor=J.+Enr%C3%ADquezauthor=A.+Erhardtauthor=H.+Wedemeyerauthor=T.+Gerlachauthor=T.+Bergauthor=J.+O.+Sternauthor=K.+Wuauthor=N.+Abdallahauthor=G.+Nehmizauthor=W.+O.+Boecherauthor=F.+M.+Bergerauthor=J.+Steffgen&title=BI+207127+is+a+potent+HCV+RNA+polymerase+inhibitor+during+5+days+monotherapy+in+patients+with+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLarrey%26aufirst%3DD.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DLohse%26aufirst%3DA.%2BW.%26aulast%3DTrepo%26aufirst%3DC.%26aulast%3DMoelleken%26aufirst%3DC.%26aulast%3DBronowicki%26aufirst%3DJ.-P.%26aulast%3DHeim%26aufirst%3DM.%2BH.%26aulast%3DArast%25C3%25A9h%26aufirst%3DK.%26aulast%3DZarski%26aufirst%3DJ.-P.%26aulast%3DBourli%25C3%25A8re%26aufirst%3DM.%26aulast%3DWiest%26aufirst%3DR.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DEnr%25C3%25ADquez%26aufirst%3DJ.%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DGerlach%26aufirst%3DT.%26aulast%3DBerg%26aufirst%3DT.%26aulast%3DStern%26aufirst%3DJ.%2BO.%26aulast%3DWu%26aufirst%3DK.%26aulast%3DAbdallah%26aufirst%3DN.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DBoecher%26aufirst%3DW.%2BO.%26aulast%3DBerger%26aufirst%3DF.%2BM.%26aulast%3DSteffgen%26aufirst%3DJ.%26atitle%3DBI%2520207127%2520is%2520a%2520potent%2520HCV%2520RNA%2520polymerase%2520inhibitor%2520during%25205%2520days%2520monotherapy%2520in%2520patients%2520with%2520chronic%2520hepatitis%2520C%26jtitle%3DHepatology%26date%3D2009%26volume%3D50%26spage%3D1044A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><a href="http://clinicaltrials.gov/ct2/show/NCT01193361?term=bms-791325&amp;rank=4" class="extLink">http://clinicaltrials.gov/ct2/show/NCT01193361?term=bms-791325&rank=4</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01193361%3Fterm%3Dbms-791325%26rank%3D4."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Anilkumar, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesburg, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selyutin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavalas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannigrahi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velazquez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feld, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcmonagle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, N.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, J. A.</span><span> </span><span class="NLM_article-title">Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5336</span><span class="NLM_x">–</span> <span class="NLM_lpage">5341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1016%2Fj.bmcl.2011.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=21840715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVKis7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=5336-5341&author=G.+N.+Anilkumarauthor=C.+A.+Lesburgauthor=O.+Selyutinauthor=S.+B.+Rosenblumauthor=Q.+Zengauthor=Y.+Jiangauthor=T.-Y.+Chanauthor=H.+Puauthor=H.+Vaccaroauthor=L.+Wangauthor=F.+Bennettauthor=K.+X.+Chenauthor=J.+Ducaauthor=S.+Gavalasauthor=Y.+Huangauthor=P.+Pintoauthor=M.+Sannigrahiauthor=F.+Velazquezauthor=S.+Venkatramanauthor=B.+Vibulbhanauthor=S.+Agrawalauthor=N.+Butkiewiczauthor=B.+Feldauthor=E.+Ferrariauthor=Z.+Heauthor=C.-K.+Jiangauthor=R.+E.+Palermoauthor=P.+Mcmonagleauthor=H.-C.+Huangauthor=N.-Y.+Shihauthor=G.+Njorogeauthor=J.+A.+Kozlowski&title=Novel+HCV+NS5B+polymerase+inhibitors%3A+Discovery+of+indole+2-carboxylic+acids+with+C3-heterocycles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">I. Novel HCV NS5B polymerase inhibitors: Discovery of indole 2-carboxylic acids with C3-heterocycles</span></div><div class="casAuthors">Anilkumar, Gopinadhan N.; Lesburg, Charles A.; Selyutin, Oleg; Rosenblum, Stuart B.; Zeng, Qingbei; Jiang, Yueheng; Chan, Tin-Yau; Pu, Haiyan; Vaccaro, Henry; Wang, Li; Bennett, Frank; Chen, Kevin X.; Duca, Jose; Gavalas, Stephen; Huang, Yuhua; Pinto, Patrick; Sannigrahi, Mousumi; Velazquez, Francisco; Venkatraman, Srikanth; Vibulbhan, Bancha; Agrawal, Sony; Butkiewicz, Nancy; Feld, Boris; Ferrari, Eric; He, Zhiqing; Jiang, Chuan-kui; Palermo, Robert E.; McMonagle, Patricia; Huang, H.-C.; Shih, Neng-Yang; Njoroge, George; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5336-5341</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">SAR development of indole-based palm site inhibitors of HCV NS5B polymerase exemplified by initial indole lead I (NS5B IC50 = 0.9 μM, replicon EC50 >100 μM) is described.  Structure-based drug design led to the incorporation of novel heterocyclic moieties at the indole C3-position which formed a bidentate interaction with the protein backbone.  SAR development resulted in lead carboxyindoles II (NS5B IC50 = 0.032 μM, replicon EC50 = 1.4 μM) and III (NS5B IC50 = 0.017 μM, replicon EC50 = 0.3 μM) with improved enzyme and replicon activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok2tI0MuqRU7Vg90H21EOLACvtfcHk0ljKohAmzBTAYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVKis7zO&md5=0934657e3c8029bab0a01ea2c5113832</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DAnilkumar%26aufirst%3DG.%2BN.%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DRosenblum%26aufirst%3DS.%2BB.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChan%26aufirst%3DT.-Y.%26aulast%3DPu%26aufirst%3DH.%26aulast%3DVaccaro%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DDuca%26aufirst%3DJ.%26aulast%3DGavalas%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DSannigrahi%26aufirst%3DM.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DFeld%26aufirst%3DB.%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DC.-K.%26aulast%3DPalermo%26aufirst%3DR.%2BE.%26aulast%3DMcmonagle%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DShih%26aufirst%3DN.-Y.%26aulast%3DNjoroge%26aufirst%3DG.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DNovel%2520HCV%2520NS5B%2520polymerase%2520inhibitors%253A%2520Discovery%2520of%2520indole%25202-carboxylic%2520acids%2520with%2520C3-heterocycles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D5336%26epage%3D5341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ferrari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS5B polymerase exhibits distinct nucleotide requirements for initiation and elongation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">33893</span><span class="NLM_x">–</span> <span class="NLM_lpage">33901</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=33893-33901&author=E.+Ferrariauthor=Z.+Heauthor=R.+E.+Palermoauthor=H.-C.+Huang&title=Hepatitis+C+virus+NS5B+polymerase+exhibits+distinct+nucleotide+requirements+for+initiation+and+elongation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DE.%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DPalermo%26aufirst%3DR.%2BE.%26aulast%3DHuang%26aufirst%3DH.-C.%26atitle%3DHepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520exhibits%2520distinct%2520nucleotide%2520requirements%2520for%2520initiation%2520and%2520elongation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D33893%26epage%3D33901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Körner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+K%C3%B6rnerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0ljKohAmzBTAYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DK%25C3%25B6rner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Chen, K. X.; Vibulbhan, B.; Yang, W.; Sannigrahi, M.; Velazquez, F.; Chan, T. Y.; Venkatraman, S.; Anilkumar, G. N.; Zeng, Q.; Bennet, F.; Jiang, Y.; Lesburg, C. A.; Duca, J.; Pinto, P.; Gavalas, S.; Huang, Y.; Wu, W.; Selyutin, O.; Agrawal, S.; Feld, B.; Huang, H. C.; Li, C.; Cheng, K. C.; Shih, N. Y.; Kozlowski, J. A.; Rosenblum, S. B.; Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Structure–activity relationship development and discovery of potent indole-based inhibitors of the hepatitis C virus NS5B polymerase</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">754</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span>.</span><div class="citationLinks">[<a href="/doi/10.1021/jm201258k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=754-765&author=K.+X.+Chen&author=B.+Vibulbhan&author=W.+Yang&author=M.+Sannigrahi&author=F.+Velazquez&author=T.+Y.+Chan&author=S.+Venkatraman&author=G.+N.+Anilkumar&author=Q.+Zeng&author=F.+Bennet&author=Y.+Jiang&author=C.+A.+Lesburg&author=J.+Duca&author=P.+Pinto&author=S.+Gavalas&author=Y.+Huang&author=W.+Wu&author=O.+Selyutin&author=S.+Agrawal&author=B.+Feld&author=H.+C.+Huang&author=C.+Li&author=K.+C.+Cheng&author=N.+Y.+Shih&author=J.+A.+Kozlowski&author=S.+B.+Rosenblum&author=F.+G.+Njoroge&title=Structure%E2%80%93activity+relationship+development+and+discovery+of+potent+indole-based+inhibitors+of+the+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm201258k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201258k%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520development%2520and%2520discovery%2520of%2520potent%2520indole-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D754%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaura, N.</span><span> </span><span class="NLM_article-title">Palladium(0)-catalyzed cross-coupling reaction of alkoxydiboron with haloarenes: A direct procedure for arylboronic esters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7508</span><span class="NLM_x">–</span> <span class="NLM_lpage">7510</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00128a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7508-7510&author=T.+Ishiyamaauthor=M.+Murataauthor=N.+Miyaura&title=Palladium%280%29-catalyzed+cross-coupling+reaction+of+alkoxydiboron+with+haloarenes%3A+A+direct+procedure+for+arylboronic+esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span></div><div class="casAuthors">Ishiyama, Tatsuo; Murata, Miki; Miyaura, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7508-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed cross-coupling reaction of the pinacol ester of diboronic acid I with haloarenes gave a direct procedure for arylboronic esters II (Ar = aryl) from aryl halides in a range of 60-98%.  The reaction was catalyzed by PdCl2(dppf) (3 mol %) at 80° in the presence of KOAc (3 equiv) in DMSO and available with various functional groups such as nitrile, cyanide, ester, and carbonyl groups.  The trans-ArPd(II)(OAc)(PPh3)2 intermediate was isolated and characterized to propose the catalytic cycle involving the transmetalation between the phenylpalladium(II) acetate complex and I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobehJBGFjDH7Vg90H21EOLACvtfcHk0linkGXoS6a5xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D&md5=2666902270ec1efc5742480b133f1255</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjo00128a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00128a024%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-catalyzed%2520cross-coupling%2520reaction%2520of%2520alkoxydiboron%2520with%2520haloarenes%253A%2520A%2520direct%2520procedure%2520for%2520arylboronic%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7508%26epage%3D7510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Jansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannhardt, G.</span><span> </span><span class="NLM_article-title">Variations of acidic functions at position 2 and substituents at positions 4, 5 and 6 of the indole moiety and their effect on NMDA-glycine site affinity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">865</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=855-865&author=M.+Jansenauthor=G.+Dannhardt&title=Variations+of+acidic+functions+at+position+2+and+substituents+at+positions+4%2C+5+and+6+of+the+indole+moiety+and+their+effect+on+NMDA-glycine+site+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJansen%26aufirst%3DM.%26aulast%3DDannhardt%26aufirst%3DG.%26atitle%3DVariations%2520of%2520acidic%2520functions%2520at%2520position%25202%2520and%2520substituents%2520at%2520positions%25204%252C%25205%2520and%25206%2520of%2520the%2520indole%2520moiety%2520and%2520their%2520effect%2520on%2520NMDA-glycine%2520site%2520affinity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D855%26epage%3D865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hughes, D. L.</span><span> </span><span class="NLM_article-title">The Mitsunobu Reaction</span> <span class="citation_source-journal">Org. Reactions</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1002%2F0471264180.or042.02" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaK2cXkvVajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=335&author=D.+L.+Hughes&title=The+Mitsunobu+Reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">The Mitsunobu reaction</span></div><div class="casAuthors">Hughes, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Reactions (New York)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">335-656</span>CODEN:
                <span class="NLM_cas:coden">ORREAW</span>;
        ISSN:<span class="NLM_cas:issn">0078-6179</span>.
    </div><div class="casAbstract">A review with 887 refs., mainly covering the di-Et azodicarboxylate/triphenylphosphine redox system with emphasis on the literature between 1981 and 1988.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKenjnWCm_GLVg90H21EOLACvtfcHk0linkGXoS6a5xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvVajtb4%253D&md5=b863281e19bd0a84a975ba0824dbf42a</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1002%2F0471264180.or042.02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0471264180.or042.02%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Mitsunobu%2520Reaction%26jtitle%3DOrg.%2520Reactions%26date%3D1992%26volume%3D42%26spage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mitsunobu, O.</span><span> </span><span class="NLM_article-title">The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.1055%2Fs-1981-29317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADyaL3MXht1Sgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1981&pages=1-28&author=O.+Mitsunobu&title=The+use+of+diethyl+azodicarboxylate+and+triphenylphosphine+in+synthesis+and+transformation+of+natural+products"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products</span></div><div class="casAuthors">Mitsunobu, Oyo</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-28</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    </div><div class="casAbstract">A review with 100 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0srI3PCMfHrVg90H21EOLACvtfcHk0liraxGoYt_h3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXht1Sgsrk%253D&md5=01d75d554d76b7c094691a7465648db2</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1055%2Fs-1981-29317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1981-29317%26sid%3Dliteratum%253Aachs%26aulast%3DMitsunobu%26aufirst%3DO.%26atitle%3DThe%2520use%2520of%2520diethyl%2520azodicarboxylate%2520and%2520triphenylphosphine%2520in%2520synthesis%2520and%2520transformation%2520of%2520natural%2520products%26jtitle%3DSynthesis%26date%3D1981%26spage%3D1%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Powers, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piper, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayorga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzola, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonn, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. P. C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span> </span><span class="NLM_article-title">SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1034</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050859x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD28XksV2ltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1034-1046&author=J.+P.+Powersauthor=D.+E.+Piperauthor=Y.+Liauthor=V.+Mayorgaauthor=J.+Anzolaauthor=J.+M.+Chenauthor=J.+C.+Jaenauthor=G.+Leeauthor=J.+Liuauthor=M.+G.+Petersonauthor=G.+R.+Tonnauthor=Q.+Yeauthor=M.+P.+C+Walkerauthor=Z.+Wang&title=SAR+and+mode+of+action+of+novel+non-nucleoside+inhibitors+of+hepatitis+C+NS5b+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">SAR and Mode of Action of Novel Non-Nucleoside Inhibitors of Hepatitis C NS5b RNA Polymerase</span></div><div class="casAuthors">Powers, Jay P.; Piper, Derek E.; Li, Yang; Mayorga, Veronica; Anzola, John; Chen, James M.; Jaen, Juan C.; Lee, Gary; Liu, Jinqian; Peterson, M. Greg; Tonn, George R.; Ye, Qiuping; Walker, Nigel P. C.; Wang, Zhulun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1034-1046</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel non-nucleoside inhibitors of the HCV RNA polymerase (NS5b) with sub-micromolar biochem. potency have been identified which are selective for the inhibition of HCV NS5b over other polymerases.  The structures of the complexes formed between several of these inhibitors and HCV NS5b were detd. by x-ray crystallog., and the inhibitors were found to bind in an allosteric binding site sep. from the active site.  Structure-activity relationships and structural studies have identified the mechanism of action for compds. in this series, several of which possess drug-like properties, as unique, reversible, covalent inhibitors of HCV NS5b.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQXM5YE5fcYLVg90H21EOLACvtfcHk0liraxGoYt_h3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksV2ltA%253D%253D&md5=722ac0edb5dabb720e30475ef5925d5f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm050859x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050859x%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DJ.%2BP.%26aulast%3DPiper%26aufirst%3DD.%2BE.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMayorga%26aufirst%3DV.%26aulast%3DAnzola%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DM.%2BG.%26aulast%3DTonn%26aufirst%3DG.%2BR.%26aulast%3DYe%26aufirst%3DQ.%26aulast%3DWalker%26aufirst%3DM.%2BP.%2BC%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DSAR%2520and%2520mode%2520of%2520action%2520of%2520novel%2520non-nucleoside%2520inhibitors%2520of%2520hepatitis%2520C%2520NS5b%2520RNA%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1034%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> was generated using the program PyMOL (The PyMOL Molecular Graphics System, Version 1.2r1, Schrödinger, LLC.).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">X-Ray crystal structure data of HCV NS5B in complex with <b>47</b> have been deposited in the Protein Data Bank with access code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYQ">3TYQ</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Potashman, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Covalent Modifiers: An Orthogonal Approach to Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8008597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33a&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1231-1246&author=M.+H.+Potashmanauthor=M.+E.+Duggan&title=Covalent+Modifiers%3A+An+Orthogonal+Approach+to+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33aR"><div class="casContent"><span class="casTitleNuber">33a</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Modifiers: An Orthogonal Approach to Drug Design</span></div><div class="casAuthors">Potashman, Michele H.; Duggan, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1231-1246</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  In this article we review a variety of examples in which therapeutic targets are covalently bound by small-mol. drugs or by compds. in advanced clin. development.  The covalent interactions can be either reversible or irreversible, depending on the reaction partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6BO6g9_F717Vg90H21EOLACvtfcHk0liraxGoYt_h3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sltbw%253D&md5=f8380d5a1cdd8638ad2a1e0405d25267</span></div><a href="/servlet/linkout?suffix=cit33a&amp;dbid=16384&amp;doi=10.1021%2Fjm8008597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8008597%26sid%3Dliteratum%253Aachs%26aulast%3DPotashman%26aufirst%3DM.%2BH.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DCovalent%2520Modifiers%253A%2520An%2520Orthogonal%2520Approach%2520to%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1231%26epage%3D1246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit33b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Powers, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asgian, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekici, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K. E.</span><span> </span><span class="NLM_article-title">Irreversible inhibitors of serine, cysteine, and threonine proteases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">4639</span><span class="NLM_x">–</span> <span class="NLM_lpage">4750</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr010182v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33b&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFSnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2002&pages=4639-4750&author=J.+C.+Powersauthor=J.+L.+Asgianauthor=O.+D.+Ekiciauthor=K.+E.+James&title=Irreversible+inhibitors+of+serine%2C+cysteine%2C+and+threonine+proteases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33bR"><div class="casContent"><span class="casTitleNuber">33b</span><div class="casTitle"><span class="NLM_cas:atitle">Irreversible inhibitors of serine, cysteine, and threonine proteases</span></div><div class="casAuthors">Powers, James C.; Asgian, Juliana L.; Ekici, Oezlem Dogan; James, Karen Ellis</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4639-4750</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Topics discussed include alkylating, acylating, phosphonylating, and sulfonylating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorivaxGhmhirVg90H21EOLACvtfcHk0liraxGoYt_h3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFSnsr4%253D&md5=eb21ff0297b87537a7d459c92f13c75d</span></div><a href="/servlet/linkout?suffix=cit33b&amp;dbid=16384&amp;doi=10.1021%2Fcr010182v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr010182v%26sid%3Dliteratum%253Aachs%26aulast%3DPowers%26aufirst%3DJ.%2BC.%26aulast%3DAsgian%26aufirst%3DJ.%2BL.%26aulast%3DEkici%26aufirst%3DO.%2BD.%26aulast%3DJames%26aufirst%3DK.%2BE.%26atitle%3DIrreversible%2520inhibitors%2520of%2520serine%252C%2520cysteine%252C%2520and%2520threonine%2520proteases%26jtitle%3DChem.%2520Rev.%26date%3D2002%26volume%3D102%26spage%3D4639%26epage%3D4750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Huth, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black-Schaefer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladror, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartley, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Toxicological evaluation of thiol-reactive compounds identified using a La assay to detect reactive molecules by nuclear magnetic resonance</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1752</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx700319t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2007&pages=1752-1759&author=J.+R.+Huthauthor=D.+Songauthor=R.+R.+Mendozaauthor=C.+L.+Black-Schaeferauthor=J.+C.+Mackauthor=S.+A.+Dorwinauthor=U.+S.+Ladrorauthor=J.+M.+Severinauthor=K.+A.+Walterauthor=D.+M.+Bartleyauthor=P.+J.+Hajduk&title=Toxicological+evaluation+of+thiol-reactive+compounds+identified+using+a+La+assay+to+detect+reactive+molecules+by+nuclear+magnetic+resonance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Ftx700319t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx700319t%26sid%3Dliteratum%253Aachs%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DMendoza%26aufirst%3DR.%2BR.%26aulast%3DBlack-Schaefer%26aufirst%3DC.%2BL.%26aulast%3DMack%26aufirst%3DJ.%2BC.%26aulast%3DDorwin%26aufirst%3DS.%2BA.%26aulast%3DLadror%26aufirst%3DU.%2BS.%26aulast%3DSeverin%26aufirst%3DJ.%2BM.%26aulast%3DWalter%26aufirst%3DK.%2BA.%26aulast%3DBartley%26aufirst%3DD.%2BM.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DToxicological%2520evaluation%2520of%2520thiol-reactive%2520compounds%2520identified%2520using%2520a%2520La%2520assay%2520to%2520detect%2520reactive%2520molecules%2520by%2520nuclear%2520magnetic%2520resonance%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2007%26volume%3D20%26spage%3D1752%26epage%3D1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Boelsterli, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leow, K. Y.</span><span> </span><span class="NLM_article-title">Bioactivation and hepatotoxicity of nitroaromatic drugs</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm201322r&amp;key=10.2174%2F138920006778520606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm201322r&amp;key=17073576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm201322r&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWgt7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=715-727&author=U.+A.+Boelsterliauthor=H.+K.+Hoauthor=S.+Zhouauthor=K.+Y.+Leow&title=Bioactivation+and+hepatotoxicity+of+nitroaromatic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactivation and hepatotoxicity of nitroaromatic drugs</span></div><div class="casAuthors">Boelsterli, Urs A.; Ho, Han Kiat; Zhou, Shufeng; Leow, Koon Yeow</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">715-727</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Certain drugs contg. a nitroarom. moiety (e.g., tolcapone, nimesulide, nilutamide, flutamide, nitrofurantoin) have been assocd. with organ-selective toxicity including rare cases of idiosyncratic liver injury.  What they have in common is the potential for multistep nitroreductive bioactivation (6-electron transfer) that produces the potentially hazardous nitroanion radical, nitroso intermediate, and N-hydroxy deriv.  These intermediates have been assocd. with increased oxidant stress and targeting of nucleophilic residues on proteins and nucleic acids.  However, other mechanisms including the formation of oxidative metabolites and mitochondrial liability, as well as inherent toxicokinetic properties, also det. the drugs' overall potency.  Therefore, structural modification not only of the nitro moiety but also of ring substituents can greatly reduced toxicity.  Novel concepts have revealed that, besides the classical microsomal nitroreductases, cytosolic and mitochondrial enzymes including nitric oxide synthase can also bioactivate certain nitroarenes (nilutamide).  Furthermore, animal models of silent mitochondrial dysfunction have demonstrated that a mitochondrial oxidant stress posed by certain nitroarom. drugs (nimesulide) can produce significant mitochondrial injury if superimposed on a genetic mitochondrial abnormality.  Finally, there may be mechanisms for all nitroarom. drugs that do not involve bioactivation of the nitro group, e.g., AHR interactions with flutamide.  Taken together, the focus of research on the hepatic toxicity of nitroarene-contg. drugs has shifted over the past years from the identification of the reactive intermediates generated during the bioreductive pathway to the underlying biomechanisms of liver injury.  Most likely one of the next paradigm shifts will include the identification of determinants of susceptibility to nitroarom. drug-induced hepatotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbZw5d9MZTE7Vg90H21EOLACvtfcHk0lj-Dx1KCbdVUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWgt7rF&md5=21e155ba17d1ad097e7652a5d22728b3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2174%2F138920006778520606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920006778520606%26sid%3Dliteratum%253Aachs%26aulast%3DBoelsterli%26aufirst%3DU.%2BA.%26aulast%3DHo%26aufirst%3DH.%2BK.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DLeow%26aufirst%3DK.%2BY.%26atitle%3DBioactivation%2520and%2520hepatotoxicity%2520of%2520nitroaromatic%2520drugs%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2006%26volume%3D7%26spage%3D715%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TYQ','PDB','3TYQ'); return false;">PDB: 3TYQ</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201322r&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm201322r%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201322r" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a58b11bb132a9","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
